{"id": "135_271_1_187", "text": "Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif.", "text_with_entity_marker": "Regulation of antiviral responses by a direct and specific interaction between [E1]TRAF3[/E1] and [E2]Cardif[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRAF3", "entity_1_idx": [[79, 84]], "entity_1_idx_in_text_with_entity_marker": [83, 88], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cardif", "entity_2_idx": [[89, 95]], "entity_2_idx_in_text_with_entity_marker": [102, 108], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "135_272_7_188", "text": "Thus, our findings suggest that the direct and specific interaction between the TRAF domain of TRAF3 and the TIM of Cardif is required for optimal Cardif-mediated antiviral responses.", "text_with_entity_marker": "Thus, our findings suggest that the direct and specific interaction between the TRAF domain of [E1]TRAF3[/E1] and the TIM of [E2]Cardif[/E2] is required for optimal Cardif-mediated antiviral responses.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TRAF3", "entity_1_idx": [[95, 100]], "entity_1_idx_in_text_with_entity_marker": [99, 104], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Cardif", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "152_306_8_206", "text": "These findings suggest that tight Cdh1 binding combined with the inaccessibility of ubiquitinatable lysines contributes to pseudosubstrate inhibition of APC(Cdh1).", "text_with_entity_marker": "These findings suggest that tight [E1]Cdh1[/E1] binding combined with the inaccessibility of ubiquitinatable lysines contributes to pseudosubstrate inhibition of [E2]APC[/E2](Cdh1).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdh1", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "APC", "entity_2_idx": [[153, 156]], "entity_2_idx_in_text_with_entity_marker": [166, 169], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "264_530_4_353", "text": "By screening a 16-day mouse embryo expression library, we identified two putative ligands of the WW domain of Yes kinase-associated protein which we named WW domain-binding proteins 1 and 2", "text_with_entity_marker": "By screening a 16-day mouse embryo expression library, we identified two putative ligands of the WW domain of [E1]Yes kinase-associated protein[/E1] which we named [E2]WW domain-binding proteins 1 and 2[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Yes kinase-associated protein", "entity_1_idx": [[110, 139]], "entity_1_idx_in_text_with_entity_marker": [114, 143], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "WW domain-binding proteins 1 and 2", "entity_2_idx": [[155, 189]], "entity_2_idx_in_text_with_entity_marker": [168, 202], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "338_677_1_448", "text": "Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.", "text_with_entity_marker": "[E1]Laforin[/E1], the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein [E2]phosphatase-1[/E2] that enhances glycogen accumulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Laforin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "phosphatase-1", "entity_2_idx": [[119, 132]], "entity_2_idx_in_text_with_entity_marker": [132, 145], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "180_361_1_232", "text": "Dimeric Ube2g2 simultaneously engages donor and acceptor ubiquitins to form Lys48-linked ubiquitin chains.", "text_with_entity_marker": "Dimeric [E1]Ube2g2[/E1] simultaneously engages donor and acceptor [E2]ubiquitins[/E2] to form Lys48-linked ubiquitin chains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Ube2g2", "entity_1_idx": [[8, 14]], "entity_1_idx_in_text_with_entity_marker": [12, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ubiquitins", "entity_2_idx": [[57, 67]], "entity_2_idx_in_text_with_entity_marker": [70, 80], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "70_142_6_94", "text": "Experiments using cells over-expressing wild-type HFE confirm the existence of beta2microglobulin(beta2m)/HFE and HFE/transferrin receptor 1 (TfR1) interactions, as well as the capacity of HFE to reduce transferrin-mediated iron uptake", "text_with_entity_marker": "Experiments using cells over-expressing wild-type HFE confirm the existence of [E1]beta2microglobulin(beta2m)[/E1][E2]HFE[/E2] confirm the existence of beta2microglobulin(beta2m)/HFE and HFE/transferrin receptor 1 (TfR1) interactions, as well as the capacity of HFE to reduce transferrin-mediated iron uptake", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta2microglobulin(beta2m)", "entity_1_idx": [[79, 105]], "entity_1_idx_in_text_with_entity_marker": [83, 109], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "HFE", "entity_2_idx": [[50, 53]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "70_142_6_95", "text": "Experiments using cells over-expressing wild-type HFE confirm the existence of beta2microglobulin(beta2m)/HFE and HFE/transferrin receptor 1 (TfR1) interactions, as well as the capacity of HFE to reduce transferrin-mediated iron uptake", "text_with_entity_marker": "Experiments using cells over-expressing wild-type [E1]HFE[/E1] confirm the existence of beta2microglobulin(beta2m)/HFE and HFE/[E2]transferrin receptor 1 (TfR1)[/E2] interactions, as well as the capacity of HFE to reduce transferrin-mediated iron uptake", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HFE", "entity_1_idx": [[50, 53]], "entity_1_idx_in_text_with_entity_marker": [54, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "transferrin receptor 1 (TfR1)", "entity_2_idx": [[118, 147]], "entity_2_idx_in_text_with_entity_marker": [131, 160], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "52_106_4_78", "text": "Among them, Thr341 in Noxo1 is directly phosphorylated by PKC in  vitro, and alanine substitution for this residue reduces not only PMA-induced Noxo1 phosphorylation but also PMA-dependent enhancement of Nox1-catalyzed superoxide production", "text_with_entity_marker": "Among them, Thr341 in Noxo1 is directly phosphorylated by [E1]PKC[/E1][E2]Noxo1[/E2] is directly phosphorylated by PKC in  vitro, and alanine substitution for this residue reduces not only PMA-induced Noxo1 phosphorylation but also PMA-dependent enhancement of Nox1-catalyzed superoxide production", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Noxo1", "entity_2_idx": [[22, 27]], "entity_2_idx_in_text_with_entity_marker": [74, 79], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "241_483_1_312", "text": "MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2.", "text_with_entity_marker": "[E1]MKK6[/E1] binds and regulates expression of Parkinson's disease-related protein [E2]LRRK2[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MKK6", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "LRRK2", "entity_2_idx": [[75, 80]], "entity_2_idx_in_text_with_entity_marker": [88, 93], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "241_484_2_313", "text": "Here, we show that LRRK2 binds to MAPK kinases (MKK) 3, 6, and 7, and that LRRK2 is able to phosphorylate MKK3, 6 and 7", "text_with_entity_marker": "Here, we show that [E1]LRRK2[/E1] binds to MAPK kinases (MKK) 3, 6, and 7, and that LRRK2 is able to phosphorylate [E2]MKK3[/E2], 6 and 7", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "LRRK2", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MKK3", "entity_2_idx": [[106, 110]], "entity_2_idx_in_text_with_entity_marker": [119, 123], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "217_436_2_285", "text": "We have shown previously that SOS3 interacts with and activates the SOS2 protein kinase", "text_with_entity_marker": "We have shown previously that [E1]SOS3[/E1] interacts with and activates the [E2]SOS2[/E2] protein kinase", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SOS3", "entity_1_idx": [[30, 34]], "entity_1_idx_in_text_with_entity_marker": [34, 38], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SOS2", "entity_2_idx": [[68, 72]], "entity_2_idx_in_text_with_entity_marker": [81, 85], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "164_330_4_212", "text": "Furthermore, we report and validate a new interaction between PP5 and an Hsp90 adaptor protein, stress-induced phosphoprotein 1 (STIP1; HOP)", "text_with_entity_marker": "Furthermore, we report and validate a new interaction between [E1]PP5[/E1] and an Hsp90 adaptor protein, [E2]stress-induced phosphoprotein 1 (STIP1[/E2]; HOP)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PP5", "entity_1_idx": [[62, 65]], "entity_1_idx_in_text_with_entity_marker": [66, 69], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "stress-induced phosphoprotein 1 (STIP1", "entity_2_idx": [[96, 134]], "entity_2_idx_in_text_with_entity_marker": [109, 147], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "33_68_8_59", "text": "In a search for proteins interacting with Wrch1, PAK1 and NCKbeta were identified as binding partners", "text_with_entity_marker": "In a search for proteins interacting with [E1]Wrch1[/E1], [E2]PAK1[/E2] and NCKbeta were identified as binding partners", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Wrch1", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PAK1", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "33_68_8_60", "text": "In a search for proteins interacting with Wrch1, PAK1 and NCKbeta were identified as binding partners", "text_with_entity_marker": "In a search for proteins interacting with [E1]Wrch1[/E1], PAK1 and [E2]NCKbeta[/E2] were identified as binding partners", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Wrch1", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "NCKbeta", "entity_2_idx": [[58, 65]], "entity_2_idx_in_text_with_entity_marker": [71, 78], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "198_397_1_261", "text": "Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer.", "text_with_entity_marker": "Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase [E1]Fer[/E1][E2]cadherin[/E2] with beta-catenin requires the non-receptor tyrosine-kinase Fer.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fer", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [111, 119], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "198_397_1_262", "text": "Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase Fer.", "text_with_entity_marker": "Continuous association of cadherin with beta-catenin requires the non-receptor tyrosine-kinase [E1]Fer[/E1][E2]beta-catenin[/E2] requires the non-receptor tyrosine-kinase Fer.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fer", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[40, 52]], "entity_2_idx_in_text_with_entity_marker": [111, 123], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "198_398_3_263", "text": "We now show that the phosphorylation of beta-catenin is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase PTP1B", "text_with_entity_marker": "We now show that the phosphorylation of beta-catenin is regulated by the combined activities of the tyrosine kinase [E1]Fer[/E1][E2]beta-catenin[/E2] is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase PTP1B", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fer", "entity_1_idx": [[116, 119]], "entity_1_idx_in_text_with_entity_marker": [120, 123], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[40, 52]], "entity_2_idx_in_text_with_entity_marker": [132, 144], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "198_398_3_264", "text": "We now show that the phosphorylation of beta-catenin is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase PTP1B", "text_with_entity_marker": "We now show that the phosphorylation of beta-catenin is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase [E1]PTP1B[/E1][E2]beta-catenin[/E2] is regulated by the combined activities of the tyrosine kinase Fer and the tyrosine phosphatase PTP1B", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PTP1B", "entity_1_idx": [[149, 154]], "entity_1_idx_in_text_with_entity_marker": [153, 158], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[40, 52]], "entity_2_idx_in_text_with_entity_marker": [167, 179], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "251_504_5_332", "text": "Bradykinin also enhanced the association of CaMKII with eNOS", "text_with_entity_marker": "[E1]Bradykinin[/E1] also enhanced the association of [E2]CaMKII[/E2] with eNOS", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bradykinin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CaMKII", "entity_2_idx": [[44, 50]], "entity_2_idx_in_text_with_entity_marker": [57, 63], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "251_504_5_333", "text": "Bradykinin also enhanced the association of CaMKII with eNOS", "text_with_entity_marker": "[E1]Bradykinin[/E1] also enhanced the association of CaMKII with [E2]eNOS[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bradykinin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "eNOS", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "215_431_1_282", "text": "ARPC1/Arc40 mediates the interaction of the actin-related protein 2 and 3 complex with Wiskott-Aldrich syndrome protein family activators.", "text_with_entity_marker": "[E1]ARPC1/Arc40[/E1] mediates the interaction of the [E2]actin-related protein 2 and 3 complex[/E2] with Wiskott-Aldrich syndrome protein family activators.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ARPC1/Arc40", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "actin-related protein 2 and 3 complex", "entity_2_idx": [[44, 81]], "entity_2_idx_in_text_with_entity_marker": [57, 94], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "212_425_1_280", "text": "Phosphorylation of the Arabidopsis AtrbohF NADPH oxidase by OST1 protein kinase.", "text_with_entity_marker": "Phosphorylation of the Arabidopsis AtrbohF NADPH oxidase by [E1]OST1[/E1][E2]AtrbohF NADPH oxidase[/E2] by OST1 protein kinase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OST1", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtrbohF NADPH oxidase", "entity_2_idx": [[35, 56]], "entity_2_idx_in_text_with_entity_marker": [77, 98], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "212_426_3_281", "text": "Here, we report that OST1 phosphorylates Ser13 and Ser174 on AtrbohF", "text_with_entity_marker": "Here, we report that [E1]OST1[/E1] phosphorylates Ser13 and Ser174 on [E2]AtrbohF[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OST1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtrbohF", "entity_2_idx": [[61, 68]], "entity_2_idx_in_text_with_entity_marker": [74, 81], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "306_613_1_419", "text": "Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain.", "text_with_entity_marker": "[E1]Menin[/E1], a tumor suppressor, associates with nonmuscle [E2]myosin II-A[/E2] heavy chain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Menin", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "myosin II-A", "entity_2_idx": [[53, 64]], "entity_2_idx_in_text_with_entity_marker": [66, 77], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "324_650_8_438", "text": "Moreover, our analysis indicates that beta-TrCP-dependent degradation of Wee1A is important for the normal onset of M-phase in vivo", "text_with_entity_marker": "Moreover, our analysis indicates that [E1]beta-TrCP[/E1]-dependent degradation of [E2]Wee1A[/E2] is important for the normal onset of M-phase in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "beta-TrCP", "entity_1_idx": [[38, 47]], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Wee1A", "entity_2_idx": [[73, 78]], "entity_2_idx_in_text_with_entity_marker": [86, 91], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "346_693_1_458", "text": "Peculiar protein-protein interactions of the novel endoplasmic reticulum membrane protein Rcr1 and ubiquitin ligase Rsp5.", "text_with_entity_marker": "Peculiar protein-protein interactions of the novel endoplasmic reticulum membrane protein [E1]Rcr1[/E1] and ubiquitin ligase [E2]Rsp5[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rcr1", "entity_1_idx": [[90, 94]], "entity_1_idx_in_text_with_entity_marker": [94, 98], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rsp5", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "346_694_2_459", "text": "By both co-immunoprecipitation and yeast two-hybrid experiments, specific interaction between Rcr1 and the ubiquitin ligase Rsp5 was found", "text_with_entity_marker": "By both co-immunoprecipitation and yeast two-hybrid experiments, specific interaction between [E1]Rcr1[/E1] and the ubiquitin ligase [E2]Rsp5[/E2] was found", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Rcr1", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rsp5", "entity_2_idx": [[124, 128]], "entity_2_idx_in_text_with_entity_marker": [137, 141], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "169_339_1_219", "text": "SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}.", "text_with_entity_marker": "[E1]SIRT1[/E1] functionally interacts with the metabolic regulator and transcriptional coactivator [E2]PGC-1{alpha}[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIRT1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PGC-1{alpha}", "entity_2_idx": [[90, 102]], "entity_2_idx_in_text_with_entity_marker": [103, 115], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "169_340_10_220", "text": "Finally we demonstrate that SIRT1 catalyzes PGC-1alpha deacetylation both in vitro and in vivo", "text_with_entity_marker": "Finally we demonstrate that [E1]SIRT1[/E1] catalyzes [E2]PGC-1alpha[/E2] deacetylation both in vitro and in vivo", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIRT1", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PGC-1alpha", "entity_2_idx": [[44, 54]], "entity_2_idx_in_text_with_entity_marker": [57, 67], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "291_584_4_402", "text": "We demonstrate that IRS-1 forms a specific complex with the cytoplasmic domain of the insulin receptor when both are expressed as hybrid proteins in yeast cells", "text_with_entity_marker": "We demonstrate that [E1]IRS-1[/E1] forms a specific complex with the cytoplasmic domain of the [E2]insulin receptor[/E2] when both are expressed as hybrid proteins in yeast cells", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[86, 102]], "entity_2_idx_in_text_with_entity_marker": [99, 115], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "248_497_1_329", "text": "Participation of Tom1L1 in EGF-stimulated endocytosis of EGF receptor.", "text_with_entity_marker": "Participation of [E1]Tom1L1[/E1] in EGF-stimulated endocytosis of [E2]EGF receptor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Tom1L1", "entity_1_idx": [[17, 23]], "entity_1_idx_in_text_with_entity_marker": [21, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "EGF receptor", "entity_2_idx": [[57, 69]], "entity_2_idx_in_text_with_entity_marker": [70, 82], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "62_125_1_88", "text": "Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family.", "text_with_entity_marker": "Involvement of [E1]maternal embryonic leucine zipper kinase (MELK)[/E1] in mammary carcinogenesis through interaction with [E2]Bcl-G[/E2], a pro-apoptotic member of the Bcl-2 family.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "maternal embryonic leucine zipper kinase (MELK)", "entity_1_idx": [[15, 62]], "entity_1_idx_in_text_with_entity_marker": [19, 66], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bcl-G", "entity_2_idx": [[114, 119]], "entity_2_idx_in_text_with_entity_marker": [127, 132], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "62_126_11_89", "text": "Immunocomplex kinase assay showed that Bcl-GL was specifically phosphorylated by MELK in vitro", "text_with_entity_marker": "Immunocomplex kinase assay showed that Bcl-GL was specifically phosphorylated by [E1]MELK[/E1][E2]Bcl-GL[/E2] was specifically phosphorylated by MELK in vitro", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MELK", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Bcl-GL", "entity_2_idx": [[39, 45]], "entity_2_idx_in_text_with_entity_marker": [98, 104], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "165_331_1_213", "text": "Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP.", "text_with_entity_marker": "[E1]Erk/Src[/E1] phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate [E2]N-WASP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Erk/Src", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "N-WASP", "entity_2_idx": [[116, 122]], "entity_2_idx_in_text_with_entity_marker": [129, 135], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "192_385_1_251", "text": "BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.", "text_with_entity_marker": "BAP-135, a target for [E1]Bruton's tyrosine kinase[/E1][E2]BAP-135[/E2], a target for Bruton's tyrosine kinase in response to B cell receptor engagement.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bruton's tyrosine kinase", "entity_1_idx": [[22, 46]], "entity_1_idx_in_text_with_entity_marker": [26, 50], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "BAP-135", "entity_2_idx": [[0, 7]], "entity_2_idx_in_text_with_entity_marker": [59, 66], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "192_386_2_252", "text": "We now describe a protein, BAP-135, that is associated with Btk in B cells and is a substrate for phosphorylation by Btk", "text_with_entity_marker": "We now describe a protein, [E1]BAP-135[/E1], that is associated with [E2]Btk[/E2] in B cells and is a substrate for phosphorylation by Btk", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BAP-135", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Btk", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1545_AIMed.d182.s1545.p0", "text": "Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.", "text_with_entity_marker": "Structure of the [E1]MDM2[/E1] oncoprotein bound to the [E2]p53[/E2] tumor suppressor transactivation domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1546_AIMed.d182.s1546.p0", "text": "The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.", "text_with_entity_marker": "The [E1]MDM2[/E1] oncoprotein is a cellular inhibitor of the [E2]p53[/E2] tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1546_AIMed.d182.s1546.p1", "text": "The MDM2 oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of p53 and downregulate its ability to activate transcription.", "text_with_entity_marker": "The [E1]MDM2[/E1] oncoprotein is a cellular inhibitor of the p53 tumor suppressor in that it can bind the transactivation domain of [E2]p53[/E2] and downregulate its ability to activate transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1548_AIMed.d182.s1548.p0", "text": "The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.", "text_with_entity_marker": "The crystal structure of the 109-residue amino-terminal domain of [E1]MDM2[/E1] bound to a 15-residue transactivation domain peptide of [E2]p53[/E2] revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[66, 70]], "entity_1_idx_in_text_with_entity_marker": [70, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1548_AIMed.d182.s1548.p5", "text": "The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that MDM2 has a deep hydrophobic cleft on which the p53 peptide binds as an amphipathic alpha helix.", "text_with_entity_marker": "The crystal structure of the 109-residue amino-terminal domain of MDM2 bound to a 15-residue transactivation domain peptide of p53 revealed that [E1]MDM2[/E1] has a deep hydrophobic cleft on which the [E2]p53[/E2] peptide binds as an amphipathic alpha helix.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[145, 149]], "entity_1_idx_in_text_with_entity_marker": [149, 153], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[192, 195]], "entity_2_idx_in_text_with_entity_marker": [205, 208], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1549_AIMed.d182.s1549.p5", "text": "The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of p53 amino acids-Phe19, Trp23, and Leu26-which insert deep into the MDM2 cleft.", "text_with_entity_marker": "The interface relies on the steric complementarity between the MDM2 cleft and the hydrophobic face of the p53 alpha helix and, in particular, on a triad of [E1]p53[/E1] amino acids-Phe19, Trp23, and Leu26-which insert deep into the [E2]MDM2[/E2] cleft.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p53", "entity_1_idx": [[156, 159]], "entity_1_idx_in_text_with_entity_marker": [160, 163], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MDM2", "entity_2_idx": [[223, 227]], "entity_2_idx_in_text_with_entity_marker": [236, 240], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1550_AIMed.d182.s1550.p2", "text": "These same p53 residues are also involved in transactivation, supporting the hypothesis that MDM2 inactivates p53 by concealing its transactivation domain.", "text_with_entity_marker": "These same p53 residues are also involved in transactivation, supporting the hypothesis that [E1]MDM2[/E1] inactivates [E2]p53[/E2] by concealing its transactivation domain.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MDM2", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[110, 113]], "entity_2_idx_in_text_with_entity_marker": [123, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d161.s1353_AIMed.d161.s1353.p0", "text": "Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, SHPTP2, with another SH2-containing protein, Grb7.", "text_with_entity_marker": "Use of the two hybrid system to detect the association of the protein-tyrosine-phosphatase, [E1]SHPTP2[/E1], with another SH2-containing protein, [E2]Grb7[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SHPTP2", "entity_1_idx": [[92, 98]], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb7", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d161.s1355_AIMed.d161.s1355.p2", "text": "SHPTP2 associates with the platelet-derived growth factor (PDGF) receptor after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.", "text_with_entity_marker": "[E1]SHPTP2[/E1] associates with the [E2]platelet-derived growth factor (PDGF) receptor[/E2] after ligand stimulation, and binding of SHPTP2 to this receptor promotes tyrosine phosphorylation of SHPTP2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SHPTP2", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "platelet-derived growth factor (PDGF) receptor", "entity_2_idx": [[27, 73]], "entity_2_idx_in_text_with_entity_marker": [40, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d161.s1357_AIMed.d161.s1357.p2", "text": "Using SHPTP2 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that SHPTP2 interacts with another signaling protein, Grb7.", "text_with_entity_marker": "Using SHPTP2 as bait and supplying an exogenous tyrosine kinase gene to the yeast cells, we have found that [E1]SHPTP2[/E1] interacts with another signaling protein, [E2]Grb7[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SHPTP2", "entity_1_idx": [[108, 114]], "entity_1_idx_in_text_with_entity_marker": [112, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb7", "entity_2_idx": [[157, 161]], "entity_2_idx_in_text_with_entity_marker": [170, 174], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d161.s1359_AIMed.d161.s1359.p0", "text": "We demonstrate that Grb7 binds to SHPTP2 in vitro under conditions where the latter is tyrosine-phosphorylated.", "text_with_entity_marker": "We demonstrate that [E1]Grb7[/E1] binds to [E2]SHPTP2[/E2] in vitro under conditions where the latter is tyrosine-phosphorylated.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb7", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SHPTP2", "entity_2_idx": [[34, 40]], "entity_2_idx_in_text_with_entity_marker": [47, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d129.s1111_AIMed.d129.s1111.p0", "text": "These antibodies specifically immunoprecipitate p23 in complex with hsp90 in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.", "text_with_entity_marker": "These antibodies specifically immunoprecipitate [E1]p23[/E1] in complex with [E2]hsp90[/E2] in all tissues tested and can be used to immunoaffinity isolate progesterone receptor complexes from chicken oviduct cytosol.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p23", "entity_1_idx": [[48, 51]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[68, 73]], "entity_2_idx_in_text_with_entity_marker": [81, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d142.s1194_AIMed.d142.s1194.p0", "text": "Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1.", "text_with_entity_marker": "Evidence for physical interaction between the zinc-finger transcription factors [E1]YY1[/E1] and [E2]Sp1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YY1", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d142.s1201_AIMed.d142.s1201.p0", "text": "We found that YY1 and Sp1 can form a physical complex.", "text_with_entity_marker": "We found that [E1]YY1[/E1] and [E2]Sp1[/E2] can form a physical complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "YY1", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sp1", "entity_2_idx": [[22, 25]], "entity_2_idx_in_text_with_entity_marker": [35, 38], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1333_AIMed.d158.s1333.p2", "text": "The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.", "text_with_entity_marker": "The death domain of [E1]tumor necrosis factor (TNF) receptor-1[/E1] (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein [E2]TRADD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tumor necrosis factor (TNF) receptor-1", "entity_1_idx": [[20, 58]], "entity_1_idx_in_text_with_entity_marker": [24, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1333_AIMed.d158.s1333.p4", "text": "The death domain of tumor necrosis factor (TNF) receptor-1 (TNFR1) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein TRADD.", "text_with_entity_marker": "The death domain of tumor necrosis factor (TNF) receptor-1 ([E1]TNFR1[/E1]) triggers distinct signaling pathways leading to apoptosis and NF-kappa B activation through its interaction with the death domain protein [E2]TRADD[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TNFR1", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d158.s1334_AIMed.d158.s1334.p2", "text": "Here, we show that TRADD interacts strongly with RIP, another death domain protein that was shown previously to associate with Fas antigen.", "text_with_entity_marker": "Here, we show that TRADD interacts strongly with [E1]RIP[/E1], another death domain protein that was shown previously to associate with [E2]Fas[/E2] antigen.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RIP", "entity_1_idx": [[49, 52]], "entity_1_idx_in_text_with_entity_marker": [53, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[127, 130]], "entity_2_idx_in_text_with_entity_marker": [140, 143], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d222.s1928_AIMed.d222.s1928.p0", "text": "The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.", "text_with_entity_marker": "The protein product of [E1]c-cbl[/E1] proto-oncogene is known to interact with several proteins, including [E2]Grb2[/E2], Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-cbl", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d222.s1928_AIMed.d222.s1928.p1", "text": "The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.", "text_with_entity_marker": "The protein product of [E1]c-cbl[/E1] proto-oncogene is known to interact with several proteins, including Grb2, [E2]Crk[/E2] and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-cbl", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Crk", "entity_2_idx": [[104, 107]], "entity_2_idx_in_text_with_entity_marker": [117, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d222.s1928_AIMed.d222.s1928.p2", "text": "The protein product of c-cbl proto-oncogene is known to interact with several proteins, including Grb2, Crk and PI3 kinase, and is thought to regulate signalling by many cell surface receptors.", "text_with_entity_marker": "The protein product of [E1]c-cbl[/E1] proto-oncogene is known to interact with several proteins, including Grb2, Crk and [E2]PI3 kinase[/E2], and is thought to regulate signalling by many cell surface receptors.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-cbl", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI3 kinase", "entity_2_idx": [[112, 122]], "entity_2_idx_in_text_with_entity_marker": [125, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d222.s1929_AIMed.d222.s1929.p4", "text": "The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that c-Cbl is a negative regulator of the epidermal growth factor receptor.", "text_with_entity_marker": "The precise function of c-Cbl in these pathways is not clear, although a genetic analysis in Caenorhabditis elegans suggests that [E1]c-Cbl[/E1] is a negative regulator of the [E2]epidermal growth factor receptor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Cbl", "entity_1_idx": [[130, 135]], "entity_1_idx_in_text_with_entity_marker": [134, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor receptor", "entity_2_idx": [[167, 199]], "entity_2_idx_in_text_with_entity_marker": [180, 212], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d222.s1931_AIMed.d222.s1931.p0", "text": "The screen identified interactions involving c-Cbl and two 14-3-3 isoforms, cytokeratin 18, human unconventional myosin IC, and a recently identified SH3 domain containing protein, SH3 P17.", "text_with_entity_marker": "The screen identified interactions involving [E1]c-Cbl[/E1] and two 14-3-3 isoforms, [E2]cytokeratin 18[/E2], human unconventional myosin IC, and a recently identified SH3 domain containing protein, SH3 P17.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "c-Cbl", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cytokeratin 18", "entity_2_idx": [[76, 90]], "entity_2_idx_in_text_with_entity_marker": [89, 103], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1866_AIMed.d215.s1866.p0", "text": "Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.", "text_with_entity_marker": "Induction of cell migration by [E1]matrix metalloprotease-2[/E1] cleavage of [E2]laminin-5[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "matrix metalloprotease-2", "entity_1_idx": [[31, 55]], "entity_1_idx_in_text_with_entity_marker": [35, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "laminin-5", "entity_2_idx": [[68, 77]], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1868_AIMed.d215.s1868.p1", "text": "Specific cleavage of laminin-5 (Ln-5) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.", "text_with_entity_marker": "Specific cleavage of [E1]laminin-5[/E1] (Ln-5) by [E2]matrix metalloprotease-2[/E2] (MMP2) was shown to induce migration of breast epithelial cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "laminin-5", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "matrix metalloprotease-2", "entity_2_idx": [[41, 65]], "entity_2_idx_in_text_with_entity_marker": [54, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1868_AIMed.d215.s1868.p2", "text": "Specific cleavage of laminin-5 (Ln-5) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.", "text_with_entity_marker": "Specific cleavage of [E1]laminin-5[/E1] (Ln-5) by matrix metalloprotease-2 ([E2]MMP2[/E2]) was shown to induce migration of breast epithelial cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "laminin-5", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP2", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1868_AIMed.d215.s1868.p3", "text": "Specific cleavage of laminin-5 (Ln-5) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.", "text_with_entity_marker": "Specific cleavage of laminin-5 ([E1]Ln-5[/E1]) by [E2]matrix metalloprotease-2[/E2] (MMP2) was shown to induce migration of breast epithelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ln-5", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "matrix metalloprotease-2", "entity_2_idx": [[41, 65]], "entity_2_idx_in_text_with_entity_marker": [54, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1868_AIMed.d215.s1868.p4", "text": "Specific cleavage of laminin-5 (Ln-5) by matrix metalloprotease-2 (MMP2) was shown to induce migration of breast epithelial cells.", "text_with_entity_marker": "Specific cleavage of laminin-5 ([E1]Ln-5[/E1]) by matrix metalloprotease-2 ([E2]MMP2[/E2]) was shown to induce migration of breast epithelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ln-5", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP2", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d215.s1871_AIMed.d215.s1871.p0", "text": "Cleavage of Ln-5 by MMP2 and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.", "text_with_entity_marker": "Cleavage of [E1]Ln-5[/E1] by [E2]MMP2[/E2] and the resulting activation of the Ln-5 cryptic site may provide new targets for modulation of tumor cell invasion and tissue remodeling.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Ln-5", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "MMP2", "entity_2_idx": [[20, 24]], "entity_2_idx_in_text_with_entity_marker": [33, 37], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s711_AIMed.d84.s711.p8", "text": "Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.", "text_with_entity_marker": "Evidence for a differential interaction of SHC and the [E1]insulin receptor substrate-1[/E1] (IRS-1) with the [E2]insulin-like growth factor-I (IGF-I) receptor[/E2] in the yeast two-hybrid system.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin receptor substrate-1", "entity_1_idx": [[55, 83]], "entity_1_idx_in_text_with_entity_marker": [59, 87], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin-like growth factor-I (IGF-I) receptor", "entity_2_idx": [[101, 146]], "entity_2_idx_in_text_with_entity_marker": [114, 159], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s711_AIMed.d84.s711.p11", "text": "Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.", "text_with_entity_marker": "Evidence for a differential interaction of SHC and the insulin receptor substrate-1 ([E1]IRS-1[/E1]) with the [E2]insulin-like growth factor-I (IGF-I) receptor[/E2] in the yeast two-hybrid system.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin-like growth factor-I (IGF-I) receptor", "entity_2_idx": [[101, 146]], "entity_2_idx_in_text_with_entity_marker": [114, 159], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p11", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the [E1]insulin-like growth factor-I receptor[/E1] (IGF-IR) and the insulin receptor (IR) with their two known substrates [E2]p52Shc[/E2] and the insulin receptor substrate-1 (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin-like growth factor-I receptor", "entity_1_idx": [[147, 184]], "entity_1_idx_in_text_with_entity_marker": [151, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[256, 262]], "entity_2_idx_in_text_with_entity_marker": [269, 275], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p13", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the [E1]insulin-like growth factor-I receptor[/E1] (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the [E2]insulin receptor substrate-1[/E2] (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin-like growth factor-I receptor", "entity_1_idx": [[147, 184]], "entity_1_idx_in_text_with_entity_marker": [151, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate-1", "entity_2_idx": [[271, 299]], "entity_2_idx_in_text_with_entity_marker": [284, 312], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p14", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the [E1]insulin-like growth factor-I receptor[/E1] (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 ([E2]IRS-1[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin-like growth factor-I receptor", "entity_1_idx": [[147, 184]], "entity_1_idx_in_text_with_entity_marker": [151, 188], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[301, 306]], "entity_2_idx_in_text_with_entity_marker": [314, 319], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p17", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor ([E1]IGF-IR[/E1]) and the insulin receptor (IR) with their two known substrates [E2]p52Shc[/E2] and the insulin receptor substrate-1 (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[186, 192]], "entity_1_idx_in_text_with_entity_marker": [190, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[256, 262]], "entity_2_idx_in_text_with_entity_marker": [269, 275], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p19", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor ([E1]IGF-IR[/E1]) and the insulin receptor (IR) with their two known substrates p52Shc and the [E2]insulin receptor substrate-1[/E2] (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[186, 192]], "entity_1_idx_in_text_with_entity_marker": [190, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate-1", "entity_2_idx": [[271, 299]], "entity_2_idx_in_text_with_entity_marker": [284, 312], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p20", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor ([E1]IGF-IR[/E1]) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 ([E2]IRS-1[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[186, 192]], "entity_1_idx_in_text_with_entity_marker": [190, 196], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[301, 306]], "entity_2_idx_in_text_with_entity_marker": [314, 319], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p22", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the [E1]insulin receptor[/E1] (IR) with their two known substrates [E2]p52Shc[/E2] and the insulin receptor substrate-1 (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[202, 218]], "entity_1_idx_in_text_with_entity_marker": [206, 222], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[256, 262]], "entity_2_idx_in_text_with_entity_marker": [269, 275], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p24", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the [E1]insulin receptor[/E1] (IR) with their two known substrates p52Shc and the [E2]insulin receptor substrate-1[/E2] (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[202, 218]], "entity_1_idx_in_text_with_entity_marker": [206, 222], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate-1", "entity_2_idx": [[271, 299]], "entity_2_idx_in_text_with_entity_marker": [284, 312], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p25", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the [E1]insulin receptor[/E1] (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 ([E2]IRS-1[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "insulin receptor", "entity_1_idx": [[202, 218]], "entity_1_idx_in_text_with_entity_marker": [206, 222], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[301, 306]], "entity_2_idx_in_text_with_entity_marker": [314, 319], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p26", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor ([E1]IR[/E1]) with their two known substrates [E2]p52Shc[/E2] and the insulin receptor substrate-1 (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IR", "entity_1_idx": [[220, 222]], "entity_1_idx_in_text_with_entity_marker": [224, 226], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[256, 262]], "entity_2_idx_in_text_with_entity_marker": [269, 275], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p28", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor ([E1]IR[/E1]) with their two known substrates p52Shc and the [E2]insulin receptor substrate-1[/E2] (IRS-1).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IR", "entity_1_idx": [[220, 222]], "entity_1_idx_in_text_with_entity_marker": [224, 226], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate-1", "entity_2_idx": [[271, 299]], "entity_2_idx_in_text_with_entity_marker": [284, 312], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s712_AIMed.d84.s712.p29", "text": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR) with their two known substrates p52Shc and the insulin receptor substrate-1 (IRS-1).", "text_with_entity_marker": "Using the yeast two-hybrid system, a genetic assay for studying protein-protein interactions, we have examined and compared the interaction of the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor ([E1]IR[/E1]) with their two known substrates p52Shc and the insulin receptor substrate-1 ([E2]IRS-1[/E2]).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IR", "entity_1_idx": [[220, 222]], "entity_1_idx_in_text_with_entity_marker": [224, 226], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[301, 306]], "entity_2_idx_in_text_with_entity_marker": [314, 319], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p0", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the [E1]IGF-IR[/E1] is essential for the interaction with [E2]p52Shc[/E2] and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p1", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the [E1]IGF-IR[/E1] is essential for the interaction with p52Shc and [E2]IRS-1[/E2], (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[83, 89]], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p31", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) [E1]p52Shc[/E1] and IRS-1 bind to the [E2]IGF-IR[/E2] in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p52Shc", "entity_1_idx": [[151, 157]], "entity_1_idx_in_text_with_entity_marker": [155, 161], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[180, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 199], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p38", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and [E1]IRS-1[/E1] bind to the [E2]IGF-IR[/E2] in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[162, 167]], "entity_1_idx_in_text_with_entity_marker": [166, 171], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[180, 186]], "entity_2_idx_in_text_with_entity_marker": [193, 199], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p56", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, [E1]IRS-1[/E1] binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the [E2]IGF-IR[/E2], and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[246, 251]], "entity_1_idx_in_text_with_entity_marker": [250, 255], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[338, 344]], "entity_2_idx_in_text_with_entity_marker": [351, 357], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p63", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of [E1]p52Shc[/E1] is required for its association with the [E2]IR[/E2] and the IGF-IR.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p52Shc", "entity_1_idx": [[384, 390]], "entity_1_idx_in_text_with_entity_marker": [388, 394], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR", "entity_2_idx": [[432, 434]], "entity_2_idx_in_text_with_entity_marker": [445, 447], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s714_AIMed.d84.s714.p64", "text": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of p52Shc is required for its association with the IR and the IGF-IR.", "text_with_entity_marker": "Our findings can be summarized as follows: (i) the tyrosine kinase activity of the IGF-IR is essential for the interaction with p52Shc and IRS-1, (ii) p52Shc and IRS-1 bind to the IGF-IR in the NPEY-juxtamembrane motif, (iii) contrary to p52Shc, IRS-1 binds also to the major autophosphorylation sites (Tyr-1131, -1135, and -1136) of the IGF-IR, and (iv) the amino-terminal domain of [E1]p52Shc[/E1] is required for its association with the IR and the [E2]IGF-IR[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p52Shc", "entity_1_idx": [[384, 390]], "entity_1_idx_in_text_with_entity_marker": [388, 394], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[443, 449]], "entity_2_idx_in_text_with_entity_marker": [456, 462], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p1", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the [E1]IGF-IR[/E1] and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, [E2]p52Shc[/E2] and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p2", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the [E1]IGF-IR[/E1] and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and [E2]IRS-1[/E2], and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p6", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the IGF-IR and the [E1]IR[/E1] share at least in part the same molecular mechanism underlying their interplay with their two substrates, [E2]p52Shc[/E2] and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IR", "entity_1_idx": [[39, 41]], "entity_1_idx_in_text_with_entity_marker": [43, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p7", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the IGF-IR and the [E1]IR[/E1] share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and [E2]IRS-1[/E2], and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IR", "entity_1_idx": [[39, 41]], "entity_1_idx_in_text_with_entity_marker": [43, 45], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p18", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) [E1]IRS-1[/E1] interacts with the [E2]IGF-IR[/E2] in a fashion that is different from that used by p52Shc.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IRS-1", "entity_1_idx": [[175, 180]], "entity_1_idx_in_text_with_entity_marker": [179, 184], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-IR", "entity_2_idx": [[200, 206]], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d84.s715_AIMed.d84.s715.p20", "text": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the IGF-IR in a fashion that is different from that used by p52Shc.", "text_with_entity_marker": "We propose that (i) the IGF-IR and the IR share at least in part the same molecular mechanism underlying their interplay with their two substrates, p52Shc and IRS-1, and (ii) IRS-1 interacts with the [E1]IGF-IR[/E1] in a fashion that is different from that used by [E2]p52Shc[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-IR", "entity_1_idx": [[200, 206]], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p52Shc", "entity_2_idx": [[256, 262]], "entity_2_idx_in_text_with_entity_marker": [269, 275], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s734_AIMed.d87.s734.p8", "text": "Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "text_with_entity_marker": "Interaction of the p85 subunit of [E1]PI 3-kinase[/E1] with the [E2]insulin receptor[/E2] (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[34, 45]], "entity_1_idx_in_text_with_entity_marker": [38, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor", "entity_2_idx": [[55, 71]], "entity_2_idx_in_text_with_entity_marker": [68, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s734_AIMed.d87.s734.p9", "text": "Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "text_with_entity_marker": "Interaction of the p85 subunit of [E1]PI 3-kinase[/E1] with the insulin receptor ([E2]IR[/E2]) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[34, 45]], "entity_1_idx_in_text_with_entity_marker": [38, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR", "entity_2_idx": [[73, 75]], "entity_2_idx_in_text_with_entity_marker": [86, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s734_AIMed.d87.s734.p11", "text": "Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "text_with_entity_marker": "Interaction of the p85 subunit of [E1]PI 3-kinase[/E1] with the insulin receptor (IR) and the [E2]IGF-1 receptor[/E2] (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[34, 45]], "entity_1_idx_in_text_with_entity_marker": [38, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1 receptor", "entity_2_idx": [[85, 99]], "entity_2_idx_in_text_with_entity_marker": [98, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s734_AIMed.d87.s734.p12", "text": "Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "text_with_entity_marker": "Interaction of the p85 subunit of [E1]PI 3-kinase[/E1] with the insulin receptor (IR) and the IGF-1 receptor ([E2]IGF-1R[/E2]) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PI 3-kinase", "entity_1_idx": [[34, 45]], "entity_1_idx_in_text_with_entity_marker": [38, 49], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R", "entity_2_idx": [[101, 107]], "entity_2_idx_in_text_with_entity_marker": [114, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s736_AIMed.d87.s736.p1", "text": "The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.", "text_with_entity_marker": "The results of his3 activation indicated that [E1]p85[/E1], N + C-SH2 and C-SH2 interact with both [E2]IR beta[/E2] and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p85", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR beta", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s736_AIMed.d87.s736.p3", "text": "The results of his3 activation indicated that p85, N + C-SH2 and C-SH2 interact with both IR beta and IGF-1R beta, whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.", "text_with_entity_marker": "The results of his3 activation indicated that [E1]p85[/E1], N + C-SH2 and C-SH2 interact with both IR beta and [E2]IGF-1R beta[/E2], whereas N-SH2 and SH3 + N-SH2 interact only with IR beta.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p85", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R beta", "entity_2_idx": [[102, 113]], "entity_2_idx_in_text_with_entity_marker": [115, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s737_AIMed.d87.s737.p0", "text": "Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.", "text_with_entity_marker": "Interaction of [E1]p85[/E1] and N+C-SH2 with [E2]IR beta[/E2] (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR beta", "entity_2_idx": [[36, 43]], "entity_2_idx_in_text_with_entity_marker": [49, 56], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s737_AIMed.d87.s737.p3", "text": "Interaction of p85 and N+C-SH2 with IR beta (delta C-43) or IGF-1R beta(delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.", "text_with_entity_marker": "Interaction of [E1]p85[/E1] and N+C-SH2 with IR beta (delta C-43) or [E2]IGF-1R beta[/E2](delta C-43) in which the C-terminal 43 amino acids (including the YXXM motif) were deleted, persisted.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[15, 18]], "entity_1_idx_in_text_with_entity_marker": [19, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R beta", "entity_2_idx": [[60, 71]], "entity_2_idx_in_text_with_entity_marker": [73, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s739_AIMed.d87.s739.p0", "text": "Activation of lacZ upon interaction of p85 with IR beta(delta C-43) was 4-fold less as compared to IR beta.", "text_with_entity_marker": "Activation of lacZ upon interaction of [E1]p85[/E1] with [E2]IR beta[/E2](delta C-43) was 4-fold less as compared to IR beta.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR beta", "entity_2_idx": [[48, 55]], "entity_2_idx_in_text_with_entity_marker": [61, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s739_AIMed.d87.s739.p2", "text": "Activation of lacZ upon interaction of p85 with IR beta(delta C-43) was 4-fold less as compared to IR beta.", "text_with_entity_marker": "Activation of lacZ upon interaction of [E1]p85[/E1] with IR beta(delta C-43) was 4-fold less as compared to [E2]IR beta[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR beta", "entity_2_idx": [[99, 106]], "entity_2_idx_in_text_with_entity_marker": [112, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s740_AIMed.d87.s740.p1", "text": "This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).", "text_with_entity_marker": "This activation with [E1]p85[/E1] and [E2]IGF-1R beta[/E2] was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R beta", "entity_2_idx": [[29, 40]], "entity_2_idx_in_text_with_entity_marker": [42, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s740_AIMed.d87.s740.p2", "text": "This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).", "text_with_entity_marker": "This activation with [E1]p85[/E1] and IGF-1R beta was 4-fold less as compared to [E2]IR beta[/E2] and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IR beta", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s740_AIMed.d87.s740.p4", "text": "This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).", "text_with_entity_marker": "This activation with [E1]p85[/E1] and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for [E2]IGF-1R beta[/E2] (delta C-43).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "p85", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IGF-1R beta", "entity_2_idx": [[120, 131]], "entity_2_idx_in_text_with_entity_marker": [133, 144], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d87.s741_AIMed.d87.s741.p0", "text": "Thus, the C-terminal domain in IGF-1R appears to exert a negative control on binding of p85 thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway.", "text_with_entity_marker": "Thus, the C-terminal domain in [E1]IGF-1R[/E1] appears to exert a negative control on binding of [E2]p85[/E2] thereby providing a possible regulatory mechanism for direct activation of the PI 3-kinase pathway.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IGF-1R", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[88, 91]], "entity_2_idx_in_text_with_entity_marker": [101, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s484_AIMed.d55.s484.p0", "text": "At relatively high concentrations, LEC induced calcium mobilization and chemotaxis via CCR1 and CCR2.", "text_with_entity_marker": "At relatively high concentrations, [E1]LEC[/E1] induced calcium mobilization and chemotaxis via [E2]CCR1[/E2] and CCR2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LEC", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR1", "entity_2_idx": [[87, 91]], "entity_2_idx_in_text_with_entity_marker": [100, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s484_AIMed.d55.s484.p1", "text": "At relatively high concentrations, LEC induced calcium mobilization and chemotaxis via CCR1 and CCR2.", "text_with_entity_marker": "At relatively high concentrations, [E1]LEC[/E1] induced calcium mobilization and chemotaxis via CCR1 and [E2]CCR2[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LEC", "entity_1_idx": [[35, 38]], "entity_1_idx_in_text_with_entity_marker": [39, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR2", "entity_2_idx": [[96, 100]], "entity_2_idx_in_text_with_entity_marker": [109, 113], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d55.s485_AIMed.d55.s485.p0", "text": "LEC also induced calcium mobilization, but marginal chemotaxis via CCR5.", "text_with_entity_marker": "[E1]LEC[/E1] also induced calcium mobilization, but marginal chemotaxis via [E2]CCR5[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LEC", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CCR5", "entity_2_idx": [[67, 71]], "entity_2_idx_in_text_with_entity_marker": [80, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1216_AIMed.d144.s1216.p0", "text": "The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.", "text_with_entity_marker": "The [E1]retinoblastoma protein[/E1] associates with the [E2]protein phosphatase type 1[/E2] catalytic subunit.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "retinoblastoma protein", "entity_1_idx": [[4, 26]], "entity_1_idx_in_text_with_entity_marker": [8, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "protein phosphatase type 1", "entity_2_idx": [[47, 73]], "entity_2_idx_in_text_with_entity_marker": [60, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d144.s1220_AIMed.d144.s1220.p0", "text": "In vitro-binding assays demonstrated that PP-1 alpha isoforms preferentially bind the hypophosphorylated form of p110RB.", "text_with_entity_marker": "In vitro-binding assays demonstrated that [E1]PP-1 alpha[/E1] isoforms preferentially bind the hypophosphorylated form of [E2]p110RB[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PP-1 alpha", "entity_1_idx": [[42, 52]], "entity_1_idx_in_text_with_entity_marker": [46, 56], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p110RB", "entity_2_idx": [[113, 119]], "entity_2_idx_in_text_with_entity_marker": [126, 132], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d198.s1687_AIMed.d198.s1687.p1", "text": "Mutagenesis of the erythropoietin receptor (EPOR) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.", "text_with_entity_marker": "Mutagenesis of the [E1]erythropoietin[/E1] receptor ([E2]EPOR[/E2]) permits analysis of the contribution that individual amino acid residues make to erythropoietin (EPO) binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "erythropoietin", "entity_1_idx": [[19, 33]], "entity_1_idx_in_text_with_entity_marker": [23, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPOR", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d35.s299_AIMed.d35.s299.p0", "text": "Cell surface PS1 formed complexes in vivo with actin-binding protein filamin (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.", "text_with_entity_marker": "Cell surface [E1]PS1[/E1] formed complexes in vivo with actin-binding protein [E2]filamin[/E2] (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PS1", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "filamin", "entity_2_idx": [[69, 76]], "entity_2_idx_in_text_with_entity_marker": [82, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d35.s299_AIMed.d35.s299.p1", "text": "Cell surface PS1 formed complexes in vivo with actin-binding protein filamin (ABP-280), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.", "text_with_entity_marker": "Cell surface [E1]PS1[/E1] formed complexes in vivo with actin-binding protein filamin ([E2]ABP-280[/E2]), which is known to form bridges between cell surface receptors and cytoskeleton and mediate cell adhesion and cell motility.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "PS1", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ABP-280", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p2", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "[E1]Gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin receptor substrate 1[/E2] and its association with Grb2 and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Gastrin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate 1", "entity_2_idx": [[47, 75]], "entity_2_idx_in_text_with_entity_marker": [60, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p12", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] and its association with [E2]Grb2[/E2] and the phosphatidylinositol 3-kinase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[47, 75]], "entity_1_idx_in_text_with_entity_marker": [51, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1519_AIMed.d179.s1519.p13", "text": "Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase.", "text_with_entity_marker": "Gastrin stimulates tyrosine phosphorylation of [E1]insulin receptor substrate 1[/E1] and its association with Grb2 and the [E2]phosphatidylinositol 3-kinase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin receptor substrate 1", "entity_1_idx": [[47, 75]], "entity_1_idx_in_text_with_entity_marker": [51, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[114, 143]], "entity_2_idx_in_text_with_entity_marker": [127, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p1", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of [E2]insulin receptor substrate 1[/E2] (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "insulin receptor substrate 1", "entity_2_idx": [[89, 117]], "entity_2_idx_in_text_with_entity_marker": [102, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1522_AIMed.d179.s1522.p2", "text": "In the present study, we demonstrate that gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1), the major cytoplasmic substrate of the insulin receptor.", "text_with_entity_marker": "In the present study, we demonstrate that [E1]gastrin[/E1] stimulates tyrosine phosphorylation of insulin receptor substrate 1 ([E2]IRS-1[/E2]), the major cytoplasmic substrate of the insulin receptor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[42, 49]], "entity_1_idx_in_text_with_entity_marker": [46, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1523_AIMed.d179.s1523.p0", "text": "The gastrin-induced phosphorylation of IRS-1 was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.", "text_with_entity_marker": "The [E1]gastrin[/E1]-induced phosphorylation of [E2]IRS-1[/E2] was rapid and transient, occurring within 30 s of treatment and diminishing thereafter.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gastrin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p5", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of [E1]IRS-1[/E1] with the p85 regulatory subunit of [E2]phosphatidylinositol 3-kinase[/E2] (PI 3-kinase).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "phosphatidylinositol 3-kinase", "entity_2_idx": [[126, 155]], "entity_2_idx_in_text_with_entity_marker": [139, 168], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1525_AIMed.d179.s1525.p6", "text": "Following gastrin stimulation, we observed a time- and dose-dependent association of IRS-1 with the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase).", "text_with_entity_marker": "Following gastrin stimulation, we observed a time- and dose-dependent association of [E1]IRS-1[/E1] with the p85 regulatory subunit of phosphatidylinositol 3-kinase ([E2]PI 3-kinase[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IRS-1", "entity_1_idx": [[85, 90]], "entity_1_idx_in_text_with_entity_marker": [89, 94], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PI 3-kinase", "entity_2_idx": [[157, 168]], "entity_2_idx_in_text_with_entity_marker": [170, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p0", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the [E2]Grb2[/E2]-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Grb2", "entity_2_idx": [[94, 98]], "entity_2_idx_in_text_with_entity_marker": [107, 111], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p1", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of [E1]Shc[/E1] and its association with the Grb2-[E2]Sos[/E2] complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Shc", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1527_AIMed.d179.s1527.p4", "text": "We have previously reported that tyrosine phosphorylation of Shc and its association with the Grb2-Sos complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "text_with_entity_marker": "We have previously reported that tyrosine phosphorylation of Shc and its association with the [E1]Grb2[/E1]-[E2]Sos[/E2] complex may contribute to the activation of the mitogen-activated protein kinase pathway by gastrin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[94, 98]], "entity_1_idx_in_text_with_entity_marker": [98, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Sos", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d179.s1528_AIMed.d179.s1528.p0", "text": "We report here that Grb2 also interacts with tyrosine-phosphorylated IRS-1 in response to gastrin.", "text_with_entity_marker": "We report here that [E1]Grb2[/E1] also interacts with tyrosine-phosphorylated [E2]IRS-1[/E2] in response to gastrin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Grb2", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IRS-1", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d109.s916_AIMed.d109.s916.p0", "text": "Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA.", "text_with_entity_marker": "Crystal structure of the heterodimeric bZIP transcription factor [E1]c-Fos[/E1]-[E2]c-Jun[/E2] bound to DNA.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Fos", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d109.s917_AIMed.d109.s917.p0", "text": "The Fos and Jun families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.", "text_with_entity_marker": "The [E1]Fos[/E1] and [E2]Jun[/E2] families of eukaryotic transcription factors heterodimerize to form complexes capable of binding 5'-TGAGTCA-3' DNA elements.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fos", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jun", "entity_2_idx": [[12, 15]], "entity_2_idx_in_text_with_entity_marker": [25, 28], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d109.s918_AIMed.d109.s918.p0", "text": "We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of c-Fos and c-Jun bound to DNA.", "text_with_entity_marker": "We have determined the X-ray crystal structure of a heterodimer of the bZIP regions of [E1]c-Fos[/E1] and [E2]c-Jun[/E2] bound to DNA.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Fos", "entity_1_idx": [[87, 92]], "entity_1_idx_in_text_with_entity_marker": [91, 96], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[97, 102]], "entity_2_idx_in_text_with_entity_marker": [110, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d109.s921_AIMed.d109.s921.p0", "text": "Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the Fos-Jun heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.", "text_with_entity_marker": "Comparison of the two crystallographically distinct protein-DNA complexes show that the coiled-coil is flexibly joined to the basic regions and that the [E1]Fos[/E1]-[E2]Jun[/E2] heterodimer does not recognize the asymmetric 5'-TGAGTCA-3' recognition element in a unique orientation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fos", "entity_1_idx": [[153, 156]], "entity_1_idx_in_text_with_entity_marker": [157, 160], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jun", "entity_2_idx": [[157, 160]], "entity_2_idx_in_text_with_entity_marker": [170, 173], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d182.s1547_AIMed.d182.s1547.p0", "text": "In certain cancers, MDM2 amplification is a common event and contributes to the inactivation of p53.", "text_with_entity_marker": "In certain cancers, [E1]MDM2[/E1] amplification is a common event and contributes to the inactivation of [E2]p53[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MDM2", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1405_AIMed.d167.s1405.p0", "text": "A truncated version of the integral membrane glycoprotein Glut 1 (GT155) was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.", "text_with_entity_marker": "A truncated version of the integral membrane glycoprotein [E1]Glut 1[/E1] ([E2]GT155[/E2]) was synthesized in a rabbit reticulocyte translation system in the presence of canine pancreatic microsomes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Glut 1", "entity_1_idx": [[58, 64]], "entity_1_idx_in_text_with_entity_marker": [62, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GT155", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1409_AIMed.d167.s1409.p0", "text": "A GT155 mutant that was not glycosylated (AGGT155) did not associate with calnexin or CAP-60.", "text_with_entity_marker": "A [E1]GT155[/E1] mutant that was not glycosylated (AGGT155) did not associate with [E2]calnexin[/E2] or CAP-60.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GT155", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calnexin", "entity_2_idx": [[74, 82]], "entity_2_idx_in_text_with_entity_marker": [87, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1409_AIMed.d167.s1409.p1", "text": "A GT155 mutant that was not glycosylated (AGGT155) did not associate with calnexin or CAP-60.", "text_with_entity_marker": "A [E1]GT155[/E1] mutant that was not glycosylated (AGGT155) did not associate with calnexin or [E2]CAP-60[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GT155", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CAP-60", "entity_2_idx": [[86, 92]], "entity_2_idx_in_text_with_entity_marker": [99, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1409_AIMed.d167.s1409.p2", "text": "A GT155 mutant that was not glycosylated (AGGT155) did not associate with calnexin or CAP-60.", "text_with_entity_marker": "A GT155 mutant that was not glycosylated (AGGT155) did not associate with [E1]calnexin[/E1] or [E2]CAP-60[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calnexin", "entity_1_idx": [[74, 82]], "entity_1_idx_in_text_with_entity_marker": [78, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CAP-60", "entity_2_idx": [[86, 92]], "entity_2_idx_in_text_with_entity_marker": [99, 105], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d189.s1607_AIMed.d189.s1607.p0", "text": "These interactions are UBE2I-specific, since another DNA repair-related ubiquitin-conjugating enzyme, RAD6 (UBC2), does not interact with these proteins.", "text_with_entity_marker": "These interactions are [E1]UBE2I[/E1]-specific, since another DNA repair-related ubiquitin-conjugating enzyme, [E2]RAD6[/E2] (UBC2), does not interact with these proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UBE2I", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RAD6", "entity_2_idx": [[102, 106]], "entity_2_idx_in_text_with_entity_marker": [115, 119], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d189.s1607_AIMed.d189.s1607.p1", "text": "These interactions are UBE2I-specific, since another DNA repair-related ubiquitin-conjugating enzyme, RAD6 (UBC2), does not interact with these proteins.", "text_with_entity_marker": "These interactions are [E1]UBE2I[/E1]-specific, since another DNA repair-related ubiquitin-conjugating enzyme, RAD6 ([E2]UBC2[/E2]), does not interact with these proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UBE2I", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "UBC2", "entity_2_idx": [[108, 112]], "entity_2_idx_in_text_with_entity_marker": [121, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d189.s1607_AIMed.d189.s1607.p2", "text": "These interactions are UBE2I-specific, since another DNA repair-related ubiquitin-conjugating enzyme, RAD6 (UBC2), does not interact with these proteins.", "text_with_entity_marker": "These interactions are UBE2I-specific, since another DNA repair-related ubiquitin-conjugating enzyme, [E1]RAD6[/E1] ([E2]UBC2[/E2]), does not interact with these proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD6", "entity_1_idx": [[102, 106]], "entity_1_idx_in_text_with_entity_marker": [106, 110], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "UBC2", "entity_2_idx": [[108, 112]], "entity_2_idx_in_text_with_entity_marker": [121, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s975_AIMed.d115.s975.p0", "text": "Deletion of this domain impairs RAP74's ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support SP1-activated transcription.", "text_with_entity_marker": "Deletion of this domain impairs [E1]RAP74[/E1]'s ability to support [E2]SRF[/E2]-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support SP1-activated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAP74", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SRF", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s975_AIMed.d115.s975.p1", "text": "Deletion of this domain impairs RAP74's ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support SP1-activated transcription.", "text_with_entity_marker": "Deletion of this domain impairs [E1]RAP74[/E1]'s ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support [E2]SP1[/E2]-activated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAP74", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SP1", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s975_AIMed.d115.s975.p2", "text": "Deletion of this domain impairs RAP74's ability to support SRF-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support SP1-activated transcription.", "text_with_entity_marker": "Deletion of this domain impairs RAP74's ability to support [E1]SRF[/E1]-activated transcription in vitro but has little effect on the protein's basal transcription activity or its ability to support [E2]SP1[/E2]-activated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SRF", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SP1", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p0", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of [E1]p21ras[/E1], coexpression of [E2]JAK2[/E2] and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21ras", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "JAK2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p1", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of [E1]p21ras[/E1], coexpression of JAK2 and [E2]Raf-1[/E2] resulted in an overall decrease in the Raf-1 kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21ras", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p2", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of [E1]p21ras[/E1], coexpression of JAK2 and Raf-1 resulted in an overall decrease in the [E2]Raf-1[/E2] kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21ras", "entity_1_idx": [[31, 37]], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p3", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of p21ras, coexpression of [E1]JAK2[/E1] and [E2]Raf-1[/E2] resulted in an overall decrease in the Raf-1 kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "JAK2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p4", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of p21ras, coexpression of [E1]JAK2[/E1] and Raf-1 resulted in an overall decrease in the [E2]Raf-1[/E2] kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "JAK2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d183.s1557_AIMed.d183.s1557.p5", "text": "In contrast, in the absence of p21ras, coexpression of JAK2 and Raf-1 resulted in an overall decrease in the Raf-1 kinase activity.", "text_with_entity_marker": "In contrast, in the absence of p21ras, coexpression of JAK2 and [E1]Raf-1[/E1] resulted in an overall decrease in the [E2]Raf-1[/E2] kinase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-1", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d30.s253_AIMed.d30.s253.p0", "text": "These results suggest that PS1 and PS2 partly differ in function.", "text_with_entity_marker": "These results suggest that [E1]PS1[/E1] and [E2]PS2[/E2] partly differ in function.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PS1", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PS2", "entity_2_idx": [[35, 38]], "entity_2_idx_in_text_with_entity_marker": [48, 51], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s926_AIMed.d110.s926.p0", "text": "The cloning of a complementary DNA encoding a human TFIID TAF, TAFII55, that has no known homolog in Drosophila TFIID is now described.", "text_with_entity_marker": "The cloning of a complementary DNA encoding a human [E1]TFIID[/E1] TAF, [E2]TAFII55[/E2], that has no known homolog in Drosophila TFIID is now described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII55", "entity_2_idx": [[63, 70]], "entity_2_idx_in_text_with_entity_marker": [76, 83], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s926_AIMed.d110.s926.p1", "text": "The cloning of a complementary DNA encoding a human TFIID TAF, TAFII55, that has no known homolog in Drosophila TFIID is now described.", "text_with_entity_marker": "The cloning of a complementary DNA encoding a human [E1]TFIID[/E1] TAF, TAFII55, that has no known homolog in Drosophila [E2]TFIID[/E2] is now described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d110.s926_AIMed.d110.s926.p2", "text": "The cloning of a complementary DNA encoding a human TFIID TAF, TAFII55, that has no known homolog in Drosophila TFIID is now described.", "text_with_entity_marker": "The cloning of a complementary DNA encoding a human TFIID TAF, [E1]TAFII55[/E1], that has no known homolog in Drosophila [E2]TFIID[/E2] is now described.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TAFII55", "entity_1_idx": [[63, 70]], "entity_1_idx_in_text_with_entity_marker": [67, 74], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1274_AIMed.d150.s1274.p0", "text": "The retinoblastoma gene product (Rb) is a nuclear phosphoprotein that regulates cell cycle progression.", "text_with_entity_marker": "The [E1]retinoblastoma[/E1] gene product ([E2]Rb[/E2]) is a nuclear phosphoprotein that regulates cell cycle progression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "retinoblastoma", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Rb", "entity_2_idx": [[33, 35]], "entity_2_idx_in_text_with_entity_marker": [46, 48], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1275_AIMed.d150.s1275.p0", "text": "Elf-1 is a lymphoid-specific Ets transcription factor that regulates inducible gene expression during T cell activation.", "text_with_entity_marker": "[E1]Elf-1[/E1] is a lymphoid-specific [E2]Ets[/E2] transcription factor that regulates inducible gene expression during T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Elf-1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ets", "entity_2_idx": [[29, 32]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p0", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of [E1]Rb[/E1] results in the release of [E2]Elf-1[/E2], which is correlated temporally with the activation of Elf-1-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Rb", "entity_1_idx": [[48, 50]], "entity_1_idx_in_text_with_entity_marker": [52, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p1", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of [E1]Rb[/E1] results in the release of Elf-1, which is correlated temporally with the activation of [E2]Elf-1[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Rb", "entity_1_idx": [[48, 50]], "entity_1_idx_in_text_with_entity_marker": [52, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1279_AIMed.d150.s1279.p2", "text": "After T cell activation, the phosphorylation of Rb results in the release of Elf-1, which is correlated temporally with the activation of Elf-1-mediated transcription.", "text_with_entity_marker": "After T cell activation, the phosphorylation of Rb results in the release of [E1]Elf-1[/E1], which is correlated temporally with the activation of [E2]Elf-1[/E2]-mediated transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Elf-1", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d150.s1280_AIMed.d150.s1280.p0", "text": "Overexpression of a phosphorylation-defective form of Rb inhibited Elf-1-dependent transcription during T cell activation.", "text_with_entity_marker": "Overexpression of a phosphorylation-defective form of [E1]Rb[/E1] inhibited [E2]Elf-1[/E2]-dependent transcription during T cell activation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Rb", "entity_1_idx": [[54, 56]], "entity_1_idx_in_text_with_entity_marker": [58, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Elf-1", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p0", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including [E1]protein kinase C[/E1] ([E2]PKC[/E2]), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinase C", "entity_1_idx": [[48, 64]], "entity_1_idx_in_text_with_entity_marker": [52, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[66, 69]], "entity_2_idx_in_text_with_entity_marker": [79, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p1", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including [E1]protein kinase C[/E1] (PKC), [E2]tyrosine kinase, phosphatidylinositol 3-kinase[/E2] (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinase C", "entity_1_idx": [[48, 64]], "entity_1_idx_in_text_with_entity_marker": [52, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase, phosphatidylinositol 3-kinase", "entity_2_idx": [[72, 118]], "entity_2_idx_in_text_with_entity_marker": [85, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p2", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including [E1]protein kinase C[/E1] (PKC), tyrosine kinase, phosphatidylinositol 3-kinase ([E2]P13-K[/E2]), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinase C", "entity_1_idx": [[48, 64]], "entity_1_idx_in_text_with_entity_marker": [52, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "P13-K", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p3", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including protein kinase C ([E1]PKC[/E1]), [E2]tyrosine kinase, phosphatidylinositol 3-kinase[/E2] (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tyrosine kinase, phosphatidylinositol 3-kinase", "entity_2_idx": [[72, 118]], "entity_2_idx_in_text_with_entity_marker": [85, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p4", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including protein kinase C ([E1]PKC[/E1]), tyrosine kinase, phosphatidylinositol 3-kinase ([E2]P13-K[/E2]), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PKC", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "P13-K", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d21.s176_AIMed.d21.s176.p5", "text": "Many of the same signaling molecules, including protein kinase C (PKC), tyrosine kinase, phosphatidylinositol 3-kinase (P13-K), and protein phosphatase, regulate the transporters for different neurotransmitters.", "text_with_entity_marker": "Many of the same signaling molecules, including protein kinase C (PKC), [E1]tyrosine kinase, phosphatidylinositol 3-kinase[/E1] ([E2]P13-K[/E2]), and protein phosphatase, regulate the transporters for different neurotransmitters.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tyrosine kinase, phosphatidylinositol 3-kinase", "entity_1_idx": [[72, 118]], "entity_1_idx_in_text_with_entity_marker": [76, 122], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "P13-K", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p0", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, [E1]14-3-3 zeta[/E1] ([E2]PLA2[/E2]) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "14-3-3 zeta", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PLA2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p1", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, [E1]14-3-3 zeta[/E1] (PLA2) and [E2]14-3-3 beta[/E2] (HS1), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "14-3-3 zeta", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "14-3-3 beta", "entity_2_idx": [[39, 50]], "entity_2_idx_in_text_with_entity_marker": [52, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p2", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, [E1]14-3-3 zeta[/E1] (PLA2) and 14-3-3 beta ([E2]HS1[/E2]), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "14-3-3 zeta", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HS1", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p3", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, 14-3-3 zeta ([E1]PLA2[/E1]) and [E2]14-3-3 beta[/E2] (HS1), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLA2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "14-3-3 beta", "entity_2_idx": [[39, 50]], "entity_2_idx_in_text_with_entity_marker": [52, 63], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p4", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, 14-3-3 zeta ([E1]PLA2[/E1]) and 14-3-3 beta ([E2]HS1[/E2]), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PLA2", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HS1", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1058_AIMed.d124.s1058.p5", "text": "These proteins, 14-3-3 zeta (PLA2) and 14-3-3 beta (HS1), are members of the 14-3-3 family of proteins.", "text_with_entity_marker": "These proteins, 14-3-3 zeta (PLA2) and [E1]14-3-3 beta[/E1] ([E2]HS1[/E2]), are members of the 14-3-3 family of proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "14-3-3 beta", "entity_1_idx": [[39, 50]], "entity_1_idx_in_text_with_entity_marker": [43, 54], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "HS1", "entity_2_idx": [[52, 55]], "entity_2_idx_in_text_with_entity_marker": [65, 68], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d124.s1059_AIMed.d124.s1059.p0", "text": "Expression of 14-3-3 proteins in Xenopus oocytes enhanced Raf-1 activity and promoted Raf-1-dependent oocyte maturation.", "text_with_entity_marker": "Expression of 14-3-3 proteins in Xenopus oocytes enhanced [E1]Raf-1[/E1] activity and promoted [E2]Raf-1[/E2]-dependent oocyte maturation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Raf-1", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1623_AIMed.d191.s1623.p0", "text": "We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of CD4 and gp120 binding.", "text_with_entity_marker": "We now find that HIV-1 begins reverse transcription much more efficiently in DCs than T cells, even though T cells have higher levels of [E1]CD4[/E1] and [E2]gp120[/E2] binding.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD4", "entity_1_idx": [[137, 140]], "entity_1_idx_in_text_with_entity_marker": [141, 144], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp120", "entity_2_idx": [[145, 150]], "entity_2_idx_in_text_with_entity_marker": [158, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d191.s1633_AIMed.d191.s1633.p0", "text": "DCs express more CCR5 and CXCR4 mRNA than T cells.", "text_with_entity_marker": "DCs express more [E1]CCR5[/E1] and [E2]CXCR4[/E2] mRNA than T cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CCR5", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CXCR4", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d99.s842_AIMed.d99.s842.p0", "text": "These observations suggest that the products of the CSA and CSB genes are involved in transcription.", "text_with_entity_marker": "These observations suggest that the products of the [E1]CSA[/E1] and [E2]CSB[/E2] genes are involved in transcription.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CSA", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CSB", "entity_2_idx": [[60, 63]], "entity_2_idx_in_text_with_entity_marker": [73, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d140.s1181_AIMed.d140.s1181.p0", "text": "We used the interaction trap, a yeast genetic selection for interacting proteins, to isolate human cyclin-dependent kinase interactor 1 (Cdi1).", "text_with_entity_marker": "We used the interaction trap, a yeast genetic selection for interacting proteins, to isolate human [E1]cyclin-dependent kinase interactor 1[/E1] ([E2]Cdi1[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cyclin-dependent kinase interactor 1", "entity_1_idx": [[99, 135]], "entity_1_idx_in_text_with_entity_marker": [103, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdi1", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d140.s1186_AIMed.d140.s1186.p0", "text": "Overexpression of wild-type Cdi1 delays progression through the cell cycle in yeast and HeLa cells; delay is dependent on Cdi1 phosphatase activity.", "text_with_entity_marker": "Overexpression of wild-type [E1]Cdi1[/E1] delays progression through the cell cycle in yeast and HeLa cells; delay is dependent on [E2]Cdi1[/E2] phosphatase activity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Cdi1", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdi1", "entity_2_idx": [[122, 126]], "entity_2_idx_in_text_with_entity_marker": [135, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p0", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], [E2]hTAFII18[/E2] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII18", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p1", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a [E2]TFIID[/E2] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p2", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a [E2]TFIID beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p3", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p4", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p5", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p6", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p7", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to [E1]hTAFII28[/E1], hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII28", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p8", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a [E2]TFIID[/E2] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID", "entity_2_idx": [[39, 44]], "entity_2_idx_in_text_with_entity_marker": [52, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p9", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a [E2]TFIID beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [52, 62], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p10", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p11", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p12", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p13", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p14", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, [E1]hTAFII18[/E1] is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII18", "entity_1_idx": [[25, 33]], "entity_1_idx_in_text_with_entity_marker": [29, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p15", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1-E2]TFIID[/E1] beta[/E2]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TFIID[/E1] beta", "entity_2_idx": [[39, 49]], "entity_2_idx_in_text_with_entity_marker": [46, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p16", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p17", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p18", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p19", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p20", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID[/E1] beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID", "entity_1_idx": [[39, 44]], "entity_1_idx_in_text_with_entity_marker": [43, 48], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p21", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific [E2]hTAFII[/E2]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII", "entity_2_idx": [[59, 65]], "entity_2_idx_in_text_with_entity_marker": [72, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p22", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p23", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p24", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p25", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a [E1]TFIID beta[/E1]-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TFIID beta", "entity_1_idx": [[39, 49]], "entity_1_idx_in_text_with_entity_marker": [43, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p26", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. [E2]hTAFII20[/E2] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII20", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p27", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p28", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p29", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific [E1]hTAFII[/E1]. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII", "entity_1_idx": [[59, 65]], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p30", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of [E2]p22[/E2], an alternatively spliced form of dTAFII30 alpha (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p22", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p31", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of p22, an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p32", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. [E1]hTAFII20[/E1] is the homologue of p22, an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "hTAFII20", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p33", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E1]p22[/E1], an alternatively spliced form of d[E2]TAFII30 alpha[/E2] (p32).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p22", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII30 alpha", "entity_2_idx": [[135, 148]], "entity_2_idx_in_text_with_entity_marker": [148, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p34", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of [E1]p22[/E1], an alternatively spliced form of dTAFII30 alpha ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p22", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d103.s869_AIMed.d103.s869.p35", "text": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of dTAFII30 alpha (p32).", "text_with_entity_marker": "In contrast to hTAFII28, hTAFII18 is a TFIID beta-specific hTAFII. hTAFII20 is the homologue of p22, an alternatively spliced form of d[E1]TAFII30 alpha[/E1] ([E2]p32[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TAFII30 alpha", "entity_1_idx": [[135, 148]], "entity_1_idx_in_text_with_entity_marker": [139, 152], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p32", "entity_2_idx": [[150, 153]], "entity_2_idx_in_text_with_entity_marker": [163, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p0", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that [E1]CD26[/E1] and [E2]ADA[/E2] co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[73, 76]], "entity_2_idx_in_text_with_entity_marker": [86, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p1", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that [E1]CD26[/E1] and ADA co-localized on the cell surface, but not inside cells, suggesting that [E2]CD26[/E2] did not transport ADA to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p2", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that [E1]CD26[/E1] and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport [E2]ADA[/E2] to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[172, 175]], "entity_2_idx_in_text_with_entity_marker": [185, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p3", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and [E1]ADA[/E1] co-localized on the cell surface, but not inside cells, suggesting that [E2]CD26[/E2] did not transport ADA to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ADA", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[149, 153]], "entity_2_idx_in_text_with_entity_marker": [162, 166], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p4", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and [E1]ADA[/E1] co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport [E2]ADA[/E2] to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ADA", "entity_1_idx": [[73, 76]], "entity_1_idx_in_text_with_entity_marker": [77, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[172, 175]], "entity_2_idx_in_text_with_entity_marker": [185, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1302_AIMed.d153.s1302.p5", "text": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that CD26 did not transport ADA to the surface.", "text_with_entity_marker": "Moreover, using immunoelectron microscopy, we demonstrated that CD26 and ADA co-localized on the cell surface, but not inside cells, suggesting that [E1]CD26[/E1] did not transport [E2]ADA[/E2] to the surface.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[149, 153]], "entity_1_idx_in_text_with_entity_marker": [153, 157], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[172, 175]], "entity_2_idx_in_text_with_entity_marker": [185, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1303_AIMed.d153.s1303.p0", "text": "In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.", "text_with_entity_marker": "In keeping with this observation, we showed that human [E1]CD26[/E1]-transfected murine pre-B cell lines lacking human [E2]ADA[/E2] acquired ADA from an extracellular source.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[110, 113]], "entity_2_idx_in_text_with_entity_marker": [123, 126], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1303_AIMed.d153.s1303.p1", "text": "In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.", "text_with_entity_marker": "In keeping with this observation, we showed that human [E1]CD26[/E1]-transfected murine pre-B cell lines lacking human ADA acquired [E2]ADA[/E2] from an extracellular source.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD26", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1303_AIMed.d153.s1303.p2", "text": "In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human ADA acquired ADA from an extracellular source.", "text_with_entity_marker": "In keeping with this observation, we showed that human CD26-transfected murine pre-B cell lines lacking human [E1]ADA[/E1] acquired [E2]ADA[/E2] from an extracellular source.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ADA", "entity_1_idx": [[110, 113]], "entity_1_idx_in_text_with_entity_marker": [114, 117], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ADA", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1304_AIMed.d153.s1304.p0", "text": "More importantly, adenosine in the absence of cell surface ADA inhibited T cell proliferation and IL-2 production induced by various stimuli.", "text_with_entity_marker": "More importantly, adenosine in the absence of cell surface [E1]ADA[/E1] inhibited T cell proliferation and [E2]IL-2[/E2] production induced by various stimuli.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ADA", "entity_1_idx": [[59, 62]], "entity_1_idx_in_text_with_entity_marker": [63, 66], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d153.s1305_AIMed.d153.s1305.p0", "text": "On the other hand, cells expressing ADA and CD26 on the surface were much more resistant to the inhibitory effect of adenosine.", "text_with_entity_marker": "On the other hand, cells expressing [E1]ADA[/E1] and [E2]CD26[/E2] on the surface were much more resistant to the inhibitory effect of adenosine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ADA", "entity_1_idx": [[36, 39]], "entity_1_idx_in_text_with_entity_marker": [40, 43], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD26", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d7.s53_AIMed.d7.s53.p0", "text": "A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.", "text_with_entity_marker": "A comparative study of [E1]E-cadherin[/E1] and [E2]stromelysin-3[/E2] expression in de novo and ex adenoma carcinoma of the colorectum.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[23, 33]], "entity_1_idx_in_text_with_entity_marker": [27, 37], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "stromelysin-3", "entity_2_idx": [[38, 51]], "entity_2_idx_in_text_with_entity_marker": [51, 64], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d7.s56_AIMed.d7.s56.p0", "text": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "text_with_entity_marker": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule ([E1]E-cadherin[/E1]) and protease [[E2]stromelysin-3[/E2] (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "stromelysin-3", "entity_2_idx": [[139, 152]], "entity_2_idx_in_text_with_entity_marker": [152, 165], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d7.s56_AIMed.d7.s56.p1", "text": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "text_with_entity_marker": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule ([E1]E-cadherin[/E1]) and protease [stromelysin-3 ([E2]ST-3[/E2])] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ST-3", "entity_2_idx": [[154, 158]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d7.s56_AIMed.d7.s56.p2", "text": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [stromelysin-3 (ST-3)] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "text_with_entity_marker": "The purpose of the present comparative immunohistochemical study was to compare rates of cell adhesion molecule (E-cadherin) and protease [[E1]stromelysin-3[/E1] ([E2]ST-3[/E2])] expression in groups of de novo (n=64) and ex adenoma (n=42) lesions in order to see whether their more aggressive behavior is associated with decreased cell adhesion and increased protease expression.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "stromelysin-3", "entity_1_idx": [[139, 152]], "entity_1_idx_in_text_with_entity_marker": [143, 156], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ST-3", "entity_2_idx": [[154, 158]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d7.s57_AIMed.d7.s57.p0", "text": "The rates of extensive ST-3 expression and decreased E-cadherin expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively).", "text_with_entity_marker": "The rates of extensive [E1]ST-3[/E1] expression and decreased [E2]E-cadherin[/E2] expression were significantly higher in the de novo group (P=0.014 and 0.005, respectively).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ST-3", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[53, 63]], "entity_2_idx_in_text_with_entity_marker": [66, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1263_AIMed.d149.s1263.p0", "text": "GRB2, a small protein comprising one SH2 domain and two SH3 domains, represents the human homologue of the Caenorhabditis elegans protein, sem-5.", "text_with_entity_marker": "[E1]GRB2[/E1], a small protein comprising one SH2 domain and two SH3 domains, represents the human homologue of the Caenorhabditis elegans protein, [E2]sem-5[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GRB2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sem-5", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1264_AIMed.d149.s1264.p0", "text": "Both GRB2 and sem-5 have been implicated in a highly conserved mechanism that regulates p21ras signalling by receptor tyrosine kinases.", "text_with_entity_marker": "Both [E1]GRB2[/E1] and [E2]sem-5[/E2] have been implicated in a highly conserved mechanism that regulates p21ras signalling by receptor tyrosine kinases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GRB2", "entity_1_idx": [[5, 9]], "entity_1_idx_in_text_with_entity_marker": [9, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "sem-5", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1264_AIMed.d149.s1264.p1", "text": "Both GRB2 and sem-5 have been implicated in a highly conserved mechanism that regulates p21ras signalling by receptor tyrosine kinases.", "text_with_entity_marker": "Both [E1]GRB2[/E1] and sem-5 have been implicated in a highly conserved mechanism that regulates [E2]p21ras[/E2] signalling by receptor tyrosine kinases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "GRB2", "entity_1_idx": [[5, 9]], "entity_1_idx_in_text_with_entity_marker": [9, 13], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21ras", "entity_2_idx": [[88, 94]], "entity_2_idx_in_text_with_entity_marker": [101, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1264_AIMed.d149.s1264.p2", "text": "Both GRB2 and sem-5 have been implicated in a highly conserved mechanism that regulates p21ras signalling by receptor tyrosine kinases.", "text_with_entity_marker": "Both GRB2 and [E1]sem-5[/E1] have been implicated in a highly conserved mechanism that regulates [E2]p21ras[/E2] signalling by receptor tyrosine kinases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "sem-5", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21ras", "entity_2_idx": [[88, 94]], "entity_2_idx_in_text_with_entity_marker": [101, 107], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d149.s1266_AIMed.d149.s1266.p0", "text": "One protein is the major insulin receptor substrate IRS-1 and the second is the SH2 domain-containing oncogenic protein, Shc.", "text_with_entity_marker": "One protein is the major insulin receptor substrate [E1]IRS-1[/E1] and the second is the SH2 domain-containing oncogenic protein, [E2]Shc[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IRS-1", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Shc", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1738_AIMed.d202.s1738.p0", "text": "Interleukin-1 (IL-1) is an important mediator of inflammatory disease.", "text_with_entity_marker": "[E1]Interleukin-1[/E1] ([E2]IL-1[/E2]) is an important mediator of inflammatory disease.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Interleukin-1", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1", "entity_2_idx": [[15, 19]], "entity_2_idx_in_text_with_entity_marker": [28, 32], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p0", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The [E1]IL-1[/E1] family currently consists of two agonists, [E2]IL-1alpha[/E2] and IL-1beta, and one antagonist, IL-1ra.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1alpha", "entity_2_idx": [[52, 61]], "entity_2_idx_in_text_with_entity_marker": [65, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p1", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The [E1]IL-1[/E1] family currently consists of two agonists, IL-1alpha and [E2]IL-1beta[/E2], and one antagonist, IL-1ra.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1beta", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p2", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The [E1]IL-1[/E1] family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, [E2]IL-1ra[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1ra", "entity_2_idx": [[96, 102]], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p3", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The IL-1 family currently consists of two agonists, [E1]IL-1alpha[/E1] and [E2]IL-1beta[/E2], and one antagonist, IL-1ra.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[52, 61]], "entity_1_idx_in_text_with_entity_marker": [56, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1beta", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p4", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The IL-1 family currently consists of two agonists, [E1]IL-1alpha[/E1] and IL-1beta, and one antagonist, [E2]IL-1ra[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1alpha", "entity_1_idx": [[52, 61]], "entity_1_idx_in_text_with_entity_marker": [56, 65], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1ra", "entity_2_idx": [[96, 102]], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1739_AIMed.d202.s1739.p5", "text": "The IL-1 family currently consists of two agonists, IL-1alpha and IL-1beta, and one antagonist, IL-1ra.", "text_with_entity_marker": "The IL-1 family currently consists of two agonists, IL-1alpha and [E1]IL-1beta[/E1], and one antagonist, [E2]IL-1ra[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1beta", "entity_1_idx": [[66, 74]], "entity_1_idx_in_text_with_entity_marker": [70, 78], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1ra", "entity_2_idx": [[96, 102]], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1740_AIMed.d202.s1740.p0", "text": "Each of these molecules binds to the type I IL-1 receptor (IL1R).", "text_with_entity_marker": "Each of these molecules binds to the [E1]type I IL-1 receptor[/E1][E2]IL-1[/E2] receptor (IL1R).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "type I IL-1 receptor", "entity_1_idx": [[37, 57]], "entity_1_idx_in_text_with_entity_marker": [41, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-1", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1740_AIMed.d202.s1740.p1", "text": "Each of these molecules binds to the type I IL-1 receptor (IL1R).", "text_with_entity_marker": "Each of these molecules binds to the type I [E1]IL-1[/E1] receptor ([E2]IL1R[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IL-1", "entity_1_idx": [[44, 48]], "entity_1_idx_in_text_with_entity_marker": [48, 52], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1R", "entity_2_idx": [[59, 63]], "entity_2_idx_in_text_with_entity_marker": [72, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d202.s1740_AIMed.d202.s1740.p2", "text": "Each of these molecules binds to the type I IL-1 receptor (IL1R).", "text_with_entity_marker": "Each of these molecules binds to the [E1]type I IL-1 receptor[/E1] ([E2]IL1R[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "type I IL-1 receptor", "entity_1_idx": [[37, 57]], "entity_1_idx_in_text_with_entity_marker": [41, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL1R", "entity_2_idx": [[59, 63]], "entity_2_idx_in_text_with_entity_marker": [72, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d147.s0_BioInfer.d147.s0.p1", "text": "Cofilin was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing actin filament turnover.", "text_with_entity_marker": "[E1]Cofilin[/E1] was identified by peptide sequencing, and cofilin recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing [E2]actin[/E2] filament turnover.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d607.s0_BioInfer.d607.s0.p0", "text": "The drastic effects of the exogenous cofilin on actin assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).", "text_with_entity_marker": "The drastic effects of the exogenous [E1]cofilin[/E1] on [E2]actin[/E2] assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[48, 53]], "entity_2_idx_in_text_with_entity_marker": [61, 66], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d607.s1_BioInfer.d607.s1.p0", "text": "The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that cofilin is deeply involved in the regulation of actin assembly in developing skeletal muscle.", "text_with_entity_marker": "The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that [E1]cofilin[/E1] is deeply involved in the regulation of [E2]actin[/E2] assembly in developing skeletal muscle.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[87, 94]], "entity_1_idx_in_text_with_entity_marker": [91, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[135, 140]], "entity_2_idx_in_text_with_entity_marker": [148, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d553.s0_BioInfer.d553.s0.p0", "text": "Studies on the interaction between actin and cofilin purified by a new method.", "text_with_entity_marker": "Studies on the interaction between [E1]actin[/E1] and [E2]cofilin[/E2] purified by a new method.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[45, 52]], "entity_2_idx_in_text_with_entity_marker": [58, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d742.s0_BioInfer.d742.s0.p0", "text": "This novel mutation was predicted to disrupt the binding of beta-catenin to alpha-catenin and may be related to the diffuse type morphology.", "text_with_entity_marker": "This novel mutation was predicted to disrupt the binding of [E1]beta-catenin[/E1] to [E2]alpha-catenin[/E2] and may be related to the diffuse type morphology.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[76, 89]], "entity_2_idx_in_text_with_entity_marker": [89, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d750.s0_BioInfer.d750.s0.p5", "text": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: Armadillo (homolog of beta-catenin), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "text_with_entity_marker": "Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: [E1]Armadillo[/E1] (homolog of [E2]beta-catenin[/E2]), Drosophila E-cadherin (DE-cadherin), and alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Armadillo", "entity_1_idx": [[108, 117]], "entity_1_idx_in_text_with_entity_marker": [112, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[130, 142]], "entity_2_idx_in_text_with_entity_marker": [143, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d37.s0_BioInfer.d37.s0.p0", "text": "All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between profilin and monomeric actin with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.", "text_with_entity_marker": "All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between [E1]profilin[/E1] and monomeric [E2]actin[/E2] with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[101, 109]], "entity_1_idx_in_text_with_entity_marker": [105, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d37.s1_BioInfer.d37.s1.p0", "text": "The interaction of Acanthamoeba actin and Acanthamoeba profilin was evaluated as a function of ionic conditions.", "text_with_entity_marker": "The interaction of Acanthamoeba [E1]actin[/E1] and Acanthamoeba [E2]profilin[/E2] was evaluated as a function of ionic conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[55, 63]], "entity_2_idx_in_text_with_entity_marker": [68, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p0", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of [E1]oncostatin M[/E1] (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oncostatin M", "entity_1_idx": [[106, 118]], "entity_1_idx_in_text_with_entity_marker": [110, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p8", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding [E1]cytokines[/E1] can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cytokines", "entity_1_idx": [[71, 80]], "entity_1_idx_in_text_with_entity_marker": [75, 84], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p9", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with [E1]interleukin-1alpha[/E1] (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "interleukin-1alpha", "entity_1_idx": [[156, 174]], "entity_1_idx_in_text_with_entity_marker": [160, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p10", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha ([E1]IL-1alpha[/E1]) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-1alpha", "entity_1_idx": [[176, 185]], "entity_1_idx_in_text_with_entity_marker": [180, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p13", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M ([E1]OSM[/E1]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and [E2]collagenase[/E2] expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "OSM", "entity_1_idx": [[120, 123]], "entity_1_idx_in_text_with_entity_marker": [124, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagenase", "entity_2_idx": [[230, 241]], "entity_2_idx_in_text_with_entity_marker": [243, 254], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p0", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] muscarinic receptors are involved in muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p5", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in [E1]muscarinic receptor[/E1]-mediated enhancement of [E2]IL-2[/E2] production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "muscarinic receptor", "entity_1_idx": [[66, 85]], "entity_1_idx_in_text_with_entity_marker": [70, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p12", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that [E1]M1[/E1] [E2]muscarinic receptors[/E2] are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "M1", "entity_1_idx": [[26, 28]], "entity_1_idx_in_text_with_entity_marker": [30, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscarinic receptors", "entity_2_idx": [[29, 49]], "entity_2_idx_in_text_with_entity_marker": [42, 62], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p33", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and [E1]c-Jun N-terminal kinase[/E1], but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Jun N-terminal kinase", "entity_1_idx": [[288, 311]], "entity_1_idx_in_text_with_entity_marker": [292, 315], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p42", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the [E1]muscarinic receptor[/E1]-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "muscarinic receptor", "entity_1_idx": [[358, 377]], "entity_1_idx_in_text_with_entity_marker": [362, 381], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p45", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/[E1]extracellular signal regulated protein kinase[/E1] and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "extracellular signal regulated protein kinase", "entity_1_idx": [[238, 283]], "entity_1_idx_in_text_with_entity_marker": [242, 287], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p46", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase ([E1]MAPK[/E1])/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MAPK", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p47", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor [E1]AP-1[/E1] and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AP-1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p48", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via [E1]p38[/E1] MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p38", "entity_1_idx": [[325, 328]], "entity_1_idx_in_text_with_entity_marker": [329, 332], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d613.s0_BioInfer.d613.s0.p49", "text": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via mitogen-activated protein kinase (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of IL-2 production.", "text_with_entity_marker": "The findings suggest that M1 muscarinic receptors are involved in muscarinic receptor-mediated enhancement of IL-2 production in Jurkat cells and that the transcription factor AP-1 and pathways via [E1]mitogen-activated protein kinase[/E1] (MAPK)/extracellular signal regulated protein kinase and c-Jun N-terminal kinase, but not via p38 MAPK, may be involved in the muscarinic receptor-mediated enhancement of [E2]IL-2[/E2] production.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[198, 230]], "entity_1_idx_in_text_with_entity_marker": [202, 234], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "IL-2", "entity_2_idx": [[402, 406]], "entity_2_idx_in_text_with_entity_marker": [415, 419], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d176.s0_BioInfer.d176.s0.p1", "text": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that profilin is directly involved in intracellular pathogen locomotion and reorganization of actin cytoskeleton of the host cell peripheral membrane.", "text_with_entity_marker": "Dispersal of profilin from such sites by oligoproline-rich peptide inhibitors suggests that [E1]profilin[/E1] is directly involved in intracellular pathogen locomotion and reorganization of [E2]actin[/E2] cytoskeleton of the host cell peripheral membrane.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[181, 186]], "entity_2_idx_in_text_with_entity_marker": [194, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d257.s0_BioInfer.d257.s0.p0", "text": "Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 encodes a heterotrimeric [E1]helicase-primase[/E1] complex that is composed of the products of the UL5, [E2]UL52[/E2], and UL8 genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[53, 69]], "entity_1_idx_in_text_with_entity_marker": [57, 73], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[123, 127]], "entity_2_idx_in_text_with_entity_marker": [136, 140], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d257.s0_BioInfer.d257.s0.p3", "text": "Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 encodes a heterotrimeric [E1]helicase-primase[/E1] complex that is composed of the products of the [E2]UL5[/E2], UL52, and UL8 genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[53, 69]], "entity_1_idx_in_text_with_entity_marker": [57, 73], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[118, 121]], "entity_2_idx_in_text_with_entity_marker": [131, 134], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d257.s0_BioInfer.d257.s0.p4", "text": "Herpes simplex virus type 1 encodes a heterotrimeric helicase-primase complex that is composed of the products of the UL5, UL52, and UL8 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 encodes a heterotrimeric [E1]helicase-primase[/E1] complex that is composed of the products of the UL5, UL52, and [E2]UL8[/E2] genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[53, 69]], "entity_1_idx_in_text_with_entity_marker": [57, 73], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[133, 136]], "entity_2_idx_in_text_with_entity_marker": [146, 149], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d139.s0_BioInfer.d139.s0.p0", "text": "Characterization of the action of porcine brain profilin on actin polymerization.", "text_with_entity_marker": "Characterization of the action of porcine [E1]brain profilin[/E1] on [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "brain profilin", "entity_1_idx": [[42, 56]], "entity_1_idx_in_text_with_entity_marker": [46, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d139.s1_BioInfer.d139.s1.p0", "text": "Moreover, addition of profilin to steady-state actin filaments causes slow depolymerization.", "text_with_entity_marker": "Moreover, addition of [E1]profilin[/E1] to steady-state [E2]actin[/E2] filaments causes slow depolymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[47, 52]], "entity_2_idx_in_text_with_entity_marker": [60, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d797.s0_BioInfer.d797.s0.p0", "text": "We believe that this complex may mediate the cortical functions of profilin at actin patches in S. pombe.", "text_with_entity_marker": "We believe that this complex may mediate the cortical functions of [E1]profilin[/E1] at [E2]actin[/E2] patches in S. pombe.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[79, 84]], "entity_2_idx_in_text_with_entity_marker": [92, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p0", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-[E2]ER[/E2] protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ER", "entity_2_idx": [[34, 36]], "entity_2_idx_in_text_with_entity_marker": [47, 49], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p1", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-ER protein leads to an accumulation of high levels of [E2]cyclin D1[/E2] protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[88, 97]], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p3", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the [E1]c-Raf-1-BxB[/E1]-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E2]p27Kip1[/E2] cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Raf-1-BxB", "entity_1_idx": [[22, 33]], "entity_1_idx_in_text_with_entity_marker": [26, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27Kip1", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p4", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-[E1]ER[/E1] protein leads to an accumulation of high levels of [E2]cyclin D1[/E2] protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ER", "entity_1_idx": [[34, 36]], "entity_1_idx_in_text_with_entity_marker": [38, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D1", "entity_2_idx": [[88, 97]], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p6", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-[E1]ER[/E1] protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E2]p27Kip1[/E2] cyclin-dependent kinase inhibitor under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ER", "entity_1_idx": [[34, 36]], "entity_1_idx_in_text_with_entity_marker": [38, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p27Kip1", "entity_2_idx": [[130, 137]], "entity_2_idx_in_text_with_entity_marker": [143, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d568.s0_BioInfer.d568.s0.p9", "text": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.", "text_with_entity_marker": "The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the [E1]p27Kip1[/E1] [E2]cyclin-dependent kinase inhibitor[/E2] under all culture conditions tested.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27Kip1", "entity_1_idx": [[130, 137]], "entity_1_idx_in_text_with_entity_marker": [134, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[138, 171]], "entity_2_idx_in_text_with_entity_marker": [151, 184], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p6", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of [E1]ActA[/E1] binds one actin monomer, in a [E2]profilin[/E2]-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[78, 86]], "entity_2_idx_in_text_with_entity_marker": [91, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d252.s0_BioInfer.d252.s0.p21", "text": "Here we show that the N-terminal domain of ActA binds one actin monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "text_with_entity_marker": "Here we show that the N-terminal domain of [E1]ActA[/E1] binds one [E2]actin[/E2] monomer, in a profilin-like fashion, and Arp2/3 complex and mimics the C-terminal domain of WASp family proteins in catalyzing filament barbed end branching by Arp2/3 complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ActA", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d626.s0_BioInfer.d626.s0.p0", "text": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein talin and the yeast protein Sla2p.", "text_with_entity_marker": "The I/LWEQ module is a conserved sequence that we have identified as an [E1]actin[/E1]-binding motif in the metazoan focal adhesion protein [E2]talin[/E2] and the yeast protein Sla2p.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d626.s0_BioInfer.d626.s0.p1", "text": "The I/LWEQ module is a conserved sequence that we have identified as an actin-binding motif in the metazoan focal adhesion protein talin and the yeast protein Sla2p.", "text_with_entity_marker": "The I/LWEQ module is a conserved sequence that we have identified as an [E1]actin[/E1]-binding motif in the metazoan focal adhesion protein talin and the yeast protein [E2]Sla2p[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sla2p", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d464.s0_BioInfer.d464.s0.p2", "text": "Only the unphosphorylated form of cofilin is an active form that binds actin, whereas the regulatory mechanisms of cofilin have not been elucidated.", "text_with_entity_marker": "Only the unphosphorylated form of [E1]cofilin[/E1] is an active form that binds [E2]actin[/E2], whereas the regulatory mechanisms of cofilin have not been elucidated.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[34, 41]], "entity_1_idx_in_text_with_entity_marker": [38, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d66.s0_BioInfer.d66.s0.p5", "text": "Another cyclin-dependent kinase inhibitor, p27KIP1, and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "text_with_entity_marker": "Another [E1]cyclin-dependent kinase inhibitor[/E1], [E2]p27KIP1[/E2], and cyclin D increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[8, 41]], "entity_1_idx_in_text_with_entity_marker": [12, 45], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27KIP1", "entity_2_idx": [[43, 50]], "entity_2_idx_in_text_with_entity_marker": [56, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s0_BioInfer.d652.s0.p0", "text": "The N-terminal talin polypeptide eventually disrupted actin stress fibres whereas the C-terminal polypeptide was without effect.", "text_with_entity_marker": "The N-terminal [E1]talin[/E1] polypeptide eventually disrupted [E2]actin[/E2] stress fibres whereas the C-terminal polypeptide was without effect.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s1_BioInfer.d652.s1.p0", "text": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.", "text_with_entity_marker": "The Pro1176 to Thr substitution found in [E1]talin[/E1] from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind [E2]actin[/E2] or vinculin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[138, 143]], "entity_2_idx_in_text_with_entity_marker": [151, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d652.s1_BioInfer.d652.s1.p2", "text": "The Pro1176 to Thr substitution found in talin from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or vinculin.", "text_with_entity_marker": "The Pro1176 to Thr substitution found in [E1]talin[/E1] from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind actin or [E2]vinculin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[41, 46]], "entity_1_idx_in_text_with_entity_marker": [45, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[147, 155]], "entity_2_idx_in_text_with_entity_marker": [160, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p0", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that [E1]profilin[/E1] binding to actin weakens the affinity of [E2]actin[/E2] for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p1", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that profilin binding to [E1]actin[/E1] weakens the affinity of [E2]actin[/E2] for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[85, 90]], "entity_2_idx_in_text_with_entity_marker": [98, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s0_BioInfer.d398.s0.p2", "text": "Kinetic measurements indicate that profilin binding to actin weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "text_with_entity_marker": "Kinetic measurements indicate that [E1]profilin[/E1] binding to [E2]actin[/E2] weakens the affinity of actin for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[35, 43]], "entity_1_idx_in_text_with_entity_marker": [39, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p0", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to [E1]actin[/E1] weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p1", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to actin weakens nucleotide binding to [E1]actin[/E1] by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[78, 83]], "entity_1_idx_in_text_with_entity_marker": [82, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p2", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the [E2]actin[/E2] central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p3", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that profilin binding to [E1]actin[/E1] weakens nucleotide binding to [E2]actin[/E2] by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[42, 47]], "entity_1_idx_in_text_with_entity_marker": [46, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p4", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to [E2]actin[/E2] weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d398.s1_BioInfer.d398.s1.p5", "text": "The data suggest that profilin binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.", "text_with_entity_marker": "The data suggest that [E1]profilin[/E1] binding to actin weakens nucleotide binding to [E2]actin[/E2] by disrupting Mg(2+) coordination in the actin central cleft.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[78, 83]], "entity_2_idx_in_text_with_entity_marker": [91, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s0_BioInfer.d183.s0.p0", "text": "Dynamic actin structures stabilized by profilin.", "text_with_entity_marker": "Dynamic [E1]actin[/E1] structures stabilized by [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[39, 47]], "entity_2_idx_in_text_with_entity_marker": [52, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d183.s1_BioInfer.d183.s1.p0", "text": "The distribution of actin filaments is altered by profilin overexpression.", "text_with_entity_marker": "The distribution of [E1]actin[/E1] filaments is altered by [E2]profilin[/E2] overexpression.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[50, 58]], "entity_2_idx_in_text_with_entity_marker": [63, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d773.s0_BioInfer.d773.s0.p0", "text": "Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, GAL4, and a negative regulatory protein, GAL80.", "text_with_entity_marker": "Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, [E1]GAL4[/E1], and a negative regulatory protein, [E2]GAL80[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GAL4", "entity_1_idx": [[130, 134]], "entity_1_idx_in_text_with_entity_marker": [134, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "GAL80", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d356.s0_BioInfer.d356.s0.p0", "text": "Integrating the actin and vimentin cytoskeletons.", "text_with_entity_marker": "Integrating the [E1]actin[/E1] and [E2]vimentin[/E2] cytoskeletons.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p2", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of cyclin E, a G1 cyclin, and [E1]p27kip[/E1], a [E2]cyclin-dependent kinase inhibitor[/E2], in BALB/c 3T3 cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p27kip", "entity_1_idx": [[57, 63]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[67, 100]], "entity_2_idx_in_text_with_entity_marker": [80, 113], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d812.s0_BioInfer.d812.s0.p3", "text": "We have examined the level of cyclin E, a G1 cyclin, and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "text_with_entity_marker": "We have examined the level of [E1]cyclin E[/E1], a [E2]G1 cyclin[/E2], and p27kip, a cyclin-dependent kinase inhibitor, in BALB/c 3T3 cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G1 cyclin", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p0", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the [E1]actin[/E1] crystal structure previously defined as the [E2]fimbrin[/E2] (Sac6p)-binding site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[206, 213]], "entity_2_idx_in_text_with_entity_marker": [219, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d538.s0_BioInfer.d538.s0.p1", "text": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the actin crystal structure previously defined as the fimbrin (Sac6p)-binding site.", "text_with_entity_marker": "Significantly, those actin mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the [E1]actin[/E1] crystal structure previously defined as the fimbrin ([E2]Sac6p[/E2])-binding site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sac6p", "entity_2_idx": [[215, 220]], "entity_2_idx_in_text_with_entity_marker": [228, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p0", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this actin clustering, [E1]profilin[/E1], a monomeric actin-binding protein that has been suggested to be involved in [E2]actin[/E2] polymerization, was shown to be essential.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[112, 117]], "entity_2_idx_in_text_with_entity_marker": [125, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p1", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this [E1]actin[/E1] clustering, [E2]profilin[/E2], a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[8, 13]], "entity_1_idx_in_text_with_entity_marker": [12, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[26, 34]], "entity_2_idx_in_text_with_entity_marker": [39, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d373.s0_BioInfer.d373.s0.p2", "text": "In this actin clustering, profilin, a monomeric actin-binding protein that has been suggested to be involved in actin polymerization, was shown to be essential.", "text_with_entity_marker": "In this actin clustering, [E1]profilin[/E1], a monomeric [E2]actin-binding protein[/E2] that has been suggested to be involved in actin polymerization, was shown to be essential.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[48, 69]], "entity_2_idx_in_text_with_entity_marker": [61, 82], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d701.s0_BioInfer.d701.s0.p2", "text": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the actin and myosin heavy chain families are independently regulated in human heart.", "text_with_entity_marker": "These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the skeletal actin gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the [E1]actin[/E1] and [E2]myosin heavy chain[/E2] families are independently regulated in human heart.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[256, 261]], "entity_1_idx_in_text_with_entity_marker": [260, 265], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[266, 284]], "entity_2_idx_in_text_with_entity_marker": [279, 297], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p1", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for [E2]semaphorins[/E2], mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorins", "entity_2_idx": [[60, 71]], "entity_2_idx_in_text_with_entity_marker": [73, 84], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p2", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for [E2]vascular endothelial growth factor 165[/E2] (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor 165", "entity_2_idx": [[113, 151]], "entity_2_idx_in_text_with_entity_marker": [126, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p3", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "[E1]Neuropilin-1[/E1] (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Neuropilin-1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p4", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for [E2]semaphorins[/E2], mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "semaphorins", "entity_2_idx": [[60, 71]], "entity_2_idx_in_text_with_entity_marker": [73, 84], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p5", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for [E2]vascular endothelial growth factor 165[/E2] (VEGF(165)), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor 165", "entity_2_idx": [[113, 151]], "entity_2_idx_in_text_with_entity_marker": [126, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s0_BioInfer.d109.s0.p6", "text": "Neuropilin-1 (NRP1) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 (VEGF(165)), an angiogenesis factor.", "text_with_entity_marker": "Neuropilin-1 ([E1]NRP1[/E1]) is a 130-kDa transmembrane receptor for semaphorins, mediators of neuronal guidance, and for vascular endothelial growth factor 165 ([E2]VEGF(165)[/E2]), an angiogenesis factor.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF(165)", "entity_2_idx": [[153, 162]], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p15", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/[E1]coagulation factor[/E1] homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "coagulation factor", "entity_1_idx": [[123, 141]], "entity_1_idx_in_text_with_entity_marker": [127, 145], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d341.s0_BioInfer.d341.s0.p0", "text": "Inhibition of cyclin D1 expression or induction of cyclin-dependent kinase inhibitor p21WAF1 expression was found in mimosine-treated lung cancer cells.", "text_with_entity_marker": "Inhibition of cyclin D1 expression or induction of [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21WAF1[/E2] expression was found in mimosine-treated lung cancer cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[51, 84]], "entity_1_idx_in_text_with_entity_marker": [55, 88], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21WAF1", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p0", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, [E1]MEC3[/E1] and [E2]RAD24[/E2] epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MEC3", "entity_1_idx": [[61, 65]], "entity_1_idx_in_text_with_entity_marker": [65, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD24", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p1", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae [E1]DDC1[/E1] gene belongs to the RAD17, [E2]MEC3[/E2] and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DDC1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEC3", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p3", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae DDC1 gene belongs to the [E1]RAD17[/E1], [E2]MEC3[/E2] and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD17", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MEC3", "entity_2_idx": [[61, 65]], "entity_2_idx_in_text_with_entity_marker": [74, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p4", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae [E1]DDC1[/E1] gene belongs to the RAD17, MEC3 and [E2]RAD24[/E2] epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DDC1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD24", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p6", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae DDC1 gene belongs to the [E1]RAD17[/E1], MEC3 and [E2]RAD24[/E2] epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD17", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAD24", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d690.s0_BioInfer.d690.s0.p8", "text": "The Saccharomyces cerevisiae DDC1 gene belongs to the RAD17, MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "text_with_entity_marker": "The Saccharomyces cerevisiae [E1]DDC1[/E1] gene belongs to the [E2]RAD17[/E2], MEC3 and RAD24 epistasis group which, together with RAD9, is proposed to act at the beginning of the DNA damage checkpoint pathway.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DDC1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD17", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d318.s0_BioInfer.d318.s0.p0", "text": "In adherens junctions, the cytoplasmic domain of cadherins bind to beta-catenin, which in turn binds to the actin-associated protein alpha-catenin.", "text_with_entity_marker": "In adherens junctions, the cytoplasmic domain of cadherins bind to [E1]beta-catenin[/E1], which in turn binds to the actin-associated protein [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[133, 146]], "entity_2_idx_in_text_with_entity_marker": [146, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d318.s0_BioInfer.d318.s0.p2", "text": "In adherens junctions, the cytoplasmic domain of cadherins bind to beta-catenin, which in turn binds to the actin-associated protein alpha-catenin.", "text_with_entity_marker": "In adherens junctions, the cytoplasmic domain of cadherins bind to beta-catenin, which in turn binds to the [E1]actin[/E1]-associated protein [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[108, 113]], "entity_1_idx_in_text_with_entity_marker": [112, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[133, 146]], "entity_2_idx_in_text_with_entity_marker": [146, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d318.s0_BioInfer.d318.s0.p3", "text": "In adherens junctions, the cytoplasmic domain of cadherins bind to beta-catenin, which in turn binds to the actin-associated protein alpha-catenin.", "text_with_entity_marker": "In adherens junctions, the cytoplasmic domain of [E1]cadherins[/E1] bind to [E2]beta-catenin[/E2], which in turn binds to the actin-associated protein alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherins", "entity_1_idx": [[49, 58]], "entity_1_idx_in_text_with_entity_marker": [53, 62], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "beta-catenin", "entity_2_idx": [[67, 79]], "entity_2_idx_in_text_with_entity_marker": [80, 92], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p2", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch [E1]pollen profilin[/E1] and [E2]actin[/E2] can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "pollen profilin", "entity_1_idx": [[6, 21]], "entity_1_idx_in_text_with_entity_marker": [10, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[26, 31]], "entity_2_idx_in_text_with_entity_marker": [39, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s0_BioInfer.d102.s0.p3", "text": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch profilin can be used as an affinity matrix to obtain birch pollen actin.", "text_with_entity_marker": "Birch pollen profilin and actin can be copurified as a complex, and purified recombinant birch [E1]profilin[/E1] can be used as an affinity matrix to obtain birch [E2]pollen actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[95, 103]], "entity_1_idx_in_text_with_entity_marker": [99, 107], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pollen actin", "entity_2_idx": [[154, 166]], "entity_2_idx_in_text_with_entity_marker": [167, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s1_BioInfer.d102.s1.p0", "text": "In this study, profilin is identified as an actin-binding protein in higher plants which is present in monocot and dicot angiosperms.", "text_with_entity_marker": "In this study, [E1]profilin[/E1] is identified as an [E2]actin-binding protein[/E2] in higher plants which is present in monocot and dicot angiosperms.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[15, 23]], "entity_1_idx_in_text_with_entity_marker": [19, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[44, 65]], "entity_2_idx_in_text_with_entity_marker": [57, 78], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p0", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by [E1]profilin[/E1]-specific antibodies that react with different epitopes of birch [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[107, 115]], "entity_1_idx_in_text_with_entity_marker": [111, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p1", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal [E1]actins[/E1] can be blocked by [E2]profilin[/E2]-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actins", "entity_1_idx": [[82, 88]], "entity_1_idx_in_text_with_entity_marker": [86, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p2", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen [E1]profilin[/E1] to plant and animal actins can be blocked by [E2]profilin[/E2]-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d102.s2_BioInfer.d102.s2.p5", "text": "The binding of 125I-labeled recombinant birch pollen profilin to plant and animal actins can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "text_with_entity_marker": "The binding of 125I-labeled recombinant birch pollen [E1]profilin[/E1] to plant and animal [E2]actins[/E2] can be blocked by profilin-specific antibodies that react with different epitopes of birch profilin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[53, 61]], "entity_1_idx_in_text_with_entity_marker": [57, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actins", "entity_2_idx": [[82, 88]], "entity_2_idx_in_text_with_entity_marker": [95, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d658.s0_BioInfer.d658.s0.p0", "text": "The phosphoprotein was identified as cofilin, an actin-binding protein, and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).", "text_with_entity_marker": "The phosphoprotein was identified as [E1]cofilin[/E1], an [E2]actin-binding protein[/E2], and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[37, 44]], "entity_1_idx_in_text_with_entity_marker": [41, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[49, 70]], "entity_2_idx_in_text_with_entity_marker": [62, 83], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p2", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of [E1]integrin[/E1] subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[104, 112]], "entity_1_idx_in_text_with_entity_marker": [108, 116], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p5", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, [E1]vinculin[/E1], and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[130, 138]], "entity_1_idx_in_text_with_entity_marker": [134, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p7", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, [E1]talin[/E1], vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[123, 128]], "entity_1_idx_in_text_with_entity_marker": [127, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d475.s0_BioInfer.d475.s0.p9", "text": "Our results showed that cell morphology, cell adhesion pattern, actin organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the collagens.", "text_with_entity_marker": "Our results showed that cell morphology, cell adhesion pattern, [E1]actin[/E1] organization, and distribution of integrin subunits, talin, vinculin, and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the [E2]collagens[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[64, 69]], "entity_1_idx_in_text_with_entity_marker": [68, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagens", "entity_2_idx": [[236, 245]], "entity_2_idx_in_text_with_entity_marker": [249, 258], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p1", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p2", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for [E2]vascular endothelial growth factor[/E2] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[38, 72], [80, 83]], "entity_2_idx_in_text_with_entity_marker": [51, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p3", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p4", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p7", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "Neuropilin 1 ([E1]NP-1[/E1]) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "NP-1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p8", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 ([E2]VEGFR-2[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGFR-2", "entity_2_idx": [[191, 198]], "entity_2_idx_in_text_with_entity_marker": [204, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p9", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for [E2]vascular endothelial growth factor[/E2] (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vascular endothelial growth factor", "entity_2_idx": [[38, 72], [80, 83]], "entity_2_idx_in_text_with_entity_marker": [51, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p10", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 ([E2]VEGF165[/E2]) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[85, 92]], "entity_2_idx_in_text_with_entity_marker": [98, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p11", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances [E2]VEGF165[/E2] function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF165", "entity_2_idx": [[133, 140]], "entity_2_idx_in_text_with_entity_marker": [146, 153], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d108.s0_BioInfer.d108.s0.p14", "text": "Neuropilin 1 (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase VEGF receptor 2 (VEGFR-2).", "text_with_entity_marker": "[E1]Neuropilin 1[/E1] (NP-1) is a receptor for vascular endothelial growth factor (VEGF) 165 (VEGF165) and acts as a coreceptor that enhances VEGF165 function through tyrosine kinase [E2]VEGF receptor 2[/E2] (VEGFR-2).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Neuropilin 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "VEGF receptor 2", "entity_2_idx": [[174, 189]], "entity_2_idx_in_text_with_entity_marker": [187, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d707.s0_BioInfer.d707.s0.p0", "text": "These regions also interact with the physiologically relevant ligands of profilin, actin and proline-rich peptides.", "text_with_entity_marker": "These regions also interact with the physiologically relevant ligands of [E1]profilin[/E1], [E2]actin[/E2] and proline-rich peptides.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p1", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast [E1]profilin[/E1] for rabbit [E2]actin[/E2] (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[22, 30]], "entity_1_idx_in_text_with_entity_marker": [26, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s0_BioInfer.d570.s0.p5", "text": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human platelet profilin for rabbit actin (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "text_with_entity_marker": "The affinity of yeast profilin for rabbit actin (2.9 microM) is approximately 30-fold weaker than the affinity of human [E1]platelet profilin[/E1] for rabbit [E2]actin[/E2] (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two profilins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet profilin", "entity_1_idx": [[120, 137]], "entity_1_idx_in_text_with_entity_marker": [124, 141], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[149, 154]], "entity_2_idx_in_text_with_entity_marker": [162, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s1_BioInfer.d570.s1.p0", "text": "The interactions of yeast and human platelet profilins with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "text_with_entity_marker": "The interactions of yeast and human platelet [E1]profilins[/E1] with rabbit [E2]skeletal muscle actin[/E2] were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[45, 54]], "entity_1_idx_in_text_with_entity_marker": [49, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[67, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s1_BioInfer.d570.s1.p2", "text": "The interactions of yeast and human platelet profilins with rabbit skeletal muscle actin were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "text_with_entity_marker": "The interactions of yeast and human [E1]platelet profilins[/E1] with rabbit [E2]skeletal muscle actin[/E2] were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet profilins", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[67, 88]], "entity_2_idx_in_text_with_entity_marker": [80, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s2_BioInfer.d570.s2.p0", "text": "The in vivo and in vitro properties of yeast profilin mutants with altered poly-L-proline and actin binding sites are discussed in the context of the crystal structure.", "text_with_entity_marker": "The in vivo and in vitro properties of yeast [E1]profilin[/E1] mutants with altered poly-L-proline and [E2]actin[/E2] binding sites are discussed in the context of the crystal structure.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p2", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit [E1]skeletal actin[/E1] with human [E2]profilin[/E2] yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "skeletal actin", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d570.s3_BioInfer.d570.s3.p3", "text": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast profilin and pyrene-labeled yeast actin.", "text_with_entity_marker": "The titration of pyrene-labeled rabbit skeletal actin with human profilin yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast [E1]profilin[/E1] and pyrene-labeled yeast [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[168, 176]], "entity_1_idx_in_text_with_entity_marker": [172, 180], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d315.s0_BioInfer.d315.s0.p0", "text": "In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "text_with_entity_marker": "In addition, we have demonstrated that increased gene dosage of either SIR1 or [E1]SIR4[/E1], two other factors required for silencing, suppresses the silencing defect of the [E2]rap1[/E2] mutants.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR4", "entity_1_idx": [[79, 83]], "entity_1_idx_in_text_with_entity_marker": [83, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rap1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d315.s0_BioInfer.d315.s0.p2", "text": "In addition, we have demonstrated that increased gene dosage of either SIR1 or SIR4, two other factors required for silencing, suppresses the silencing defect of the rap1 mutants.", "text_with_entity_marker": "In addition, we have demonstrated that increased gene dosage of either [E1]SIR1[/E1] or SIR4, two other factors required for silencing, suppresses the silencing defect of the [E2]rap1[/E2] mutants.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SIR1", "entity_1_idx": [[71, 75]], "entity_1_idx_in_text_with_entity_marker": [75, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "rap1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p0", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with [E1]myosin[/E1]'s binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p1", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the [E1]myosin heavy chain[/E1] (Myh) predicted to interfere strongly with [E2]myosin[/E2]'s binding to actin was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[41, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p2", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain ([E1]Myh[/E1]) predicted to interfere strongly with [E2]myosin[/E2]'s binding to actin was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myh", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p3", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the [E1]myosin heavy chain[/E1] (Myh) predicted to interfere strongly with myosin's binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[41, 59]], "entity_1_idx_in_text_with_entity_marker": [45, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d413.s0_BioInfer.d413.s0.p4", "text": "MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.", "text_with_entity_marker": "MATERIALS AND METHODS: A mutation in the myosin heavy chain ([E1]Myh[/E1]) predicted to interfere strongly with myosin's binding to [E2]actin[/E2] was designed and used to create an animal model for HCM.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Myh", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s0_BioInfer.d522.s0.p0", "text": "Reversible binding of actin to gelsolin and profilin in human platelet extracts.", "text_with_entity_marker": "Reversible binding of [E1]actin[/E1] to gelsolin and [E2]profilin[/E2] in human platelet extracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[44, 52]], "entity_2_idx_in_text_with_entity_marker": [57, 65], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s0_BioInfer.d522.s0.p2", "text": "Reversible binding of actin to gelsolin and profilin in human platelet extracts.", "text_with_entity_marker": "Reversible binding of [E1]actin[/E1] to [E2]gelsolin[/E2] and profilin in human platelet extracts.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gelsolin", "entity_2_idx": [[31, 39]], "entity_2_idx_in_text_with_entity_marker": [44, 52], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s1_BioInfer.d522.s1.p0", "text": "Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).", "text_with_entity_marker": "Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and [E1]profilin[/E1], respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to [E2]actin[/E2] with sufficient affinity to withstand dilution (high-affinity complexes).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[122, 130]], "entity_1_idx_in_text_with_entity_marker": [126, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s1_BioInfer.d522.s1.p1", "text": "Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract gelsolin and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to actin with sufficient affinity to withstand dilution (high-affinity complexes).", "text_with_entity_marker": "Sepharose beads coupled to either monoclonal anti-gelsolin antibodies or to polyproline were used to extract [E1]gelsolin[/E1] and profilin, respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to [E2]actin[/E2] with sufficient affinity to withstand dilution (high-affinity complexes).", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "gelsolin", "entity_1_idx": [[109, 117]], "entity_1_idx_in_text_with_entity_marker": [113, 121], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s2_BioInfer.d522.s2.p0", "text": "Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "text_with_entity_marker": "[E1]Thrombin[/E1], within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with [E2]actin[/E2], but these complexes were not present 5 min after stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Thrombin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s2_BioInfer.d522.s2.p1", "text": "Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "text_with_entity_marker": "[E1]Thrombin[/E1], within seconds, caused quantitative conversion of [E2]platelet profilin[/E2] and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Thrombin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet profilin", "entity_2_idx": [[60, 77]], "entity_2_idx_in_text_with_entity_marker": [73, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s2_BioInfer.d522.s2.p2", "text": "Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "text_with_entity_marker": "[E1]Thrombin[/E1], within seconds, caused quantitative conversion of [E2]platelet[/E2] profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Thrombin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet", "entity_2_idx": [[60, 68], [82, 90]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s2_BioInfer.d522.s2.p3", "text": "Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "text_with_entity_marker": "Thrombin, within seconds, caused quantitative conversion of [E1]platelet profilin[/E1] and gelsolin to high-affinity complexes with [E2]actin[/E2], but these complexes were not present 5 min after stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet profilin", "entity_1_idx": [[60, 77]], "entity_1_idx_in_text_with_entity_marker": [64, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d522.s2_BioInfer.d522.s2.p4", "text": "Thrombin, within seconds, caused quantitative conversion of platelet profilin and gelsolin to high-affinity complexes with actin, but these complexes were not present 5 min after stimulation.", "text_with_entity_marker": "Thrombin, within seconds, caused quantitative conversion of [E1]platelet[/E1] profilin and gelsolin to high-affinity complexes with [E2]actin[/E2], but these complexes were not present 5 min after stimulation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet", "entity_1_idx": [[60, 68], [82, 90]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[123, 128]], "entity_2_idx_in_text_with_entity_marker": [136, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p0", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the [E1]actin[/E1] monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p7", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp[/E1]2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[4, 7], [9, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d577.s0_BioInfer.d577.s0.p10", "text": "The Arp2/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein profilin, giving active nucleation over a low background of spontaneous nucleation.", "text_with_entity_marker": "The [E1]Arp2[/E1]/3 complex with full-length Scar, Scar containing P, W, and A domains, or Scar containing W and A domains overcomes inhibition of nucleation by the actin monomer-binding protein [E2]profilin[/E2], giving active nucleation over a low background of spontaneous nucleation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[186, 194]], "entity_2_idx_in_text_with_entity_marker": [199, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d564.s0_BioInfer.d564.s0.p14", "text": "The alpha-catenin molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the actin cytoskeleton.", "text_with_entity_marker": "The [E1]alpha-catenin[/E1] molecule links E-cadherin/ beta-catenin or E-cadherin/plakoglobin complexes to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[4, 17]], "entity_1_idx_in_text_with_entity_marker": [8, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[101, 106]], "entity_2_idx_in_text_with_entity_marker": [114, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p0", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E1]ATPase[/E1] than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ATPase", "entity_1_idx": [[127, 133]], "entity_1_idx_in_text_with_entity_marker": [131, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p1", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher actin-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p5", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E1]actin[/E1]-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d589.s0_BioInfer.d589.s0.p0", "text": "The cadherin-associated proteins, alpha-catenin and beta-catenin, were present in both mesotheliomas and adenocarcinomas.", "text_with_entity_marker": "The [E1]cadherin[/E1]-associated proteins, [E2]alpha-catenin[/E2] and beta-catenin, were present in both mesotheliomas and adenocarcinomas.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[34, 47]], "entity_2_idx_in_text_with_entity_marker": [47, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d589.s0_BioInfer.d589.s0.p1", "text": "The cadherin-associated proteins, alpha-catenin and beta-catenin, were present in both mesotheliomas and adenocarcinomas.", "text_with_entity_marker": "The [E1]cadherin[/E1]-associated proteins, alpha-catenin and [E2]beta-catenin[/E2], were present in both mesotheliomas and adenocarcinomas.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[4, 12]], "entity_1_idx_in_text_with_entity_marker": [8, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[52, 64]], "entity_2_idx_in_text_with_entity_marker": [65, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d447.s0_BioInfer.d447.s0.p0", "text": "Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.", "text_with_entity_marker": "Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of [E1]HSH49[/E1] are not required for interaction with [E2]CUS1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HSH49", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CUS1", "entity_2_idx": [[234, 238]], "entity_2_idx_in_text_with_entity_marker": [247, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d447.s0_BioInfer.d447.s0.p5", "text": "Mutations that alter putative RNA-binding residues of either HSH49 RRM are lethal in vivo, but do not prevent binding to CUS1 in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.", "text_with_entity_marker": "Mutations that alter putative RNA-binding residues of either [E1]HSH49[/E1] RRM are lethal in vivo, but do not prevent binding to [E2]CUS1[/E2] in vitro, suggesting that the predicted RNA-binding surfaces of HSH49 are not required for interaction with CUS1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HSH49", "entity_1_idx": [[61, 66]], "entity_1_idx_in_text_with_entity_marker": [65, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CUS1", "entity_2_idx": [[121, 125]], "entity_2_idx_in_text_with_entity_marker": [134, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d447.s1_BioInfer.d447.s1.p0", "text": "Recombinant HSH49 protein has a general RNA-binding activity that does not require CUS1.", "text_with_entity_marker": "Recombinant [E1]HSH49[/E1] protein has a general RNA-binding activity that does not require [E2]CUS1[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HSH49", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CUS1", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d19.s0_BioInfer.d19.s0.p0", "text": "[Activation induces dephosphorylation of cofilin (an actin/PIP2-binding protein) and its translocation to plasma membranes in leukocytes].", "text_with_entity_marker": "[Activation induces dephosphorylation of [E1]cofilin[/E1] (an [E2]actin[/E2]/PIP2-binding protein) and its translocation to plasma membranes in leukocytes].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[41, 48]], "entity_1_idx_in_text_with_entity_marker": [45, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d223.s0_BioInfer.d223.s0.p1", "text": "Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.", "text_with_entity_marker": "Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for [E1]synaptojanin[/E1] family members in [E2]actin[/E2] function.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "synaptojanin", "entity_1_idx": [[143, 155]], "entity_1_idx_in_text_with_entity_marker": [147, 159], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d223.s0_BioInfer.d223.s0.p6", "text": "Furthermore, the deletion of SJL1 suppresses the temperature-sensitive growth defect of sac6, a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.", "text_with_entity_marker": "Furthermore, the deletion of [E1]SJL1[/E1] suppresses the temperature-sensitive growth defect of [E2]sac6[/E2], a mutant in yeast fimbrin, supporting a role for synaptojanin family members in actin function.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SJL1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "sac6", "entity_2_idx": [[88, 92]], "entity_2_idx_in_text_with_entity_marker": [101, 105], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p4", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[103, 114]], "entity_2_idx_in_text_with_entity_marker": [116, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p5", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, [E1]plakoglobin[/E1], alpha-catenin, and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[103, 114]], "entity_1_idx_in_text_with_entity_marker": [107, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p6", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, [E1]plakoglobin[/E1], [E2]alpha-catenin[/E2], and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[103, 114]], "entity_1_idx_in_text_with_entity_marker": [107, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p7", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], plakoglobin, alpha-catenin, and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p8", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that [E1]beta-catenin[/E1], plakoglobin, [E2]alpha-catenin[/E2], and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[89, 101]], "entity_1_idx_in_text_with_entity_marker": [93, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d289.s0_BioInfer.d289.s0.p9", "text": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, alpha-catenin, and cadherin-5 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "text_with_entity_marker": "Immunofluorescence microscopy of monolayers between 2 and 3 h post-TGF-beta1 showed that beta-catenin, plakoglobin, [E1]alpha-catenin[/E1], and [E2]cadherin-5[/E2] were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin-5", "entity_2_idx": [[135, 145]], "entity_2_idx_in_text_with_entity_marker": [148, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p0", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of [E1]Munc-18-2[/E1] with [E2]syntaxin 3[/E2] controls the association of apical SNAREs in epithelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[30, 40]], "entity_2_idx_in_text_with_entity_marker": [43, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p1", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of [E1]Munc-18-2[/E1] with syntaxin 3 controls the association of apical [E2]SNAREs[/E2] in epithelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Munc-18-2", "entity_1_idx": [[15, 24]], "entity_1_idx_in_text_with_entity_marker": [19, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAREs", "entity_2_idx": [[76, 82]], "entity_2_idx_in_text_with_entity_marker": [89, 95], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s0_BioInfer.d360.s0.p2", "text": "Interaction of Munc-18-2 with syntaxin 3 controls the association of apical SNAREs in epithelial cells.", "text_with_entity_marker": "Interaction of Munc-18-2 with [E1]syntaxin 3[/E1] controls the association of apical [E2]SNAREs[/E2] in epithelial cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "syntaxin 3", "entity_1_idx": [[30, 40]], "entity_1_idx_in_text_with_entity_marker": [34, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAREs", "entity_2_idx": [[76, 82]], "entity_2_idx_in_text_with_entity_marker": [89, 95], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d360.s1_BioInfer.d360.s1.p0", "text": "The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of Munc-18-2 to associate with syntaxin 3 in vitro.", "text_with_entity_marker": "The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of [E1]Munc-18-2[/E1] to associate with [E2]syntaxin 3[/E2] in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Munc-18-2", "entity_1_idx": [[165, 174]], "entity_1_idx_in_text_with_entity_marker": [169, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[193, 203]], "entity_2_idx_in_text_with_entity_marker": [206, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s0_BioInfer.d61.s0.p1", "text": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.", "text_with_entity_marker": "Analysis of various truncated [E1]alpha-catenin[/E1] molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[30, 43]], "entity_1_idx_in_text_with_entity_marker": [34, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[136, 147]], "entity_2_idx_in_text_with_entity_marker": [149, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s0_BioInfer.d61.s0.p2", "text": "Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and plakoglobin.", "text_with_entity_marker": "Analysis of various truncated [E1]alpha-catenin[/E1] molecules revealed that amino-terminal residues 48-163 are able to bind to [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[30, 43]], "entity_1_idx_in_text_with_entity_marker": [34, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[119, 131]], "entity_2_idx_in_text_with_entity_marker": [132, 144], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p3", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and [E1]plakoglobin[/E1] bind to the same region of [E2]alpha-catenin[/E2], beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[54, 65]], "entity_1_idx_in_text_with_entity_marker": [58, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[93, 106]], "entity_2_idx_in_text_with_entity_marker": [106, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p4", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that [E1]beta-catenin[/E1] and plakoglobin bind to the same region of [E2]alpha-catenin[/E2], beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[37, 49]], "entity_1_idx_in_text_with_entity_marker": [41, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[93, 106]], "entity_2_idx_in_text_with_entity_marker": [106, 119], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p5", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, [E1]beta-catenin[/E1] competed with the binding of plakoglobin to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[108, 120]], "entity_1_idx_in_text_with_entity_marker": [112, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s1_BioInfer.d61.s1.p6", "text": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of plakoglobin to alpha-catenin and vice versa.", "text_with_entity_marker": "Consistent with the observation that beta-catenin and plakoglobin bind to the same region of alpha-catenin, beta-catenin competed with the binding of [E1]plakoglobin[/E1] to [E2]alpha-catenin[/E2] and vice versa.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[150, 161]], "entity_1_idx_in_text_with_entity_marker": [154, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[165, 178]], "entity_2_idx_in_text_with_entity_marker": [178, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s2_BioInfer.d61.s2.p1", "text": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in [E1]alpha-catenin[/E1] required for molecular interaction with [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[98, 111]], "entity_1_idx_in_text_with_entity_marker": [102, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[152, 164]], "entity_2_idx_in_text_with_entity_marker": [165, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s2_BioInfer.d61.s2.p2", "text": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in alpha-catenin required for molecular interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Using an in vitro assay system involving bacterially expressed proteins, we localized a region in [E1]alpha-catenin[/E1] required for molecular interaction with beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[98, 111]], "entity_1_idx_in_text_with_entity_marker": [102, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[169, 180]], "entity_2_idx_in_text_with_entity_marker": [182, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d61.s3_BioInfer.d61.s3.p1", "text": "When transfected into L cells expressing E-cadherin, the amino-terminal region of alpha-catenin (from residue 1 to 226) formed complexes with beta-catenin supporting the in vitro binding experiment results.", "text_with_entity_marker": "When transfected into L cells expressing E-cadherin, the amino-terminal region of [E1]alpha-catenin[/E1] (from residue 1 to 226) formed complexes with [E2]beta-catenin[/E2] supporting the in vitro binding experiment results.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[82, 95]], "entity_1_idx_in_text_with_entity_marker": [86, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[142, 154]], "entity_2_idx_in_text_with_entity_marker": [155, 167], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d131.s0_BioInfer.d131.s0.p1", "text": "CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen that contains [E2]dipeptidyl peptidase IV[/E2] activity and is known to bind adenosine deaminase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dipeptidyl peptidase IV", "entity_2_idx": [[50, 73]], "entity_2_idx_in_text_with_entity_marker": [63, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d131.s0_BioInfer.d131.s0.p2", "text": "CD26 is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind adenosine deaminase.", "text_with_entity_marker": "[E1]CD26[/E1] is a T cell activation antigen that contains dipeptidyl peptidase IV activity and is known to bind [E2]adenosine deaminase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD26", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "adenosine deaminase", "entity_2_idx": [[104, 123]], "entity_2_idx_in_text_with_entity_marker": [117, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p1", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, UL8, [E2]UL52[/E2]) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p3", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex ([E2]UL5[/E2], UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d157.s0_BioInfer.d157.s0.p4", "text": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV helicase-primase complex (UL5, UL8, UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "text_with_entity_marker": "Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV [E1]helicase-primase[/E1] complex (UL5, [E2]UL8[/E2], UL52) and the major DNA-binding protein (UL29), was already sufficient to mediate the helper effect.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[122, 138]], "entity_1_idx_in_text_with_entity_marker": [126, 142], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[153, 156]], "entity_2_idx_in_text_with_entity_marker": [166, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d350.s0_BioInfer.d350.s0.p2", "text": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of cyclin D1.", "text_with_entity_marker": "In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the [E1]cyclin dependent kinase inhibitor[/E1] [E2]p27[/E2], which blocks the activating effects of cyclin D1.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin dependent kinase inhibitor", "entity_1_idx": [[178, 211]], "entity_1_idx_in_text_with_entity_marker": [182, 215], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p27", "entity_2_idx": [[212, 215]], "entity_2_idx_in_text_with_entity_marker": [225, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p0", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate cyclin E-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p1", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or [E1]cyclin D1[/E1] was sufficient to activate [E2]cyclin E[/E2]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin D1", "entity_1_idx": [[23, 32]], "entity_1_idx_in_text_with_entity_marker": [27, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p5", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate [E1]cyclin E[/E1]-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p7", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate cyclin E-[E2]Cdk2[/E2] by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cdk2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p10", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of [E1]c-Myc[/E1] or cyclin D1 was sufficient to activate [E2]cyclin E[/E2]-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "c-Myc", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d204.s0_BioInfer.d204.s0.p13", "text": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment.", "text_with_entity_marker": "Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2], as has been described, following estrogen treatment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[148, 181]], "entity_1_idx_in_text_with_entity_marker": [152, 185], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s0_BioInfer.d1.s0.p0", "text": "A binary complex of birch profilin and skeletal muscle actin could be isolated by gel chromatography.", "text_with_entity_marker": "A binary complex of birch [E1]profilin[/E1] and [E2]skeletal muscle actin[/E2] could be isolated by gel chromatography.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[26, 34]], "entity_1_idx_in_text_with_entity_marker": [30, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p0", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for muscle and [E2]brain actin[/E2] polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "brain actin", "entity_2_idx": [[76, 87]], "entity_2_idx_in_text_with_entity_marker": [89, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p3", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for [E2]muscle[/E2] and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle", "entity_2_idx": [[65, 71], [82, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s1_BioInfer.d1.s1.p4", "text": "Birch profilin increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal actin.", "text_with_entity_marker": "Birch [E1]profilin[/E1] increased the critical concentration required for muscle and brain actin polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[242, 247]], "entity_2_idx_in_text_with_entity_marker": [255, 260], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s2_BioInfer.d1.s2.p0", "text": "Interaction of plant profilin with mammalian actin.", "text_with_entity_marker": "Interaction of plant [E1]profilin[/E1] with mammalian [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s3_BioInfer.d1.s3.p0", "text": "In viscometric assays, the birch protein was seen to modulate actin filament formation analogous to animal profilin.", "text_with_entity_marker": "In viscometric assays, the birch protein was seen to modulate [E1]actin[/E1] filament formation analogous to animal [E2]profilin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[62, 67]], "entity_1_idx_in_text_with_entity_marker": [66, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d1.s4_BioInfer.d1.s4.p0", "text": "These data indicate that the actin-binding domains in plant and animal profilins are functionally highly conserved, although the overall sequence similarity is less than 25%.", "text_with_entity_marker": "These data indicate that the [E1]actin[/E1]-binding domains in plant and animal [E2]profilins[/E2] are functionally highly conserved, although the overall sequence similarity is less than 25%.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[29, 34]], "entity_1_idx_in_text_with_entity_marker": [33, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilins", "entity_2_idx": [[71, 80]], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d825.s0_BioInfer.d825.s0.p0", "text": "We suggest that the talin in the nodes functions, via a cross-linking activity, in the convergence of actin filaments at the membrane during development of the ribs.", "text_with_entity_marker": "We suggest that the [E1]talin[/E1] in the nodes functions, via a cross-linking activity, in the convergence of [E2]actin[/E2] filaments at the membrane during development of the ribs.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[102, 107]], "entity_2_idx_in_text_with_entity_marker": [115, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p4", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because [E1]beta-catenin[/E1] is known to interact with [E2]alpha-catenin[/E2], which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[8, 20]], "entity_1_idx_in_text_with_entity_marker": [12, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[47, 60]], "entity_2_idx_in_text_with_entity_marker": [60, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p5", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the [E1]actin[/E1] binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p10", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of [E1]E-cadherin[/E1] and the actin binding site of [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[147, 157]], "entity_1_idx_in_text_with_entity_marker": [151, 161], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[188, 201]], "entity_2_idx_in_text_with_entity_marker": [201, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d92.s0_BioInfer.d92.s0.p13", "text": "Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "text_with_entity_marker": "Because beta-catenin is known to interact with [E1]alpha-catenin[/E1], which binds to [E2]actin[/E2], we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[47, 60]], "entity_1_idx_in_text_with_entity_marker": [51, 64], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p24", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/[E2]dystrophin related protein[/E2], and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[238, 264]], "entity_2_idx_in_text_with_entity_marker": [251, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p26", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of [E2]dystrophin[/E2], utrophin/dystrophin related protein, and the Torpedo 87K protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin", "entity_2_idx": [[217, 227]], "entity_2_idx_in_text_with_entity_marker": [230, 240], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d211.s0_BioInfer.d211.s0.p27", "text": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both beta 2- and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo 87K protein.", "text_with_entity_marker": "Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like beta 1-syntrophin, both [E1]beta 2-[/E1] and alpha 1-syntrophin interact with peptides encoding the syntrophin-binding region of dystrophin, utrophin/dystrophin related protein, and the Torpedo [E2]87K[/E2] protein.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta 2-", "entity_1_idx": [[121, 128], [141, 151]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K", "entity_2_idx": [[282, 285]], "entity_2_idx_in_text_with_entity_marker": [295, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p11", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and [E1]plakoglobin[/E1] which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[107, 118]], "entity_1_idx_in_text_with_entity_marker": [111, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p12", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the [E2]cadherin[/E2]-catenin complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p13", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the [E1]cadherin[/E1]-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[150, 158]], "entity_1_idx_in_text_with_entity_marker": [154, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p14", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d541.s0_BioInfer.d541.s0.p0", "text": "Since both caldesmon and profilin have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "text_with_entity_marker": "Since both [E1]caldesmon[/E1] and [E2]profilin[/E2] have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of actin filaments in living cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "caldesmon", "entity_1_idx": [[11, 20]], "entity_1_idx_in_text_with_entity_marker": [15, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p0", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1]myosin[/E1] heavy chain, [E2]actin[/E2], light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[179, 185], [225, 238]], "entity_1_idx_in_text_with_entity_marker": [183, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p1", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1-E2]myosin[/E1-E2] heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[179, 185], [206, 219]], "entity_1_idx_in_text_with_entity_marker": [186, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[179, 185], [225, 238]], "entity_2_idx_in_text_with_entity_marker": [186, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p2", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1-E2]myosin[/E1] heavy chain[/E2], actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[179, 185], [225, 238]], "entity_1_idx_in_text_with_entity_marker": [186, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin[/E1] heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [186, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p3", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1]myosin[/E1] heavy chain, [E2]actin[/E2], light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[179, 185], [206, 219]], "entity_1_idx_in_text_with_entity_marker": [183, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p4", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1]myosin heavy chain[/E1], [E2]actin[/E2], light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[179, 197]], "entity_1_idx_in_text_with_entity_marker": [183, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[199, 204]], "entity_2_idx_in_text_with_entity_marker": [212, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d766.s0_BioInfer.d766.s0.p5", "text": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, myosin heavy chain, actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "text_with_entity_marker": "To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, [E1-E2]myosin[/E1] heavy chain[/E2], actin, light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[179, 185], [206, 219]], "entity_1_idx_in_text_with_entity_marker": [186, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin[/E1] heavy chain", "entity_2_idx": [[179, 197]], "entity_2_idx_in_text_with_entity_marker": [186, 209], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d504.s0_BioInfer.d504.s0.p0", "text": "Purification of a cortical complex containing two unconventional actins from Acanthamoeba by affinity chromatography on profilin-agarose.", "text_with_entity_marker": "Purification of a cortical complex containing two unconventional [E1]actins[/E1] from Acanthamoeba by affinity chromatography on [E2]profilin[/E2]-agarose.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actins", "entity_1_idx": [[65, 71]], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[120, 128]], "entity_2_idx_in_text_with_entity_marker": [133, 141], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p60", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p61", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p62", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p63", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p64", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p65", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p66", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p67", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p68", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E1]RAD17[/E1], RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p69", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E1]RAD17[/E1], RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[182, 187]], "entity_1_idx_in_text_with_entity_marker": [186, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p0", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], myosin, [E2]filamin[/E2], and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "filamin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p1", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, [E1]filamin[/E1], and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "filamin", "entity_1_idx": [[111, 118]], "entity_1_idx_in_text_with_entity_marker": [115, 122], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p2", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, [E1]myosin[/E1], [E2]filamin[/E2], and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "filamin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p3", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], myosin, filamin, and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p4", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for [E1]actin[/E1], [E2]myosin[/E2], filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[103, 109]], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d502.s0_BioInfer.d502.s0.p5", "text": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, myosin, filamin, and talin in order to follow the assembly of the contractile proteins into the cleavage furrows.", "text_with_entity_marker": "PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for actin, [E1]myosin[/E1], filamin, and [E2]talin[/E2] in order to follow the assembly of the contractile proteins into the cleavage furrows.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin", "entity_1_idx": [[103, 109]], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p0", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to vinculin, [E2]talin[/E2] and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p1", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to [E2]vinculin[/E2], talin and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[103, 111]], "entity_2_idx_in_text_with_entity_marker": [116, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p2", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of [E1]actin[/E1] microfilaments also labeled with antibodies to vinculin, talin and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p3", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to [E1]vinculin[/E1], [E2]talin[/E2] and beta 1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p4", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, [E1]talin[/E1] and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[113, 118]], "entity_1_idx_in_text_with_entity_marker": [117, 122], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d481.s0_BioInfer.d481.s0.p5", "text": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to vinculin, talin and beta 1-integrin.", "text_with_entity_marker": "Particle aggregates associated with this array of actin microfilaments also labeled with antibodies to [E1]vinculin[/E1], talin and [E2]beta 1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[103, 111]], "entity_1_idx_in_text_with_entity_marker": [107, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta 1-integrin", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p0", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, [E2]UL9[/E2], UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [51, 54], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p1", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], [E2]UL8[/E2], UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[33, 36]], "entity_2_idx_in_text_with_entity_marker": [46, 49], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p2", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, UL9, UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p3", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated [E1]UL5[/E1], UL8, UL9, [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p4", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], [E2]UL9[/E2], UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL9", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [51, 54], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p5", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, [E1]UL9[/E1], UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p6", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, [E1]UL9[/E1], [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p7", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], UL9, UL42, and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p8", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, [E1]UL8[/E1], UL9, [E2]UL42[/E2], and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[43, 47]], "entity_2_idx_in_text_with_entity_marker": [56, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d699.s0_BioInfer.d699.s0.p9", "text": "These genes were designated UL5, UL8, UL9, UL42, and UL52 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "text_with_entity_marker": "These genes were designated UL5, UL8, UL9, [E1]UL42[/E1], and [E2]UL52[/E2] and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[43, 47]], "entity_1_idx_in_text_with_entity_marker": [47, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[53, 57]], "entity_2_idx_in_text_with_entity_marker": [66, 70], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p0", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the [E1]skeletal muscle actin[/E1], or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "skeletal muscle actin", "entity_1_idx": [[223, 244]], "entity_1_idx_in_text_with_entity_marker": [227, 248], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p1", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, [E1]Myf5[/E1], the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf5", "entity_1_idx": [[213, 217]], "entity_1_idx_in_text_with_entity_marker": [217, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p2", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, [E1]MRF4[/E1], Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MRF4", "entity_1_idx": [[207, 211]], "entity_1_idx_in_text_with_entity_marker": [211, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p3", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p4", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p5", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous [E1]myogenin[/E1] and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the [E2]myosin heavy chain[/E2] genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myogenin", "entity_1_idx": [[138, 146]], "entity_1_idx_in_text_with_entity_marker": [142, 150], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[253, 271]], "entity_2_idx_in_text_with_entity_marker": [266, 284], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p6", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, [E1]Myf5[/E1], the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf5", "entity_1_idx": [[213, 217]], "entity_1_idx_in_text_with_entity_marker": [217, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p7", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, [E1]MRF4[/E1], Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MRF4", "entity_1_idx": [[207, 211]], "entity_1_idx_in_text_with_entity_marker": [211, 215], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p8", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous [E1]MyoD1[/E1], MRF4, Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD1", "entity_1_idx": [[200, 205]], "entity_1_idx_in_text_with_entity_marker": [204, 209], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d557.s0_BioInfer.d557.s0.p9", "text": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and myosin light chain 2 gene but not the endogenous MyoD1, MRF4, Myf5, the skeletal muscle actin, or the myosin heavy chain genes.", "text_with_entity_marker": "Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous myogenin and [E1]myosin light chain 2[/E1] gene but not the endogenous MyoD1, MRF4, Myf5, the [E2]skeletal muscle actin[/E2], or the myosin heavy chain genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain 2", "entity_1_idx": [[151, 171]], "entity_1_idx_in_text_with_entity_marker": [155, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal muscle actin", "entity_2_idx": [[223, 244]], "entity_2_idx_in_text_with_entity_marker": [236, 257], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p0", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both RAD50 and [E1]RAD51[/E1] produces a phenotype similar to that produced by deletion of [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD51", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p1", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both [E1]RAD50[/E1] and [E2]RAD51[/E2] produces a phenotype similar to that produced by deletion of RAD52.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD50", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p2", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both [E1]RAD50[/E1] and RAD51 produces a phenotype similar to that produced by deletion of [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD50", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s1_BioInfer.d166.s1.p0", "text": "rad59 mutations completely abolished the ability to generate type II survivors, while rad50 mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.", "text_with_entity_marker": "[E1]rad59[/E1] mutations completely abolished the ability to generate type II survivors, while [E2]rad50[/E2] mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad59", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad50", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p0", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for [E1]alpha-catenin[/E1], beta-catenin, [E2]E-cadherin[/E2], and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[109, 122]], "entity_1_idx_in_text_with_entity_marker": [113, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[138, 148]], "entity_2_idx_in_text_with_entity_marker": [151, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p1", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, [E1]E-cadherin[/E1], and CD44 isoform 6 ([E2]CD44v6[/E2]), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[138, 148]], "entity_1_idx_in_text_with_entity_marker": [142, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44v6", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p2", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, [E1]beta-catenin[/E1], [E2]E-cadherin[/E2], and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[124, 136]], "entity_1_idx_in_text_with_entity_marker": [128, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[138, 148]], "entity_2_idx_in_text_with_entity_marker": [151, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p3", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, [E1]E-cadherin[/E1], and [E2]CD44[/E2] isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[138, 148]], "entity_1_idx_in_text_with_entity_marker": [142, 152], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[154, 158], [167, 168]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p4", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for [E1]alpha-catenin[/E1], beta-catenin, E-cadherin, and CD44 isoform 6 ([E2]CD44v6[/E2]), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[109, 122]], "entity_1_idx_in_text_with_entity_marker": [113, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44v6", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p5", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[109, 122]], "entity_1_idx_in_text_with_entity_marker": [113, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[124, 136]], "entity_2_idx_in_text_with_entity_marker": [137, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p6", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for [E1]alpha-catenin[/E1], beta-catenin, E-cadherin, and [E2]CD44[/E2] isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[109, 122]], "entity_1_idx_in_text_with_entity_marker": [113, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[154, 158], [167, 168]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p7", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, [E1]beta-catenin[/E1], E-cadherin, and CD44 isoform 6 ([E2]CD44v6[/E2]), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[124, 136]], "entity_1_idx_in_text_with_entity_marker": [128, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44v6", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p8", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and [E1]CD44[/E1] isoform 6 ([E2]CD44v6[/E2]), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD44", "entity_1_idx": [[154, 158], [167, 168]], "entity_1_idx_in_text_with_entity_marker": [158, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[170, 176]], "entity_2_idx_in_text_with_entity_marker": [183, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d101.s0_BioInfer.d101.s0.p9", "text": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, beta-catenin, E-cadherin, and CD44 isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "text_with_entity_marker": "Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for alpha-catenin, [E1]beta-catenin[/E1], E-cadherin, and [E2]CD44[/E2] isoform 6 (CD44v6), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[124, 136]], "entity_1_idx_in_text_with_entity_marker": [128, 140], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CD44", "entity_2_idx": [[154, 158], [167, 168]], "entity_2_idx_in_text_with_entity_marker": [167, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p0", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an [E1]MSH3[/E1]-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and [E2]MSH2[/E2] genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p1", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type [E1]MSH6[/E1] and [E2]MSH2[/E2] genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[118, 122]], "entity_1_idx_in_text_with_entity_marker": [122, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[127, 131]], "entity_2_idx_in_text_with_entity_marker": [140, 144], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d811.s0_BioInfer.d811.s0.p2", "text": "We have established an MSH3-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type MSH6 and MSH2 genes, to HHUA cells.", "text_with_entity_marker": "We have established an [E1]MSH3[/E1]-deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type [E2]MSH6[/E2] and MSH2 genes, to HHUA cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[118, 122]], "entity_2_idx_in_text_with_entity_marker": [131, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p0", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, [E2]talin[/E2], and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p1", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, [E1]talin[/E1], and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p2", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E1]vinculin[/E1], [E2]talin[/E2], and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p3", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p4", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "[E1]alpha-Sm actin[/E1] inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E2]vinculin[/E2], talin, and beta1-integrin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-Sm actin", "entity_1_idx": [[0, 14]], "entity_1_idx_in_text_with_entity_marker": [4, 18], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[137, 145]], "entity_2_idx_in_text_with_entity_marker": [150, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d558.s1_BioInfer.d558.s1.p5", "text": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against vinculin, talin, and beta1-integrin.", "text_with_entity_marker": "alpha-Sm actin inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against [E1]vinculin[/E1], talin, and [E2]beta1-integrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[137, 145]], "entity_1_idx_in_text_with_entity_marker": [141, 149], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta1-integrin", "entity_2_idx": [[158, 172]], "entity_2_idx_in_text_with_entity_marker": [171, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p20", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[110, 122]], "entity_2_idx_in_text_with_entity_marker": [123, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p0", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including [E1]talin[/E1] and [E2]vinculin[/E2], mediate interactions with the actin filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[92, 100]], "entity_2_idx_in_text_with_entity_marker": [105, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p1", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and [E1]vinculin[/E1], mediate interactions with the [E2]actin[/E2] filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[92, 100]], "entity_1_idx_in_text_with_entity_marker": [96, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[132, 137]], "entity_2_idx_in_text_with_entity_marker": [145, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d466.s0_BioInfer.d466.s0.p2", "text": "On the internal (cytoplasmic) side of focal contacts, several proteins, including talin and vinculin, mediate interactions with the actin filament bundles of the cytoskeleton.", "text_with_entity_marker": "On the internal (cytoplasmic) side of focal contacts, several proteins, including [E1]talin[/E1] and vinculin, mediate interactions with the [E2]actin[/E2] filament bundles of the cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[132, 137]], "entity_2_idx_in_text_with_entity_marker": [145, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p20", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), [E2]phosphoprotein[/E2] (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[273, 287], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [286, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p21", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein ([E2]P[/E2]; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[289, 290]], "entity_2_idx_in_text_with_entity_marker": [302, 303], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p22", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural ([E2]V[/E2]; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V", "entity_2_idx": [[340, 341]], "entity_2_idx_in_text_with_entity_marker": [353, 354], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p23", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid ([E1]N[/E1]; 66 kDa), fusion ([E2]F0[/E2]; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[240, 241]], "entity_1_idx_in_text_with_entity_marker": [244, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[260, 262]], "entity_2_idx_in_text_with_entity_marker": [273, 275], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p24", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion ([E1]F0[/E1]; 63 kDa), phosphoprotein (P; 49 kDa), matrix ([E2]M[/E2]; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F0", "entity_1_idx": [[260, 262]], "entity_1_idx_in_text_with_entity_marker": [264, 266], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[309, 310]], "entity_2_idx_in_text_with_entity_marker": [322, 323], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p25", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and [E2]non-structural[/E2] (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "non-structural", "entity_2_idx": [[324, 338], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [337, 351], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p26", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E1]fusion[/E1] (F0; 63 kDa), phosphoprotein (P; 49 kDa), [E2]matrix[/E2] (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[252, 258], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [256, 262], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[301, 307], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p27", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase ([E1]HN[/E1]; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "HN", "entity_1_idx": [[213, 215]], "entity_1_idx_in_text_with_entity_marker": [217, 219], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p28", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the [E1]large[/E1] (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large", "entity_1_idx": [[163, 168], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d721.s0_BioInfer.d721.s0.p29", "text": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), nucleocapsid (N; 66 kDa), fusion (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "text_with_entity_marker": "The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the large (L; 190 kDa), haemagglutinin neuraminidase (HN; 74 kDa), [E1]nucleocapsid[/E1] (N; 66 kDa), [E2]fusion[/E2] (F0; 63 kDa), phosphoprotein (P; 49 kDa), matrix (M; 43 kDa) and non-structural (V; 35 kDa) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[226, 238], [351, 359]], "entity_1_idx_in_text_with_entity_marker": [230, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion", "entity_2_idx": [[252, 258], [351, 359]], "entity_2_idx_in_text_with_entity_marker": [265, 271], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p0", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of [E1]beta-catenin[/E1] and alpha-catenin, as well as a more detailed study of [E2]N-cadherin[/E2], during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[161, 171]], "entity_2_idx_in_text_with_entity_marker": [174, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p1", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and [E1]alpha-catenin[/E1], as well as a more detailed study of [E2]N-cadherin[/E2], during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[110, 123]], "entity_1_idx_in_text_with_entity_marker": [114, 127], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[161, 171]], "entity_2_idx_in_text_with_entity_marker": [174, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d748.s0_BioInfer.d748.s0.p2", "text": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of beta-catenin and alpha-catenin, as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "text_with_entity_marker": "Those observations were extended to include a spatiotemporal immunohistochemical analyses of [E1]beta-catenin[/E1] and [E2]alpha-catenin[/E2], as well as a more detailed study of N-cadherin, during segmentation, compaction, and compartmentalization of the somite.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[93, 105]], "entity_1_idx_in_text_with_entity_marker": [97, 109], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[110, 123]], "entity_2_idx_in_text_with_entity_marker": [123, 136], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d96.s0_BioInfer.d96.s0.p0", "text": "Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified myosin heavy chain and actin ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).", "text_with_entity_marker": "Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified [E1]myosin heavy chain[/E1] and [E2]actin[/E2] ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[124, 142]], "entity_1_idx_in_text_with_entity_marker": [128, 146], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p0", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, [E1]SSB[/E1], and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "SSB", "entity_1_idx": [[240, 243]], "entity_1_idx_in_text_with_entity_marker": [244, 247], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p1", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p2", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, [E1]UL52[/E1], [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL52", "entity_1_idx": [[234, 238]], "entity_1_idx_in_text_with_entity_marker": [238, 242], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p3", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p4", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p5", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, [E1]UL5[/E1], UL8, UL9, UL42, UL52, [E2]SSB[/E2], and Pol, that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SSB", "entity_2_idx": [[240, 243]], "entity_2_idx_in_text_with_entity_marker": [253, 256], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p6", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, [E1]UL42[/E1], UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[228, 232]], "entity_1_idx_in_text_with_entity_marker": [232, 236], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p7", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, [E1]UL52[/E1], SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL52", "entity_1_idx": [[234, 238]], "entity_1_idx_in_text_with_entity_marker": [238, 242], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p8", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, [E1]UL8[/E1], UL9, UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[218, 221]], "entity_1_idx_in_text_with_entity_marker": [222, 225], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d579.s0_BioInfer.d579.s0.p9", "text": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.", "text_with_entity_marker": "The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, [E1]UL9[/E1], UL42, UL52, SSB, and [E2]Pol[/E2], that are essential for viral DNA replication.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL9", "entity_1_idx": [[223, 226]], "entity_1_idx_in_text_with_entity_marker": [227, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Pol", "entity_2_idx": [[249, 252]], "entity_2_idx_in_text_with_entity_marker": [262, 265], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d426.s0_BioInfer.d426.s0.p0", "text": "Mitochondrial genes (16.2%), myosin heavy chain genes (9%) and the actin alpha skeletal muscle gene (9%) were the most abundant transcripts.", "text_with_entity_marker": "Mitochondrial genes (16.2%), [E1]myosin heavy chain[/E1] genes (9%) and the [E2]actin alpha skeletal muscle[/E2] gene (9%) were the most abundant transcripts.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[29, 47]], "entity_1_idx_in_text_with_entity_marker": [33, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin alpha skeletal muscle", "entity_2_idx": [[67, 94]], "entity_2_idx_in_text_with_entity_marker": [80, 107], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p0", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total profilin and [E1]actin[/E1] concentrations in PMN revealed that the molar ratio of profilin to [E2]actin[/E2] was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p1", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total [E1]profilin[/E1] and [E2]actin[/E2] concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p2", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total profilin and [E1]actin[/E1] concentrations in PMN revealed that the molar ratio of [E2]profilin[/E2] to actin was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[40, 45]], "entity_1_idx_in_text_with_entity_marker": [44, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[101, 109]], "entity_2_idx_in_text_with_entity_marker": [114, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p3", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total [E1]profilin[/E1] and actin concentrations in PMN revealed that the molar ratio of profilin to [E2]actin[/E2] was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p4", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of [E1]profilin[/E1] to [E2]actin[/E2] was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[101, 109]], "entity_1_idx_in_text_with_entity_marker": [105, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d41.s1_BioInfer.d41.s1.p5", "text": "Determination of the total profilin and actin concentrations in PMN revealed that the molar ratio of profilin to actin was 1 to 5.2.", "text_with_entity_marker": "Determination of the total [E1]profilin[/E1] and actin concentrations in PMN revealed that the molar ratio of [E2]profilin[/E2] to actin was 1 to 5.2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[101, 109]], "entity_2_idx_in_text_with_entity_marker": [114, 122], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p10", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p11", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p12", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the H, F, [E2]NP[/E2] and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[159, 161], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [172, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p13", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), [E1]fusion[/E1] ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[57, 63], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p14", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and [E2]matrix[/E2] (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[119, 125], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p15", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the [E1]haemagglutinin[/E1] (H), fusion ([E2]F[/E2]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "haemagglutinin", "entity_1_idx": [[37, 51], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [41, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[65, 66]], "entity_2_idx_in_text_with_entity_marker": [78, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p16", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), [E2]nucleocapsid protein[/E2] (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[69, 89], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [82, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p17", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the [E2]H[/E2], F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[153, 154], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [166, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p18", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and [E2]P proteins[/E2] of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P proteins", "entity_2_idx": [[166, 176]], "entity_2_idx_in_text_with_entity_marker": [179, 189], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p19", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion ([E1]F[/E1]), nucleocapsid protein (NP), [E2]phosphoprotein[/E2] (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[65, 66]], "entity_1_idx_in_text_with_entity_marker": [69, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[96, 110], [130, 138]], "entity_2_idx_in_text_with_entity_marker": [109, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p0", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E1]srs2[/E1] [E2]rad54[/E2] and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p1", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, [E1]RAD24[/E1], and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD24", "entity_1_idx": [[163, 168]], "entity_1_idx_in_text_with_entity_marker": [167, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p2", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions [E1]RAD9[/E1], RAD17, RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p3", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and [E1]MEC3[/E1], indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p4", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p5", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p6", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p7", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and [E1]srs2Delta[/E1] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[42, 51]], "entity_1_idx_in_text_with_entity_marker": [46, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p8", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta [E1]rdh54Delta[/E1] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E2]srs2[/E2] rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rdh54Delta", "entity_1_idx": [[52, 62]], "entity_1_idx_in_text_with_entity_marker": [56, 66], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[200, 204]], "entity_2_idx_in_text_with_entity_marker": [213, 217], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p9", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the [E1]srs2[/E1] rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2", "entity_1_idx": [[200, 204]], "entity_1_idx_in_text_with_entity_marker": [204, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p50", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, [E1]RAD17[/E1], RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD17", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p51", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] [E2]rad54Delta[/E2] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad54Delta", "entity_2_idx": [[27, 37]], "entity_2_idx_in_text_with_entity_marker": [40, 50], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p52", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and [E2]srs2Delta[/E2] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2Delta", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p53", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p54", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p55", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the [E1]srs2Delta[/E1] rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "srs2Delta", "entity_1_idx": [[17, 26]], "entity_1_idx_in_text_with_entity_marker": [21, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p56", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and [E2]srs2Delta[/E2] rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2Delta", "entity_2_idx": [[42, 51]], "entity_2_idx_in_text_with_entity_marker": [55, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p57", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta [E2]rdh54Delta[/E2] double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54Delta", "entity_2_idx": [[52, 62]], "entity_2_idx_in_text_with_entity_marker": [65, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p58", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and [E2]srs2[/E2] rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "srs2", "entity_2_idx": [[215, 219]], "entity_2_idx_in_text_with_entity_marker": [228, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d401.s0_BioInfer.d401.s0.p59", "text": "Lethality of the srs2Delta rad54Delta and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 rdh54 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "text_with_entity_marker": "Lethality of the srs2Delta [E1]rad54Delta[/E1] and srs2Delta rdh54Delta double mutants can also be rescued by mutations in the DNA damage checkpoint functions RAD9, RAD17, RAD24, and MEC3, indicating that the srs2 rad54 and srs2 [E2]rdh54[/E2] mutant combinations lead to an intermediate that is sensed by these checkpoint functions.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "rad54Delta", "entity_1_idx": [[27, 37]], "entity_1_idx_in_text_with_entity_marker": [31, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rdh54", "entity_2_idx": [[220, 225]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d114.s0_BioInfer.d114.s0.p0", "text": "RAD52 or RAD51 recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).", "text_with_entity_marker": "[E1]RAD52[/E1] or [E2]RAD51[/E2] recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[9, 14]], "entity_2_idx_in_text_with_entity_marker": [22, 27], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p0", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], N-cadherin, [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p1", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, [E1]alpha-catenin[/E1], or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[126, 139]], "entity_1_idx_in_text_with_entity_marker": [130, 143], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p2", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p3", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E1]N-cadherin[/E1], [E2]alpha-catenin[/E2], or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[114, 124]], "entity_1_idx_in_text_with_entity_marker": [118, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p4", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], N-cadherin, alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p5", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of [E2]E-cadherin[/E2], N-cadherin, alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p6", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of [E1]E-cadherin[/E1], [E2]N-cadherin[/E2], alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[102, 112]], "entity_1_idx_in_text_with_entity_marker": [106, 116], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[114, 124]], "entity_2_idx_in_text_with_entity_marker": [127, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p7", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p8", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E1]N-cadherin[/E1], alpha-catenin, or [E2]beta-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[114, 124]], "entity_1_idx_in_text_with_entity_marker": [118, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d482.s0_BioInfer.d482.s0.p9", "text": "P-cadherin expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, N-cadherin, alpha-catenin, or beta-catenin.", "text_with_entity_marker": "[E1]P-cadherin[/E1] expression is a better indicator of clinical outcome than alterations in the expression of E-cadherin, [E2]N-cadherin[/E2], alpha-catenin, or beta-catenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P-cadherin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N-cadherin", "entity_2_idx": [[114, 124]], "entity_2_idx_in_text_with_entity_marker": [127, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p0", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, [E1]alpha-catenin[/E1], beta-catenin and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[20, 33]], "entity_1_idx_in_text_with_entity_marker": [24, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p1", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, alpha-catenin, [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[35, 47]], "entity_1_idx_in_text_with_entity_marker": [39, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p2", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], alpha-catenin, beta-catenin and [E2]plakoglobin[/E2] expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[52, 63]], "entity_2_idx_in_text_with_entity_marker": [65, 76], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p3", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced E-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2] and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[20, 33]], "entity_1_idx_in_text_with_entity_marker": [24, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[35, 47]], "entity_2_idx_in_text_with_entity_marker": [48, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p4", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[20, 33]], "entity_2_idx_in_text_with_entity_marker": [33, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d512.s0_BioInfer.d512.s0.p5", "text": "Reduced E-cadherin, alpha-catenin, beta-catenin and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "text_with_entity_marker": "Reduced [E1]E-cadherin[/E1], alpha-catenin, [E2]beta-catenin[/E2] and plakoglobin expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[8, 18]], "entity_1_idx_in_text_with_entity_marker": [12, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[35, 47]], "entity_2_idx_in_text_with_entity_marker": [48, 60], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p0", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p1", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[52, 65]], "entity_1_idx_in_text_with_entity_marker": [56, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p2", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], E-cadherin, alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p3", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "plakoglobin", "entity_1_idx": [[81, 92]], "entity_1_idx_in_text_with_entity_marker": [85, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p4", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "plakoglobin", "entity_1_idx": [[81, 92]], "entity_1_idx_in_text_with_entity_marker": [85, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p5", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[67, 79]], "entity_1_idx_in_text_with_entity_marker": [71, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[81, 92]], "entity_2_idx_in_text_with_entity_marker": [94, 105], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p6", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p7", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins ([E1]N-cadherin[/E1], [E2]E-cadherin[/E2], alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[28, 38]], "entity_1_idx_in_text_with_entity_marker": [32, 42], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[40, 50]], "entity_2_idx_in_text_with_entity_marker": [53, 63], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p8", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker [E2]Ki-67[/E2] were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Ki-67", "entity_2_idx": [[134, 139]], "entity_2_idx_in_text_with_entity_marker": [147, 152], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d25.s0_BioInfer.d25.s0.p9", "text": "Adherens junction proteins (N-cadherin, E-cadherin, alpha-catenin, beta-catenin, plakoglobin, and actin) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "text_with_entity_marker": "Adherens junction proteins (N-cadherin, [E1]E-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, and [E2]actin[/E2]) and the proliferation marker Ki-67 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[40, 50]], "entity_1_idx_in_text_with_entity_marker": [44, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[98, 103]], "entity_2_idx_in_text_with_entity_marker": [111, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p0", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p1", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), [E2]alpha-catenin[/E2] (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[166, 179]], "entity_2_idx_in_text_with_entity_marker": [179, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p2", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p3", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] (E-cad), alpha-catenin ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p4", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of [E1]E-cadherin[/E1] ([E2]E-cad[/E2]), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[146, 156]], "entity_1_idx_in_text_with_entity_marker": [150, 160], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cad", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p5", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p6", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and [E1]beta-catenin[/E1] ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[196, 208]], "entity_1_idx_in_text_with_entity_marker": [200, 212], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p7", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin ([E1]alpha-cat[/E1]) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-cat", "entity_1_idx": [[181, 190]], "entity_1_idx_in_text_with_entity_marker": [185, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p8", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin (alpha-cat) and [E2]beta-catenin[/E2] (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[196, 208]], "entity_2_idx_in_text_with_entity_marker": [209, 221], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p9", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p10", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), [E1]alpha-catenin[/E1] ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[166, 179]], "entity_1_idx_in_text_with_entity_marker": [170, 183], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p11", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), [E2]alpha-catenin[/E2] (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[166, 179]], "entity_2_idx_in_text_with_entity_marker": [179, 192], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p12", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin ([E1]alpha-cat[/E1]) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-cat", "entity_1_idx": [[181, 190]], "entity_1_idx_in_text_with_entity_marker": [185, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p13", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin (alpha-cat) and beta-catenin ([E2]beta-cat[/E2]) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-cat", "entity_2_idx": [[210, 218]], "entity_2_idx_in_text_with_entity_marker": [223, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d34.s0_BioInfer.d34.s0.p14", "text": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin (E-cad), alpha-catenin (alpha-cat) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "text_with_entity_marker": "AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of E-cadherin ([E1]E-cad[/E1]), alpha-catenin ([E2]alpha-cat[/E2]) and beta-catenin (beta-cat) in ACC, and compared it with that in the normal labial gland.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cad", "entity_1_idx": [[158, 163]], "entity_1_idx_in_text_with_entity_marker": [162, 167], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-cat", "entity_2_idx": [[181, 190]], "entity_2_idx_in_text_with_entity_marker": [194, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p0", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes [E1]MSH2[/E1], MLH1, [E2]MSH6[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p1", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes [E1]MSH2[/E1], [E2]MLH1[/E2], MSH6 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MLH1", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p2", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "[E1]PMS2[/E1] is one of a complex of genes encoding DNA repair proteins that includes [E2]MSH2[/E2], MLH1, MSH6 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PMS2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH2", "entity_2_idx": [[77, 81]], "entity_2_idx_in_text_with_entity_marker": [90, 94], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p3", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes [E1]MSH2[/E1], MLH1, MSH6 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[77, 81]], "entity_1_idx_in_text_with_entity_marker": [81, 85], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p4", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, [E1]MLH1[/E1], [E2]MSH6[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p5", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "[E1]PMS2[/E1] is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, [E2]MSH6[/E2] and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PMS2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH6", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p6", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, [E1]MSH6[/E1] and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[89, 93]], "entity_1_idx_in_text_with_entity_marker": [93, 97], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p7", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "[E1]PMS2[/E1] is one of a complex of genes encoding DNA repair proteins that includes MSH2, [E2]MLH1[/E2], MSH6 and MSH3.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PMS2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MLH1", "entity_2_idx": [[83, 87]], "entity_2_idx_in_text_with_entity_marker": [96, 100], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p8", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, [E1]MLH1[/E1], MSH6 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[83, 87]], "entity_1_idx_in_text_with_entity_marker": [87, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d489.s0_BioInfer.d489.s0.p9", "text": "PMS2 is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and MSH3.", "text_with_entity_marker": "[E1]PMS2[/E1] is one of a complex of genes encoding DNA repair proteins that includes MSH2, MLH1, MSH6 and [E2]MSH3[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PMS2", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MSH3", "entity_2_idx": [[98, 102]], "entity_2_idx_in_text_with_entity_marker": [111, 115], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p0", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, lactic dehydrogenase, [E1]profilin[/E1], and [E2]actin depolymerizing factor[/E2] levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[87, 114]], "entity_2_idx_in_text_with_entity_marker": [100, 127], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p1", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, [E1]lactic dehydrogenase[/E1], [E2]profilin[/E2], and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lactic dehydrogenase", "entity_1_idx": [[51, 71]], "entity_1_idx_in_text_with_entity_marker": [55, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[73, 81]], "entity_2_idx_in_text_with_entity_marker": [86, 94], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d700.s0_BioInfer.d700.s0.p2", "text": "These increases were specific; DNA, total protein, lactic dehydrogenase, profilin, and actin depolymerizing factor levels were unchanged in the overexpressing cells.", "text_with_entity_marker": "These increases were specific; DNA, total protein, [E1]lactic dehydrogenase[/E1], profilin, and [E2]actin depolymerizing factor[/E2] levels were unchanged in the overexpressing cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lactic dehydrogenase", "entity_1_idx": [[51, 71]], "entity_1_idx_in_text_with_entity_marker": [55, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin depolymerizing factor", "entity_2_idx": [[87, 114]], "entity_2_idx_in_text_with_entity_marker": [100, 127], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d821.s0_BioInfer.d821.s0.p20", "text": "We show that the HSV-1 UL5, UL8, UL29, UL30, UL42, and UL52 gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "text_with_entity_marker": "We show that the HSV-1 UL5, UL8, UL29, UL30, [E1]UL42[/E1], and [E2]UL52[/E2] gene products along with the AAV Rep68 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d511.s0_BioInfer.d511.s0.p0", "text": "Redistribution of actin, profilin and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs", "text_with_entity_marker": "Redistribution of [E1]actin[/E1], [E2]profilin[/E2] and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[25, 33]], "entity_2_idx_in_text_with_entity_marker": [38, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p0", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein ([E1]ABP[/E1]) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ABP", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p1", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] (ABP) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p2", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of [E1]talin[/E1] and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[156, 161]], "entity_1_idx_in_text_with_entity_marker": [160, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p3", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and [E2]myosin[/E2] to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p4", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] ([E2]ABP[/E2]) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ABP", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p5", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein ([E1]ABP[/E1]) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ABP", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p6", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein ([E2]ABP[/E2]) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "ABP", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p7", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their [E1]actin-binding protein[/E1] (ABP) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding protein", "entity_1_idx": [[99, 120]], "entity_1_idx_in_text_with_entity_marker": [103, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p8", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their [E2]actin-binding protein[/E2] (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin-binding protein", "entity_2_idx": [[99, 120]], "entity_2_idx_in_text_with_entity_marker": [112, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d781.s0_BioInfer.d781.s0.p9", "text": "Under all conditions, platelets retained 40-50% of their total actin and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of talin and myosin to the supernatant.", "text_with_entity_marker": "Under all conditions, platelets retained 40-50% of their total [E1]actin[/E1] and greater than 70% of their actin-binding protein (ABP) but lost greater than 80% of [E2]talin[/E2] and myosin to the supernatant.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d775.s0_BioInfer.d775.s0.p20", "text": "Transfection of plasmids encoding the BRSV minigenome, nucleocapsid protein (N), phosphoprotein (P) and L protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "text_with_entity_marker": "Transfection of plasmids encoding the BRSV minigenome, [E1]nucleocapsid protein[/E1] (N), phosphoprotein (P) and [E2]L[/E2] protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 RNA polymerase gave rise to CAT activity and progeny with the minigenome.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[55, 75]], "entity_1_idx_in_text_with_entity_marker": [59, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[104, 105]], "entity_2_idx_in_text_with_entity_marker": [117, 118], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p0", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p1", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p2", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E2]BNI1[/E2], and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BNI1", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p3", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that [E1]cdc12p[/E1] is a member of a family of proteins including Drosophila [E2]diaphanous[/E2], Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cdc12p", "entity_1_idx": [[18, 24]], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "diaphanous", "entity_2_idx": [[82, 92]], "entity_2_idx_in_text_with_entity_marker": [95, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p4", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe [E1]fus1[/E1], which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fus1", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p5", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E1]BNI1[/E1], and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BNI1", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p6", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae BNI1, and S. pombe [E2]fus1[/E2], which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fus1", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p7", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae [E1]BNI1[/E1], and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BNI1", "entity_1_idx": [[119, 123]], "entity_1_idx_in_text_with_entity_marker": [123, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p8", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other [E2]actin[/E2]-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[187, 192]], "entity_2_idx_in_text_with_entity_marker": [200, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d250.s0_BioInfer.d250.s0.p9", "text": "Here we show that cdc12p is a member of a family of proteins including Drosophila diaphanous, Saccharomyces cerevisiae BNI1, and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "text_with_entity_marker": "Here we show that cdc12p is a member of a family of proteins including Drosophila [E1]diaphanous[/E1], Saccharomyces cerevisiae [E2]BNI1[/E2], and S. pombe fus1, which are involved in cytokinesis or other actin-mediated processes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "diaphanous", "entity_1_idx": [[82, 92]], "entity_1_idx_in_text_with_entity_marker": [86, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BNI1", "entity_2_idx": [[119, 123]], "entity_2_idx_in_text_with_entity_marker": [132, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p0", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], myosin light chain, [E2]phosphorylatable myosin light chain[/E2] and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[100, 135]], "entity_2_idx_in_text_with_entity_marker": [113, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p1", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, [E1]phosphorylatable myosin light chain[/E1] and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphorylatable myosin light chain", "entity_1_idx": [[100, 135]], "entity_1_idx_in_text_with_entity_marker": [104, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p2", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, [E1]myosin light chain[/E1], [E2]phosphorylatable myosin light chain[/E2] and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "phosphorylatable myosin light chain", "entity_2_idx": [[100, 135]], "entity_2_idx_in_text_with_entity_marker": [113, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p3", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], myosin light chain, phosphorylatable myosin light chain and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p4", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of [E1]myosin heavy chain[/E1], [E2]myosin light chain[/E2], phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[60, 78]], "entity_1_idx_in_text_with_entity_marker": [64, 82], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain", "entity_2_idx": [[80, 98]], "entity_2_idx_in_text_with_entity_marker": [93, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d668.s0_BioInfer.d668.s0.p5", "text": "The procedure allows for the simultaneous quantification of myosin heavy chain, myosin light chain, phosphorylatable myosin light chain and actin from as little as 50 mg of tissue.", "text_with_entity_marker": "The procedure allows for the simultaneous quantification of myosin heavy chain, [E1]myosin light chain[/E1], phosphorylatable myosin light chain and [E2]actin[/E2] from as little as 50 mg of tissue.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin light chain", "entity_1_idx": [[80, 98]], "entity_1_idx_in_text_with_entity_marker": [84, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d200.s0_BioInfer.d200.s0.p0", "text": "Exposure of the rabbit retina to a combination of an A1-adenosine receptor antagonist, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), and adenosine deaminase did not affect the enhancing action of DAMGO on the light-evoked release of ACh.", "text_with_entity_marker": "Exposure of the rabbit retina to a combination of an [E1]A1-adenosine receptor[/E1] antagonist, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), and [E2]adenosine deaminase[/E2] did not affect the enhancing action of DAMGO on the light-evoked release of ACh.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A1-adenosine receptor", "entity_1_idx": [[53, 74]], "entity_1_idx_in_text_with_entity_marker": [57, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[135, 154]], "entity_2_idx_in_text_with_entity_marker": [148, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p20", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, [E2]MSH3[/E2], MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p0", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] (ABP), talin, and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p1", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] (ABP), [E2]talin[/E2], and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p2", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] ([E2]ABP[/E2]), talin, and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ABP", "entity_2_idx": [[199, 202]], "entity_2_idx_in_text_with_entity_marker": [212, 215], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p3", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), [E1]talin[/E1], and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "talin", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p4", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein ([E1]ABP[/E1]), talin, and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ABP", "entity_1_idx": [[199, 202]], "entity_1_idx_in_text_with_entity_marker": [203, 206], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p5", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein ([E1]ABP[/E1]), [E2]talin[/E2], and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ABP", "entity_1_idx": [[199, 202]], "entity_1_idx_in_text_with_entity_marker": [203, 206], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s0_HPRD50.d16.s0.p1", "text": "GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress", "text_with_entity_marker": "[E1]GADD45b[/E1] and GADD45g are [E2]cdc2[/E2]/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GADD45b", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "pm0114403", "entity_1_type_id": 51, "entity_2": "cdc2", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s0_HPRD50.d16.s0.p2", "text": "GADD45b and GADD45g are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress", "text_with_entity_marker": "GADD45b and [E1]GADD45g[/E1] are [E2]cdc2[/E2]/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GADD45g", "entity_1_idx": [[12, 19]], "entity_1_idx_in_text_with_entity_marker": [16, 23], "entity_1_type": "pm0116690", "entity_1_type_id": 52, "entity_2": "cdc2", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s2_HPRD50.d16.s2.p0", "text": "Recent evidence has implicated Gadd45a in inhibition of cdc2/cyclinB1 kinase and in G2/M cell cycle arrest", "text_with_entity_marker": "Recent evidence has implicated [E1]Gadd45a[/E1] in inhibition of [E2]cdc2[/E2]/cyclinB1 kinase and in G2/M cell cycle arrest", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45a", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "pm0112301", "entity_1_type_id": 54, "entity_2": "cdc2", "entity_2_idx": [[56, 60]], "entity_2_idx_in_text_with_entity_marker": [69, 73], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s3_HPRD50.d16.s3.p1", "text": "Yet, whether Gadd45b and/or Gadd45g function as inhibitors of cdc2/cyclinB1 kinase and/or play a role in G2/M cell cycle arrest has not been fully established", "text_with_entity_marker": "Yet, whether [E1]Gadd45b[/E1] and/or Gadd45g function as inhibitors of [E2]cdc2[/E2]/cyclinB1 kinase and/or play a role in G2/M cell cycle arrest has not been fully established", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45b", "entity_1_idx": [[13, 20]], "entity_1_idx_in_text_with_entity_marker": [17, 24], "entity_1_type": "pm0114403", "entity_1_type_id": 51, "entity_2": "cdc2", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s3_HPRD50.d16.s3.p2", "text": "Yet, whether Gadd45b and/or Gadd45g function as inhibitors of cdc2/cyclinB1 kinase and/or play a role in G2/M cell cycle arrest has not been fully established", "text_with_entity_marker": "Yet, whether Gadd45b and/or [E1]Gadd45g[/E1] function as inhibitors of [E2]cdc2[/E2]/cyclinB1 kinase and/or play a role in G2/M cell cycle arrest has not been fully established", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45g", "entity_1_idx": [[28, 35]], "entity_1_idx_in_text_with_entity_marker": [32, 39], "entity_1_type": "pm0116690", "entity_1_type_id": 52, "entity_2": "cdc2", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p2", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that [E1]Gadd45b[/E1] and Gadd45g, as well as GADD45a, interact with both [E2]Cdk1[/E2] and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45b", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "pm0114403", "entity_1_type_id": 51, "entity_2": "Cdk1", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p3", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that [E1]Gadd45b[/E1] and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the [E2]Cdk1[/E2]/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45b", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "pm0114403", "entity_1_type_id": 51, "entity_2": "Cdk1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p5", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that Gadd45b and [E1]Gadd45g[/E1], as well as GADD45a, interact with both [E2]Cdk1[/E2] and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45g", "entity_1_idx": [[45, 52]], "entity_1_idx_in_text_with_entity_marker": [49, 56], "entity_1_type": "pm0116690", "entity_1_type_id": 52, "entity_2": "Cdk1", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p6", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that Gadd45b and [E1]Gadd45g[/E1], as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the [E2]Cdk1[/E2]/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Gadd45g", "entity_1_idx": [[45, 52]], "entity_1_idx_in_text_with_entity_marker": [49, 56], "entity_1_type": "pm0116690", "entity_1_type_id": 52, "entity_2": "Cdk1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p7", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that Gadd45b and Gadd45g, as well as [E1]GADD45a[/E1], interact with both [E2]Cdk1[/E2] and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GADD45a", "entity_1_idx": [[65, 72]], "entity_1_idx_in_text_with_entity_marker": [69, 76], "entity_1_type": "pm0112301", "entity_1_type_id": 54, "entity_2": "Cdk1", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s5_HPRD50.d16.s5.p8", "text": "Data also has been obtained that Gadd45b and Gadd45g, as well as GADD45a, interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the Cdk1/cyclinB1 complex", "text_with_entity_marker": "Data also has been obtained that Gadd45b and Gadd45g, as well as [E1]GADD45a[/E1], interact with both Cdk1 and cyclinB1, resulting in inhibition of the kinase activity of the [E2]Cdk1[/E2]/cyclinB1 complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GADD45a", "entity_1_idx": [[65, 72]], "entity_1_idx_in_text_with_entity_marker": [69, 76], "entity_1_type": "pm0112301", "entity_1_type_id": 54, "entity_2": "Cdk1", "entity_2_idx": [[166, 170]], "entity_2_idx_in_text_with_entity_marker": [179, 183], "entity_2_type": "pm0113152", "entity_2_type_id": 53}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s6_HPRD50.d16.s6.p0", "text": "Inhibition of Cdk1/cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex, whereas Gadd45g did not disrupt the complex", "text_with_entity_marker": "Inhibition of [E1]Cdk1[/E1]/cyclinB1 kinase activity by [E2]Gadd45b[/E2] and Gadd45a was found to involve disruption of the complex, whereas Gadd45g did not disrupt the complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdk1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "pm0113152", "entity_1_type_id": 53, "entity_2": "Gadd45b", "entity_2_idx": [[47, 54]], "entity_2_idx_in_text_with_entity_marker": [60, 67], "entity_2_type": "pm0114403", "entity_2_type_id": 51}], "directed": false, "reverse": false}
{"id": "HPRD50.d16.s6_HPRD50.d16.s6.p1", "text": "Inhibition of Cdk1/cyclinB1 kinase activity by Gadd45b and Gadd45a was found to involve disruption of the complex, whereas Gadd45g did not disrupt the complex", "text_with_entity_marker": "Inhibition of [E1]Cdk1[/E1]/cyclinB1 kinase activity by Gadd45b and [E2]Gadd45a[/E2] was found to involve disruption of the complex, whereas Gadd45g did not disrupt the complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdk1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "pm0113152", "entity_1_type_id": 53, "entity_2": "Gadd45a", "entity_2_idx": [[59, 66]], "entity_2_idx_in_text_with_entity_marker": [72, 79], "entity_2_type": "pm0112301", "entity_2_type_id": 54}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s0_HPRD50.d19.s0.p2", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor", "text_with_entity_marker": "[E1]p300[/E1]/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A ([E2]MEF2A[/E2]) and thyroid hormone receptor-retinoid X receptor", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p300", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0126787", "entity_1_type_id": 65, "entity_2": "MEF2A", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "pm0122391", "entity_2_type_id": 67}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s0_HPRD50.d19.s0.p4", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor", "text_with_entity_marker": "p300/[E1]cAMP-response-element-binding-protein[/E1] ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A ([E2]MEF2A[/E2]) and thyroid hormone receptor-retinoid X receptor", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cAMP-response-element-binding-protein", "entity_1_idx": [[5, 42]], "entity_1_idx_in_text_with_entity_marker": [9, 46], "entity_1_type": "pm0100874", "entity_1_type_id": 66, "entity_2": "MEF2A", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "pm0122391", "entity_2_type_id": 67}], "directed": false, "reverse": false}
{"id": "HPRD50.d19.s0_HPRD50.d19.s0.p5", "text": "p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor", "text_with_entity_marker": "p300/cAMP-response-element-binding-protein ('[E1]CREB[/E1]')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A ([E2]MEF2A[/E2]) and thyroid hormone receptor-retinoid X receptor", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "pm0100874", "entity_1_type_id": 66, "entity_2": "MEF2A", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "pm0122391", "entity_2_type_id": 67}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s0_HPRD50.d5.s0.p0", "text": "Cytohesin-1 regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with LFA-1", "text_with_entity_marker": "[E1]Cytohesin-1[/E1] regulates beta-2 integrin-mediated adhesion through both ARF-GEF function and interaction with [E2]LFA-1[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Cytohesin-1", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "pm0124251", "entity_1_type_id": 20, "entity_2": "LFA-1", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "pm0104657||pm0114514", "entity_2_type_id": 21}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s1_HPRD50.d5.s1.p0", "text": "Here we provide evidence of how cytohesin-1, an integrin-binding protein and guanine-nucleotide exchange factor (GEF) for ARF GTPases, regulates cell adhesion", "text_with_entity_marker": "Here we provide evidence of how [E1]cytohesin-1[/E1], an integrin-binding protein and guanine-nucleotide exchange factor (GEF) for [E2]ARF[/E2] GTPases, regulates cell adhesion", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cytohesin-1", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "pm0124251", "entity_1_type_id": 20, "entity_2": "ARF", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "pm0126206", "entity_2_type_id": 22}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s2_HPRD50.d5.s2.p0", "text": "Mutational analyses of the beta-2 cytoplasmic domain revealed that the adhesive function of LFA-1 depends on its interaction with cytohesin-1, unless the integrin is activated by exogenous divalent cations", "text_with_entity_marker": "Mutational analyses of the beta-2 cytoplasmic domain revealed that the adhesive function of [E1]LFA-1[/E1] depends on its interaction with [E2]cytohesin-1[/E2], unless the integrin is activated by exogenous divalent cations", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LFA-1", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "pm0104657||pm0114514", "entity_1_type_id": 21, "entity_2": "cytohesin-1", "entity_2_idx": [[130, 141]], "entity_2_idx_in_text_with_entity_marker": [143, 154], "entity_2_type": "pm0124251", "entity_2_type_id": 20}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s3_HPRD50.d5.s3.p0", "text": "Secondly, cytohesin-1 induces expression of an extracellular activation epitope of LFA-1, and the exchange factor function is not essential for this activity", "text_with_entity_marker": "Secondly, [E1]cytohesin-1[/E1] induces expression of an extracellular activation epitope of [E2]LFA-1[/E2], and the exchange factor function is not essential for this activity", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cytohesin-1", "entity_1_idx": [[10, 21]], "entity_1_idx_in_text_with_entity_marker": [14, 25], "entity_1_type": "pm0124251", "entity_1_type_id": 20, "entity_2": "LFA-1", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "pm0104657||pm0114514", "entity_2_type_id": 21}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s4_HPRD50.d5.s4.p0", "text": "In contrast, LFA-1-mediated cell adhesion and spreading on intercellular cell adhesion molecule 1 is strongly inhibited by a cytohesin-1 mutant, which fails to catalyze ARF GDP-GTP exchange in vitro", "text_with_entity_marker": "In contrast, LFA-1-mediated cell adhesion and spreading on intercellular cell adhesion molecule 1 is strongly inhibited by a [E1]cytohesin-1[/E1] mutant, which fails to catalyze [E2]ARF[/E2] GDP-GTP exchange in vitro", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cytohesin-1", "entity_1_idx": [[125, 136]], "entity_1_idx_in_text_with_entity_marker": [129, 140], "entity_1_type": "pm0124251", "entity_1_type_id": 20, "entity_2": "ARF", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "pm0126206", "entity_2_type_id": 22}], "directed": false, "reverse": false}
{"id": "HPRD50.d5.s5_HPRD50.d5.s5.p0", "text": "Thus, cytohesin-1 is involved in the activation of LFA-1, most probably through direct interaction with the integrin, and induces cell spreading by its ARF-GEF activity", "text_with_entity_marker": "Thus, [E1]cytohesin-1[/E1] is involved in the activation of [E2]LFA-1[/E2], most probably through direct interaction with the integrin, and induces cell spreading by its ARF-GEF activity", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cytohesin-1", "entity_1_idx": [[6, 17]], "entity_1_idx_in_text_with_entity_marker": [10, 21], "entity_1_type": "pm0124251", "entity_1_type_id": 20, "entity_2": "LFA-1", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "pm0104657||pm0114514", "entity_2_type_id": 21}], "directed": false, "reverse": false}
{"id": "HPRD50.d9.s0_HPRD50.d9.s0.p0", "text": "Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII)", "text_with_entity_marker": "Here, we cloned and characterized a mouse orthologue of human [E1]KIAA1427[/E1] protein as an atypical [E2]Syt[/E2] (named Syt XIII)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "KIAA1427", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "pm0110335", "entity_1_type_id": 34, "entity_2": "Syt", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "pm0109470||pm0116152", "entity_2_type_id": 35}], "directed": false, "reverse": false}
{"id": "HPRD50.d9.s0_HPRD50.d9.s0.p1", "text": "Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII)", "text_with_entity_marker": "Here, we cloned and characterized a mouse orthologue of human [E1]KIAA1427[/E1] protein as an atypical Syt (named [E2]Syt XIII[/E2])", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "KIAA1427", "entity_1_idx": [[62, 70]], "entity_1_idx_in_text_with_entity_marker": [66, 74], "entity_1_type": "pm0110335", "entity_1_type_id": 34, "entity_2": "Syt XIII", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "pm0110335", "entity_2_type_id": 34}], "directed": false, "reverse": false}
{"id": "HPRD50.d9.s0_HPRD50.d9.s0.p2", "text": "Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical Syt (named Syt XIII)", "text_with_entity_marker": "Here, we cloned and characterized a mouse orthologue of human KIAA1427 protein as an atypical [E1]Syt[/E1] (named [E2]Syt XIII[/E2])", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Syt", "entity_1_idx": [[94, 97]], "entity_1_idx_in_text_with_entity_marker": [98, 101], "entity_1_type": "pm0109470||pm0116152", "entity_1_type_id": 35, "entity_2": "Syt XIII", "entity_2_idx": [[105, 113]], "entity_2_idx_in_text_with_entity_marker": [118, 126], "entity_2_type": "pm0110335", "entity_2_type_id": 34}], "directed": false, "reverse": false}
{"id": "HPRD50.d9.s1_HPRD50.d9.s1.p0", "text": "Subcellular fractionation and antibody-uptake experiments indicate that Syt XIII is indeed a type-I membrane protein, but, unlike other Syt isoforms, lacks an N-terminal extracellular domain", "text_with_entity_marker": "Subcellular fractionation and antibody-uptake experiments indicate that [E1]Syt XIII[/E1] is indeed a type-I membrane protein, but, unlike other [E2]Syt[/E2] isoforms, lacks an N-terminal extracellular domain", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Syt XIII", "entity_1_idx": [[72, 80]], "entity_1_idx_in_text_with_entity_marker": [76, 84], "entity_1_type": "pm0110335", "entity_1_type_id": 34, "entity_2": "Syt", "entity_2_idx": [[136, 139]], "entity_2_idx_in_text_with_entity_marker": [149, 152], "entity_2_type": "pm0109470||pm0116152", "entity_2_type_id": 35}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s0_HPRD50.d2.s0.p0", "text": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer", "text_with_entity_marker": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the [E1]CG beta[/E1] subunit or the [E2]CG beta alpha[/E2] and FSH beta monomer", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CG beta", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "CG beta alpha", "entity_2_idx": [[117, 130]], "entity_2_idx_in_text_with_entity_marker": [130, 143], "entity_2_type": "pm0125097", "entity_2_type_id": 8}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s0_HPRD50.d2.s0.p1", "text": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer", "text_with_entity_marker": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the [E1]CG beta[/E1] subunit or the CG beta alpha and [E2]FSH beta[/E2] monomer", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CG beta", "entity_1_idx": [[94, 101]], "entity_1_idx_in_text_with_entity_marker": [98, 105], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "FSH beta", "entity_2_idx": [[135, 143]], "entity_2_idx_in_text_with_entity_marker": [148, 156], "entity_2_type": "pm0104723", "entity_2_type_id": 9}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s0_HPRD50.d2.s0.p2", "text": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the CG beta alpha and FSH beta monomer", "text_with_entity_marker": "We tested this point by cotransfecting CHO cells with the genes encoding F beta alpha and the CG beta subunit or the [E1]CG beta alpha[/E1] and [E2]FSH beta[/E2] monomer", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CG beta alpha", "entity_1_idx": [[117, 130]], "entity_1_idx_in_text_with_entity_marker": [121, 134], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "FSH beta", "entity_2_idx": [[135, 143]], "entity_2_idx_in_text_with_entity_marker": [148, 156], "entity_2_type": "pm0104723", "entity_2_type_id": 9}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s2_HPRD50.d2.s2.p0", "text": "This is relevant for the case of LH and FSH, because both are synthesized in the same cell (i.e., pituitary gonadotrophs) and several of the alpha subunit sequences required for association with either the LH beta or FSH beta subunits are different", "text_with_entity_marker": "This is relevant for the case of LH and FSH, because both are synthesized in the same cell (i.e., pituitary gonadotrophs) and several of the alpha subunit sequences required for association with either the [E1]LH beta[/E1] or [E2]FSH beta[/E2] subunits are different", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LH beta", "entity_1_idx": [[206, 213]], "entity_1_idx_in_text_with_entity_marker": [210, 217], "entity_1_type": "pm0117290", "entity_1_type_id": 10, "entity_2": "FSH beta", "entity_2_idx": [[217, 225]], "entity_2_idx_in_text_with_entity_marker": [230, 238], "entity_2_type": "pm0104723", "entity_2_type_id": 9}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s3_HPRD50.d2.s3.p0", "text": "Previously, we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, CG beta alpha and F beta alpha, respectively", "text_with_entity_marker": "Previously, we showed that the [E1]CG beta[/E1] or [E2]FSH beta[/E2] subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, CG beta alpha and F beta alpha, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CG beta", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "FSH beta", "entity_2_idx": [[42, 50]], "entity_2_idx_in_text_with_entity_marker": [55, 63], "entity_2_type": "pm0104723", "entity_2_type_id": 9}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s3_HPRD50.d2.s3.p1", "text": "Previously, we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, CG beta alpha and F beta alpha, respectively", "text_with_entity_marker": "Previously, we showed that the [E1]CG beta[/E1] or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, [E2]CG beta alpha[/E2] and F beta alpha, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CG beta", "entity_1_idx": [[31, 38]], "entity_1_idx_in_text_with_entity_marker": [35, 42], "entity_1_type": "pm0125097", "entity_1_type_id": 8, "entity_2": "CG beta alpha", "entity_2_idx": [[154, 167]], "entity_2_idx_in_text_with_entity_marker": [167, 180], "entity_2_type": "pm0125097", "entity_2_type_id": 8}], "directed": false, "reverse": false}
{"id": "HPRD50.d2.s3_HPRD50.d2.s3.p2", "text": "Previously, we showed that the CG beta or FSH beta subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, CG beta alpha and F beta alpha, respectively", "text_with_entity_marker": "Previously, we showed that the CG beta or [E1]FSH beta[/E1] subunit genes can be genetically fused to the alpha gene to produce biologically active single chains, [E2]CG beta alpha[/E2] and F beta alpha, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FSH beta", "entity_1_idx": [[42, 50]], "entity_1_idx_in_text_with_entity_marker": [46, 54], "entity_1_type": "pm0104723", "entity_1_type_id": 9, "entity_2": "CG beta alpha", "entity_2_idx": [[154, 167]], "entity_2_idx_in_text_with_entity_marker": [167, 180], "entity_2_type": "pm0125097", "entity_2_type_id": 8}], "directed": false, "reverse": false}
{"id": "IEPA.d124.s297_IEPA.d124.s297.p0", "text": "By comparison with the promoters of alpha-amylase genes, which are also induced by GA, we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a GA response complex", "text_with_entity_marker": "By comparison with the promoters of [E1]alpha-amylase[/E1] genes, which are also induced by [E2]GA[/E2], we suggest that GARE is coupled with the upstream element and the pyrimidine box to form a GA response complex", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[36, 49]], "entity_1_idx_in_text_with_entity_marker": [40, 53], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GA", "entity_2_idx": [[83, 85]], "entity_2_idx_in_text_with_entity_marker": [96, 98], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s374_IEPA.d157.s374.p0", "text": "We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the gibberellin-induced expression of alpha-amylase in the aleurone layer and the scutellar tissues", "text_with_entity_marker": "We have studied the effects of neomycin, a potent inhibitor of inositol phospholipid-specific phospholipase C (PLC), on the germination of rice seed and the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] in the aleurone layer and the scutellar tissues", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[157, 168]], "entity_1_idx_in_text_with_entity_marker": [161, 172], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[191, 204]], "entity_2_idx_in_text_with_entity_marker": [204, 217], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s375_IEPA.d157.s375.p0", "text": "It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the gibberellin-induced expression of alpha-amylase in both secretory tissues", "text_with_entity_marker": "It was shown that, in the absence of exogenous Ca2+, neomycin markedly reduced the germination speed and seedling growth of rice seeds and inhibited the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] in both secretory tissues", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[153, 164]], "entity_1_idx_in_text_with_entity_marker": [157, 168], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[187, 200]], "entity_2_idx_in_text_with_entity_marker": [200, 213], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d157.s376_IEPA.d157.s376.p0", "text": "These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the gibberellin-induced expression of alpha-amylase molecules closely related to the germination processes of rice seed", "text_with_entity_marker": "These results strongly suggest that the phosphoinositide-Ca2+ signal transduction pathway may play an important role in the [E1]gibberellin[/E1]-induced expression of [E2]alpha-amylase[/E2] molecules closely related to the germination processes of rice seed", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "gibberellin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[158, 171]], "entity_2_idx_in_text_with_entity_marker": [171, 184], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s446_IEPA.d187.s446.p0", "text": "Gibbestatin B inhibits the GA-induced expression of alpha-amylase expression in cereal seeds [In Process Citation]", "text_with_entity_marker": "Gibbestatin B inhibits the [E1]GA[/E1]-induced expression of [E2]alpha-amylase[/E2] expression in cereal seeds [In Process Citation]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[27, 29]], "entity_1_idx_in_text_with_entity_marker": [31, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[52, 65]], "entity_2_idx_in_text_with_entity_marker": [65, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s447_IEPA.d187.s447.p0", "text": "The expression of alpha-amylase in aleurone layers of barley is known to be induced by gibberellin A3 (GA).", "text_with_entity_marker": "The expression of [E1]alpha-amylase[/E1] in aleurone layers of barley is known to be induced by [E2]gibberellin A3[/E2] (GA).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "alpha-amylase", "entity_1_idx": [[18, 31]], "entity_1_idx_in_text_with_entity_marker": [22, 35], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "gibberellin A3", "entity_2_idx": [[87, 101]], "entity_2_idx_in_text_with_entity_marker": [100, 114], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s448_IEPA.d187.s448.p0", "text": "In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the GA-induced expression of alpha-amylase in barley and rice, with IC50 values of 125 and 70 microM, respectively.", "text_with_entity_marker": "In the present study, gibbestatin B (GNB) was isolated from Streptomyces sp. C-39 as an inhibitor of the [E1]GA[/E1]-induced expression of [E2]alpha-amylase[/E2] in barley and rice, with IC50 values of 125 and 70 microM, respectively.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[105, 107]], "entity_1_idx_in_text_with_entity_marker": [109, 111], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[130, 143]], "entity_2_idx_in_text_with_entity_marker": [143, 156], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s449_IEPA.d187.s449.p0", "text": "GNB suppressed accumulation of GA-induced barley high-pI type B and rice RAmylA alpha-amylase transcripts.", "text_with_entity_marker": "GNB suppressed accumulation of [E1]GA[/E1]-induced barley high-pI type B and rice RAmylA [E2]alpha-amylase[/E2] transcripts.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[31, 33]], "entity_1_idx_in_text_with_entity_marker": [35, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[80, 93]], "entity_2_idx_in_text_with_entity_marker": [93, 106], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d187.s450_IEPA.d187.s450.p0", "text": "These analyses indicate that GNB inhibits the GA-induced expression of alpha-amylase by regulating one of the steps involved in ABA signaling, but not by acting as a weak ABA analog.", "text_with_entity_marker": "These analyses indicate that GNB inhibits the [E1]GA[/E1]-induced expression of [E2]alpha-amylase[/E2] by regulating one of the steps involved in ABA signaling, but not by acting as a weak ABA analog.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GA", "entity_1_idx": [[46, 48]], "entity_1_idx_in_text_with_entity_marker": [50, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "alpha-amylase", "entity_2_idx": [[71, 84]], "entity_2_idx_in_text_with_entity_marker": [84, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s48_IEPA.d24.s48.p0", "text": "The aim of the present study was to investigate how oxytocin given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of insulin, glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms", "text_with_entity_marker": "The aim of the present study was to investigate how [E1]oxytocin[/E1] given subcutaneously (SC) and intracerebroventricularly (ICV) influences the secretion of [E2]insulin[/E2], glucagon and glucose and to investigate whether the effect on these variables of suckling in lactating rats is mediated by oxytocinergic mechanisms", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[52, 60]], "entity_1_idx_in_text_with_entity_marker": [56, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[151, 158]], "entity_2_idx_in_text_with_entity_marker": [164, 171], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s49_IEPA.d24.s49.p0", "text": "Subcutaneous injections of oxytocin increased insulin, glucagon and glucose levels significantly", "text_with_entity_marker": "Subcutaneous injections of [E1]oxytocin[/E1] increased [E2]insulin[/E2], glucagon and glucose levels significantly", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[27, 35]], "entity_1_idx_in_text_with_entity_marker": [31, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[46, 53]], "entity_2_idx_in_text_with_entity_marker": [59, 66], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s50_IEPA.d24.s50.p0", "text": "Two nanograms oxytocin given ICV had no effect on glucagon and glucose levels but caused a significant rise in insulin levels at this time point", "text_with_entity_marker": "Two nanograms [E1]oxytocin[/E1] given ICV had no effect on glucagon and glucose levels but caused a significant rise in [E2]insulin[/E2] levels at this time point", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[14, 22]], "entity_1_idx_in_text_with_entity_marker": [18, 26], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s51_IEPA.d24.s51.p5", "text": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on oxytocin-induced insulin secretion was difficult to evaluate", "text_with_entity_marker": "The oxytocin antagonist 1-deamino-2-D-Tyr-(OEt)-4-Thr-8-Orn-oxytocin administered ICV increased insulin levels itself and therefore the effect on [E1]oxytocin[/E1]-induced [E2]insulin[/E2] secretion was difficult to evaluate", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[146, 154]], "entity_1_idx_in_text_with_entity_marker": [150, 158], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[163, 170]], "entity_2_idx_in_text_with_entity_marker": [176, 183], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s52_IEPA.d24.s52.p0", "text": "Intracerebroventricular injections of 200 ng oxytocin caused a significant rise not only of insulin but also of glucagon and glucose levels", "text_with_entity_marker": "Intracerebroventricular injections of 200 ng [E1]oxytocin[/E1] caused a significant rise not only of [E2]insulin[/E2] but also of glucagon and glucose levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[45, 53]], "entity_1_idx_in_text_with_entity_marker": [49, 57], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[92, 99]], "entity_2_idx_in_text_with_entity_marker": [105, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d24.s53_IEPA.d24.s53.p0", "text": "In contrast, nanogram amounts of oxytocin administered ICV cause a rise of insulin levels", "text_with_entity_marker": "In contrast, nanogram amounts of [E1]oxytocin[/E1] administered ICV cause a rise of [E2]insulin[/E2] levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[75, 82]], "entity_2_idx_in_text_with_entity_marker": [88, 95], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s278_IEPA.d115.s278.p0", "text": "It has been suggested that insulin secretion from pancreatic islets may be  mediated in part by activation of phospholipases C (PLCs) and  phosphoinositide hydrolysis.", "text_with_entity_marker": "It has been suggested that [E1]insulin[/E1] secretion from pancreatic islets may be  mediated in part by activation of [E2]phospholipases C[/E2] (PLCs) and  phosphoinositide hydrolysis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipases C", "entity_2_idx": [[110, 126]], "entity_2_idx_in_text_with_entity_marker": [123, 139], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d115.s279_IEPA.d115.s279.p0", "text": "The purpose of this study was to determine  whether the relatively modest fuel-stimulated insulin secretion responses  of rodent beta-cell lines might be explained by inadequate expression or  activation of PLC isoforms.", "text_with_entity_marker": "The purpose of this study was to determine  whether the relatively modest fuel-stimulated [E1]insulin[/E1] secretion responses  of rodent beta-cell lines might be explained by inadequate expression or  activation of [E2]PLC[/E2] isoforms.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[207, 210]], "entity_2_idx_in_text_with_entity_marker": [220, 223], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d181.s435_IEPA.d181.s435.p0", "text": "Activity and expression of the three UCP's are stimulated by several neuromediators and hormones such as noradrenaline, tri-iodothyronine and leptin", "text_with_entity_marker": "Activity and expression of the three [E1]UCP[/E1]'s are stimulated by several neuromediators and hormones such as noradrenaline, tri-iodothyronine and [E2]leptin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP", "entity_1_idx": [[37, 40]], "entity_1_idx_in_text_with_entity_marker": [41, 44], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[142, 148]], "entity_2_idx_in_text_with_entity_marker": [155, 161], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d144.s345_IEPA.d144.s345.p0", "text": "Hypothalamic neuropeptide Y and its neuroendocrine regulation by leptin", "text_with_entity_marker": "Hypothalamic [E1]neuropeptide Y[/E1] and its neuroendocrine regulation by [E2]leptin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "neuropeptide Y", "entity_1_idx": [[13, 27]], "entity_1_idx_in_text_with_entity_marker": [17, 31], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[65, 71]], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s146_IEPA.d57.s146.p0", "text": "Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of PLC activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by insulin.", "text_with_entity_marker": "Activation of EGFR overexpressing 3T3-L1 adipocytes leads to a 3.4 +/- 1.2-fold stimulation of [E1]PLC[/E1] activity over basal levels vs. only 1.06 +/- 0.01-fold stimulation by [E2]insulin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[169, 176]], "entity_2_idx_in_text_with_entity_marker": [182, 189], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d57.s147_IEPA.d57.s147.p0", "text": "Despite the low levels of insulin-induced PLC activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "text_with_entity_marker": "Despite the low levels of [E1]insulin[/E1]-induced [E2]PLC[/E2] activity, insulin-stimulated glucose transport activity was similarly inhibited by U73122 (55.9 +/- 13.1% inhibition)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[26, 33]], "entity_1_idx_in_text_with_entity_marker": [30, 37], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PLC", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d153.s369_IEPA.d153.s369.p0", "text": "Interestingly, both 5-HT and leptin modulate the action of NPY, which may form a part of a common output pathway for the expression of appetite", "text_with_entity_marker": "Interestingly, both 5-HT and [E1]leptin[/E1] modulate the action of [E2]NPY[/E2], which may form a part of a common output pathway for the expression of appetite", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d143.s343_IEPA.d143.s343.p0", "text": "Oxytocin central injections to intact animals stimulated insulin synthesis and secretion without changing of islets area", "text_with_entity_marker": "[E1]Oxytocin[/E1] central injections to intact animals stimulated [E2]insulin[/E2] synthesis and secretion without changing of islets area", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Oxytocin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[57, 64]], "entity_2_idx_in_text_with_entity_marker": [70, 77], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d143.s344_IEPA.d143.s344.p0", "text": "Thus, oxytocin administration stimulates insulin synthesis and secretion in intact and diabetic animals and this effect is more expressed with central injections", "text_with_entity_marker": "Thus, [E1]oxytocin[/E1] administration stimulates [E2]insulin[/E2] synthesis and secretion in intact and diabetic animals and this effect is more expressed with central injections", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[41, 48]], "entity_2_idx_in_text_with_entity_marker": [54, 61], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p0", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, [E1]glycosyl-phosphatidylinositol-specific phospholipase C[/E1] (GPI-PLC), which in isolated rat adipocytes is activated by [E2]insulin[/E2], was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "glycosyl-phosphatidylinositol-specific phospholipase C", "entity_1_idx": [[13, 67]], "entity_1_idx_in_text_with_entity_marker": [17, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[128, 135]], "entity_2_idx_in_text_with_entity_marker": [141, 148], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s328_IEPA.d138.s328.p1", "text": "In addition, glycosyl-phosphatidylinositol-specific phospholipase C (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus insulin in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "text_with_entity_marker": "In addition, [E1]glycosyl-phosphatidylinositol-specific phospholipase C[/E1] (GPI-PLC), which in isolated rat adipocytes is activated by insulin, was stimulated to up to 5-fold by glucose and 10-fold by glucose plus [E2]insulin[/E2] in both yeast spheroplasts and intact cells leading to a concentration-dependent leftward shift of the glucose-response curve for activation of the GPI-PLC", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "glycosyl-phosphatidylinositol-specific phospholipase C", "entity_1_idx": [[13, 67]], "entity_1_idx_in_text_with_entity_marker": [17, 71], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[207, 214]], "entity_2_idx_in_text_with_entity_marker": [220, 227], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s329_IEPA.d138.s329.p0", "text": "GPI-PLC was most pronouncedly stimulated by authentic human insulin compared to various insulin analogues and insulin-like growth factor I", "text_with_entity_marker": "[E1]GPI-PLC[/E1] was most pronouncedly stimulated by authentic human [E2]insulin[/E2] compared to various insulin analogues and insulin-like growth factor I", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GPI-PLC", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[60, 67]], "entity_2_idx_in_text_with_entity_marker": [73, 80], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s331_IEPA.d138.s331.p0", "text": "The insulin concentrations effective in modulating PP2A, PKA, cAMP-PDE, and GPI-PLC activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation", "text_with_entity_marker": "The [E1]insulin[/E1] concentrations effective in modulating PP2A, PKA, cAMP-PDE, and [E2]GPI-PLC[/E2] activities correlate well with those required for half-saturation of the specific binding sites as well as for stimulation of protein phosphorylation and glycogen accumulation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[4, 11]], "entity_1_idx_in_text_with_entity_marker": [8, 15], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "GPI-PLC", "entity_2_idx": [[76, 83]], "entity_2_idx_in_text_with_entity_marker": [89, 96], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d138.s332_IEPA.d138.s332.p2", "text": "The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and GPI-PLC) involved in the transduction of the insulin signal from the respective receptor systems to glycogen synthase and phosphorylase", "text_with_entity_marker": "The data suggest that mammalian insulin-sensitive cells and yeast share (part of) the key regulatory mechanism (consisting of PP2A, PKA, cAMP-PDE, and [E1]GPI-PLC[/E1]) involved in the transduction of the [E2]insulin[/E2] signal from the respective receptor systems to glycogen synthase and phosphorylase", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GPI-PLC", "entity_1_idx": [[151, 158]], "entity_1_idx_in_text_with_entity_marker": [155, 162], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[196, 203]], "entity_2_idx_in_text_with_entity_marker": [209, 216], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s469_IEPA.d195.s469.p0", "text": "Leptin Rapidly Inhibits Hypothalamic Neuropeptide Y Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice", "text_with_entity_marker": "[E1]Leptin[/E1] Rapidly Inhibits Hypothalamic [E2]Neuropeptide Y[/E2] Secretion and Stimulates Corticotropin-Releasing Hormone Secretion in Adrenalectomized Mice", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "Neuropeptide Y", "entity_2_idx": [[37, 51]], "entity_2_idx_in_text_with_entity_marker": [50, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s470_IEPA.d195.s470.p0", "text": "Leptin may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as neuropeptide Y (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake", "text_with_entity_marker": "[E1]Leptin[/E1] may rapidly inhibit food intake by altering the secretion of hypothalamic neuropeptides such as [E2]neuropeptide Y[/E2] (NPY), a stimulator of food intake, and/or corticotropin-releasing hormone (CRH), an inhibitor of food intake", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Leptin", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[103, 117]], "entity_2_idx_in_text_with_entity_marker": [116, 130], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s474_IEPA.d195.s474.p0", "text": "Within 20 min after exposure to leptin, NPY secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%", "text_with_entity_marker": "Within 20 min after exposure to [E1]leptin[/E1], [E2]NPY[/E2] secretion from hypothalamic preparations obtained from adrenalectomized mice was lowered by 27% and CRH secretion was elevated by 51%", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[32, 38]], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d195.s475_IEPA.d195.s475.p0", "text": "The current study demonstrates that leptin rapidly influences the secretion of hypothalamic NPY and CRH and that these actions of leptin within the hypothalamus are restrained by the presence of endogenous corticosterone", "text_with_entity_marker": "The current study demonstrates that [E1]leptin[/E1] rapidly influences the secretion of hypothalamic [E2]NPY[/E2] and CRH and that these actions of leptin within the hypothalamus are restrained by the presence of endogenous corticosterone", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[36, 42]], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[92, 95]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d30.s62_IEPA.d30.s62.p0", "text": "The influence of myrigalone B, a flavonoid from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from cholesterol fed rabbits was investigated", "text_with_entity_marker": "The influence of myrigalone B, a [E1]flavonoid[/E1] from the fruit exudate of Myrica gale L. on Cu(2+)-induced oxidation of low density lipoprotein from [E2]cholesterol[/E2] fed rabbits was investigated", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "flavonoid", "entity_1_idx": [[33, 42]], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "cholesterol", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d111.s269_IEPA.d111.s269.p0", "text": "Plasma oxytocin, and some functionally related peptides (CCK, gastrin, somatostatin and insulin), were measured by standard radioimmunoassay techniques", "text_with_entity_marker": "Plasma [E1]oxytocin[/E1], and some functionally related peptides (CCK, gastrin, somatostatin and [E2]insulin[/E2]), were measured by standard radioimmunoassay techniques", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "oxytocin", "entity_1_idx": [[7, 15]], "entity_1_idx_in_text_with_entity_marker": [11, 19], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d11.s24_IEPA.d11.s24.p0", "text": "[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of A beta P, from 20 to 125 micrograms/ml, and phospholipase C activation was measured", "text_with_entity_marker": "[3H]Inositol prelabeled LA-N-2 cells were exposed to varying concentrations of [E1]A beta P[/E1], from 20 to 125 micrograms/ml, and [E2]phospholipase C[/E2] activation was measured", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A beta P", "entity_1_idx": [[79, 87]], "entity_1_idx_in_text_with_entity_marker": [83, 91], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[123, 138]], "entity_2_idx_in_text_with_entity_marker": [136, 151], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p0", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased [E1]leptin[/E1] signaling to the [E2]NPY[/E2] and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[69, 72]], "entity_2_idx_in_text_with_entity_marker": [82, 85], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p1", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased [E1]leptin[/E1] signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating [E2]leptin[/E2] during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[45, 51]], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[140, 146]], "entity_2_idx_in_text_with_entity_marker": [153, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d189.s453_IEPA.d189.s453.p2", "text": "These findings are consistent with increased leptin signaling to the NPY and POMC neurons in the ARC by physiological levels of circulating leptin during normal feeding", "text_with_entity_marker": "These findings are consistent with increased leptin signaling to the [E1]NPY[/E1] and POMC neurons in the ARC by physiological levels of circulating [E2]leptin[/E2] during normal feeding", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[69, 72]], "entity_1_idx_in_text_with_entity_marker": [73, 76], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[140, 146]], "entity_2_idx_in_text_with_entity_marker": [153, 159], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d147.s357_IEPA.d147.s357.p0", "text": "Ten protein kinases have been assayed for their ability to phosphorylate in vitro the recombinant bovine PrP (25-242) (rbPrP)", "text_with_entity_marker": "Ten [E1]protein kinases[/E1] have been assayed for their ability to phosphorylate in vitro the [E2]recombinant bovine PrP[/E2] (25-242) (rbPrP)", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "protein kinases", "entity_1_idx": [[4, 19]], "entity_1_idx_in_text_with_entity_marker": [8, 23], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "recombinant bovine PrP", "entity_2_idx": [[86, 108]], "entity_2_idx_in_text_with_entity_marker": [99, 121], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p0", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in [E1]leptin[/E1] action, we examined the effects of intracerebroventricular (i.c.v.) injection of [E2]leptin[/E2] with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[161, 167]], "entity_2_idx_in_text_with_entity_marker": [174, 180], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p1", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in [E1]leptin[/E1] action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial [E2]uncoupling protein-1[/E2] (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[73, 79]], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-1", "entity_2_idx": [[301, 321]], "entity_2_idx_in_text_with_entity_marker": [314, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s190_IEPA.d80.s190.p2", "text": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of leptin with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial uncoupling protein-1 (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "text_with_entity_marker": "To explore the possible roles of the hypothalamic melanocortin system in leptin action, we examined the effects of intracerebroventricular (i.c.v.) injection of [E1]leptin[/E1] with or without SHU9119, a potent antagonist of alpha-melanocyte stimulating hormone, on food intake, body weight, and mitochondrial [E2]uncoupling protein-1[/E2] (UCP-1) mRNA expression in the brown adipose tissue (BAT) in rats", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[161, 167]], "entity_1_idx_in_text_with_entity_marker": [165, 171], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein-1", "entity_2_idx": [[301, 321]], "entity_2_idx_in_text_with_entity_marker": [314, 334], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d180.s433_IEPA.d180.s433.p0", "text": "Circadian fluctuations of NPY and leptin levels maintain normal body homeostasis", "text_with_entity_marker": "Circadian fluctuations of [E1]NPY[/E1] and [E2]leptin[/E2] levels maintain normal body homeostasis", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[34, 40]], "entity_2_idx_in_text_with_entity_marker": [47, 53], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s366_IEPA.d151.s366.p0", "text": "OBJECTIVE: To determine whether hormonal status may affect neuropeptide Y (NPY), galanin, and leptin release in postmenopausal women and in young women", "text_with_entity_marker": "OBJECTIVE: To determine whether hormonal status may affect [E1]neuropeptide Y[/E1] (NPY), galanin, and [E2]leptin[/E2] release in postmenopausal women and in young women", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropeptide Y", "entity_1_idx": [[59, 73]], "entity_1_idx_in_text_with_entity_marker": [63, 77], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[94, 100]], "entity_2_idx_in_text_with_entity_marker": [107, 113], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s367_IEPA.d151.s367.p0", "text": "CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "text_with_entity_marker": "CONCLUSIONS: Our results suggest that the differences is plasma [E1]leptin[/E1], [E2]NPY[/E2], and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[64, 70]], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[72, 75]], "entity_2_idx_in_text_with_entity_marker": [85, 88], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s367_IEPA.d151.s367.p1", "text": "CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "text_with_entity_marker": "CONCLUSIONS: Our results suggest that the differences is plasma [E1]leptin[/E1], NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher [E2]NPY[/E2] levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[64, 70]], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[234, 237]], "entity_2_idx_in_text_with_entity_marker": [247, 250], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d151.s367_IEPA.d151.s367.p2", "text": "CONCLUSIONS: Our results suggest that the differences is plasma leptin, NPY, and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher NPY levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "text_with_entity_marker": "CONCLUSIONS: Our results suggest that the differences is plasma leptin, [E1]NPY[/E1], and galanin between postmenopausal women and young women may be related to body mass index rather than to differences in hormonal status and that the higher [E2]NPY[/E2] levels in both lean and obese postmenopausal women than in young women indicate that factors other than body mass index may be involved", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[72, 75]], "entity_1_idx_in_text_with_entity_marker": [76, 79], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[234, 237]], "entity_2_idx_in_text_with_entity_marker": [247, 250], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d22.s0_LLL.d22.s0.p1", "text": "sigma X also contributes to the expression of CsbB, a putative membrane-bound glucosyl transferase that is partially controlled by the sigma B stress response sigma factor.", "text_with_entity_marker": "[E1]sigma X[/E1] also contributes to the expression of [E2]CsbB[/E2], a putative membrane-bound glucosyl transferase that is partially controlled by the sigma B stress response sigma factor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma X", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "CsbB", "entity_2_idx": [[46, 50]], "entity_2_idx_in_text_with_entity_marker": [59, 63], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d22.s0_LLL.d22.s0.p2", "text": "sigma X also contributes to the expression of CsbB, a putative membrane-bound glucosyl transferase that is partially controlled by the sigma B stress response sigma factor.", "text_with_entity_marker": "sigma X also contributes to the expression of [E1]CsbB[/E1], a putative membrane-bound glucosyl transferase that is partially controlled by the [E2]sigma B[/E2] stress response sigma factor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CsbB", "entity_1_idx": [[46, 50]], "entity_1_idx_in_text_with_entity_marker": [50, 54], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma B", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s0_LLL.d27.s0.p0", "text": "DNase I footprinting showed that SpoIIID binds strongly to two sites in the cotC promoter region, binds weakly to one site in the cotX promoter, and does not bind specifically to cotB.", "text_with_entity_marker": "DNase I footprinting showed that [E1]SpoIIID[/E1] binds strongly to two sites in the [E2]cotC[/E2] promoter region, binds weakly to one site in the cotX promoter, and does not bind specifically to cotB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotC", "entity_2_idx": [[76, 80]], "entity_2_idx_in_text_with_entity_marker": [89, 93], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s0_LLL.d27.s0.p1", "text": "DNase I footprinting showed that SpoIIID binds strongly to two sites in the cotC promoter region, binds weakly to one site in the cotX promoter, and does not bind specifically to cotB.", "text_with_entity_marker": "DNase I footprinting showed that [E1]SpoIIID[/E1] binds strongly to two sites in the cotC promoter region, binds weakly to one site in the [E2]cotX[/E2] promoter, and does not bind specifically to cotB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotX", "entity_2_idx": [[130, 134]], "entity_2_idx_in_text_with_entity_marker": [143, 147], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s0_LLL.d27.s0.p2", "text": "DNase I footprinting showed that SpoIIID binds strongly to two sites in the cotC promoter region, binds weakly to one site in the cotX promoter, and does not bind specifically to cotB.", "text_with_entity_marker": "DNase I footprinting showed that [E1]SpoIIID[/E1] binds strongly to two sites in the cotC promoter region, binds weakly to one site in the cotX promoter, and does not bind specifically to [E2]cotB[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[33, 40]], "entity_1_idx_in_text_with_entity_marker": [37, 44], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotB", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p1", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the [E1]cotB[/E1], cotC, and cotX genes by final [E2]sigma(K)[/E2] RNA polymerase is activated by a small, DNA-binding protein called GerE.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotB", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(K)", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p2", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the cotB, [E1]cotC[/E1], and cotX genes by final [E2]sigma(K)[/E2] RNA polymerase is activated by a small, DNA-binding protein called GerE.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotC", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(K)", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p3", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the cotB, cotC, and [E1]cotX[/E1] genes by final [E2]sigma(K)[/E2] RNA polymerase is activated by a small, DNA-binding protein called GerE.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotX", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(K)", "entity_2_idx": [[57, 65]], "entity_2_idx_in_text_with_entity_marker": [70, 78], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p4", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the [E1]cotB[/E1], cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called [E2]GerE[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotB", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "GerE", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p5", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the cotB, [E1]cotC[/E1], and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called [E2]GerE[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotC", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "GerE", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s1_LLL.d27.s1.p6", "text": "Transcription of the cotB, cotC, and cotX genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called GerE.", "text_with_entity_marker": "Transcription of the cotB, cotC, and [E1]cotX[/E1] genes by final sigma(K) RNA polymerase is activated by a small, DNA-binding protein called [E2]GerE[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotX", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "GerE", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s2_LLL.d27.s2.p1", "text": "In vitro transcription experiments suggest that the differential pattern of cot gene expression results from the combined action of GerE and another transcription factor, SpoIIID.", "text_with_entity_marker": "In vitro transcription experiments suggest that the differential pattern of [E1]cot[/E1] gene expression results from the combined action of [E2]GerE[/E2] and another transcription factor, SpoIIID.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cot", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "GerE", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s2_LLL.d27.s2.p2", "text": "In vitro transcription experiments suggest that the differential pattern of cot gene expression results from the combined action of GerE and another transcription factor, SpoIIID.", "text_with_entity_marker": "In vitro transcription experiments suggest that the differential pattern of [E1]cot[/E1] gene expression results from the combined action of GerE and another transcription factor, [E2]SpoIIID[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cot", "entity_1_idx": [[76, 79]], "entity_1_idx_in_text_with_entity_marker": [80, 83], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SpoIIID", "entity_2_idx": [[171, 178]], "entity_2_idx_in_text_with_entity_marker": [184, 191], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d27.s3_LLL.d27.s3.p0", "text": "A low concentration of GerE activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "text_with_entity_marker": "A low concentration of [E1]GerE[/E1] activated cotB transcription by final [E2]sigma(K)[/E2] RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigma(K)", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d27.s3_LLL.d27.s3.p1", "text": "A low concentration of GerE activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "text_with_entity_marker": "A low concentration of [E1]GerE[/E1] activated [E2]cotB[/E2] transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotB", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s3_LLL.d27.s3.p2", "text": "A low concentration of GerE activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "text_with_entity_marker": "A low concentration of [E1]GerE[/E1] activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of [E2]cotX[/E2] or cotC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotX", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [175, 179], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s3_LLL.d27.s3.p3", "text": "A low concentration of GerE activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "text_with_entity_marker": "A low concentration of [E1]GerE[/E1] activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or [E2]cotC[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotC", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s3_LLL.d27.s3.p4", "text": "A low concentration of GerE activated cotB transcription by final sigma(K) RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "text_with_entity_marker": "A low concentration of GerE activated [E1]cotB[/E1] transcription by final [E2]sigma(K)[/E2] RNA polymerase, whereas a higher concentration was needed to activate transcription of cotX or cotC.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cotB", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(K)", "entity_2_idx": [[66, 74]], "entity_2_idx_in_text_with_entity_marker": [79, 87], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d27.s4_LLL.d27.s4.p0", "text": "SpoIIID at low concentration repressed cotC transcription, whereas a higher concentration only partially repressed cotX transcription and had little effect on cotB transcription.", "text_with_entity_marker": "[E1]SpoIIID[/E1] at low concentration repressed [E2]cotC[/E2] transcription, whereas a higher concentration only partially repressed cotX transcription and had little effect on cotB transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotC", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s4_LLL.d27.s4.p1", "text": "SpoIIID at low concentration repressed cotC transcription, whereas a higher concentration only partially repressed cotX transcription and had little effect on cotB transcription.", "text_with_entity_marker": "[E1]SpoIIID[/E1] at low concentration repressed cotC transcription, whereas a higher concentration only partially repressed [E2]cotX[/E2] transcription and had little effect on cotB transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotX", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d27.s4_LLL.d27.s4.p2", "text": "SpoIIID at low concentration repressed cotC transcription, whereas a higher concentration only partially repressed cotX transcription and had little effect on cotB transcription.", "text_with_entity_marker": "[E1]SpoIIID[/E1] at low concentration repressed cotC transcription, whereas a higher concentration only partially repressed cotX transcription and had little effect on [E2]cotB[/E2] transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SpoIIID", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "cotB", "entity_2_idx": [[159, 163]], "entity_2_idx_in_text_with_entity_marker": [172, 176], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d29.s0_LLL.d29.s0.p0", "text": "A sigmaW-dependent promoter (PW) precedes sigW, demonstrating that this transcription factor is positively autoregulated.", "text_with_entity_marker": "A [E1]sigmaW[/E1]-dependent promoter (PW) precedes [E2]sigW[/E2], demonstrating that this transcription factor is positively autoregulated.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigmaW", "entity_1_idx": [[2, 8]], "entity_1_idx_in_text_with_entity_marker": [6, 12], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "sigW", "entity_2_idx": [[42, 46]], "entity_2_idx_in_text_with_entity_marker": [55, 59], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d20.s0_LLL.d20.s0.p0", "text": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "text_with_entity_marker": "[E1]ComK[/E1] negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the [E2]FlgM[/E2] antisigma factor that inhibits sigmaD activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "FlgM", "entity_2_idx": [[138, 142]], "entity_2_idx_in_text_with_entity_marker": [151, 155], "entity_2_type": "agent/target", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "LLL.d20.s0_LLL.d20.s0.p1", "text": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "text_with_entity_marker": "[E1]ComK[/E1] negatively controls the transcription of [E2]hag[/E2] by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "hag", "entity_2_idx": [[46, 49]], "entity_2_idx_in_text_with_entity_marker": [59, 62], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d20.s0_LLL.d20.s0.p2", "text": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "text_with_entity_marker": "[E1]ComK[/E1] negatively controls the transcription of hag by stimulating the transcription of [E2]comF[/E2]-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "comF", "entity_2_idx": [[86, 90]], "entity_2_idx_in_text_with_entity_marker": [99, 103], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d20.s0_LLL.d20.s0.p3", "text": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "text_with_entity_marker": "[E1]ComK[/E1] negatively controls the transcription of hag by stimulating the transcription of comF-[E2]flgM[/E2], thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ComK", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "flgM", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d20.s0_LLL.d20.s0.p8", "text": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the FlgM antisigma factor that inhibits sigmaD activity.", "text_with_entity_marker": "ComK negatively controls the transcription of hag by stimulating the transcription of comF-flgM, thereby increasing the production of the [E1]FlgM[/E1] antisigma factor that inhibits [E2]sigmaD[/E2] activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FlgM", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "agent/target", "entity_1_type_id": 2, "entity_2": "sigmaD", "entity_2_idx": [[174, 180]], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
